|
G
|
Bdnf
|
brain derived neurotrophic factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 PMID:22344221 |
|
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
|
|
G
|
Cdkal1
|
CDKAL1 threonylcarbamoyladenosine tRNA methylthiotransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 PMID:22344221 |
|
NCBI chrNW_004936552:5,903,042...6,347,498
Ensembl chrNW_004936552:5,833,409...6,347,017
|
|
G
|
Fto
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 PMID:22344221 |
|
NCBI chrNW_004936475:6,321,725...6,689,410
Ensembl chrNW_004936475:6,321,711...6,689,588
|
|
G
|
Gipr
|
gastric inhibitory polypeptide receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344221 |
|
NCBI chrNW_004936706:2,052,069...2,062,722
Ensembl chrNW_004936706:2,053,433...2,061,241
|
|
G
|
Gp2
|
glycoprotein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 |
|
NCBI chrNW_004936501:5,816,629...5,828,470
|
|
G
|
Hrc
|
histidine rich calcium binding protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17030629 |
|
NCBI chrNW_004936664:3,088,072...3,092,034
Ensembl chrNW_004936664:3,083,602...3,092,308
|
|
G
|
Klf9
|
KLF transcription factor 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344221 |
|
NCBI chrNW_004936503:6,517,748...6,553,532
Ensembl chrNW_004936503:6,517,687...6,548,336
|
|
G
|
LOC101968793
|
glucosamine-6-phosphate isomerase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 |
|
NCBI chrNW_004936482:11,382,358...11,423,823
Ensembl chrNW_004936482:11,397,322...11,423,885 Ensembl chrNW_004936482:11,397,322...11,423,885
|
|
G
|
Map2k5
|
mitogen-activated protein kinase kinase 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 |
|
NCBI chrNW_004936471:27,491,255...27,728,572
Ensembl chrNW_004936471:27,491,342...27,728,607
|
|
G
|
Mc4r
|
melanocortin 4 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 PMID:22344221 |
|
NCBI chrNW_004936497:4,636,370...4,638,205
Ensembl chrNW_004936497:4,636,758...4,637,759
|
|
G
|
Pcsk1
|
proprotein convertase subtilisin/kexin type 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 |
|
NCBI chrNW_004936523:7,009,966...7,050,300
Ensembl chrNW_004936523:7,010,068...7,050,468
|
|
G
|
Pomc
|
proopiomelanocortin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:1316127 |
|
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
G
|
Ptn
|
pleiotrophin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:36566969 |
|
NCBI chrNW_004936592:1,706,979...1,806,345
Ensembl chrNW_004936592:1,707,693...1,730,617
|
|
G
|
Sec16b
|
SEC16 homolog B, endoplasmic reticulum export factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 PMID:22344221 |
|
NCBI chrNW_004936481:10,782,988...10,821,204
Ensembl chrNW_004936481:10,783,054...10,821,206
|
|
G
|
Tfap2b
|
transcription factor AP-2 beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22344219 |
|
NCBI chrNW_004936476:9,855,992...9,884,788
Ensembl chrNW_004936476:9,857,773...9,884,784
|
|
G
|
Wrap53
|
WD repeat containing antisense to TP53
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31243981 |
|
NCBI chrNW_004936595:936,184...952,784
Ensembl chrNW_004936595:936,487...952,791
|
|
|
G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15199296 |
|
NCBI chrNW_004936557:3,358,809...3,403,461
Ensembl chrNW_004936557:3,357,016...3,403,714
|
|
G
|
LOC101972957
|
vitamin D 25-hydroxylase
|
|
ISO
|
DNA:SNP:CDS: rs12794714 (human)
|
RGD |
PMID:34906413 |
RGD:401900724 |
NCBI chrNW_004936528:3,881,630...3,897,613
Ensembl chrNW_004936528:3,881,087...3,900,302
|
|
|
G
|
Ctf1
|
cardiotrophin 1
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936501:13,286,821...13,291,280
|
|
G
|
Gucy2c
|
guanylate cyclase 2C
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936587:2,742,911...2,811,139
Ensembl chrNW_004936587:2,742,911...2,810,969
|
|
G
|
Lep
|
leptin
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Neil1
|
nei like DNA glycosylase 1
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936471:34,184,273...34,192,675
Ensembl chrNW_004936471:34,186,729...34,192,501
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15309680 |
|
NCBI chrNW_004936629:3,672,445...3,725,645
Ensembl chrNW_004936629:3,672,460...3,725,626
|
|
G
|
Pparg
|
peroxisome proliferator activated receptor gamma
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
|
ISO
|
mRNA:increased expression:gastrocnemius muscle (rat)
|
RGD |
PMID:23320128 |
RGD:7241841 |
NCBI chrNW_004936477:4,881,230...5,488,208
Ensembl chrNW_004936477:5,199,881...5,488,226
|
|
G
|
Prkci
|
protein kinase C iota
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936593:2,170,539...2,236,904
Ensembl chrNW_004936593:2,170,808...2,236,673
|
|
G
|
Sirt3
|
sirtuin 3
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936888:63,131...78,536
Ensembl chrNW_004936888:63,546...77,950
|
|
G
|
Slc2a9
|
solute carrier family 2 member 9
|
|
ISO
|
|
MouseDO |
|
|
NCBI chrNW_004936477:16,700,915...16,836,424
Ensembl chrNW_004936477:16,717,002...16,834,663
|
|
|
G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
|
ISO
|
protein:increased oxidation:cardiac muscle cell
|
RGD |
PMID:23997093 |
RGD:13782087 |
NCBI chrNW_004936558:3,300,941...3,357,595
Ensembl chrNW_004936558:3,300,941...3,357,941
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
ISO
|
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G
|
Bcl2
|
BCL2 apoptosis regulator
|
treatment
|
ISO
|
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G
|
Fadd
|
Fas associated via death domain
|
treatment
|
ISO
|
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chrNW_004936599:633,501...639,412
Ensembl chrNW_004936599:633,330...639,456
|
|
G
|
Fas
|
Fas cell surface death receptor
|
|
ISO
|
|
RGD |
PMID:30172001 |
RGD:13792561 |
NCBI chrNW_004936735:209,369...234,582
|
|
G
|
Lep
|
leptin
|
|
ISO
|
OMIM:605552
|
MouseDO |
|
|
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Lpl
|
lipoprotein lipase
|
treatment
|
ISO
|
|
RGD |
PMID:26996629 |
RGD:13794382 |
NCBI chrNW_004936555:4,084,099...4,108,219
Ensembl chrNW_004936555:4,084,099...4,108,365
|
|
G
|
Mttp
|
microsomal triglyceride transfer protein
|
|
ISO
|
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 1
|
ClinVar |
PMID:8533758 PMID:9671739 PMID:16721486 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936520:3,337,726...3,417,818
Ensembl chrNW_004936520:3,338,881...3,381,627
|
|
G
|
Tlr2
|
toll like receptor 2
|
susceptibility
|
ISO
|
|
RGD |
PMID:19841034 |
RGD:15090861 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G
|
Tp53inp1
|
tumor protein p53 inducible nuclear protein 1
|
|
ISO
|
OMIM:605552
|
MouseDO |
|
|
NCBI chrNW_004936544:7,882,710...7,891,668
Ensembl chrNW_004936544:7,881,102...7,891,463
|
|
|
G
|
Ahdc1
|
AT-hook DNA binding motif containing 1
|
|
ISO
|
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3
|
ClinVar |
PMID:25741868 PMID:29696776 PMID:33644933 |
|
NCBI chrNW_004936474:11,824,692...11,846,355
Ensembl chrNW_004936474:11,824,697...11,876,817
|
|
G
|
Dyrk1b
|
dual specificity tyrosine phosphorylation regulated kinase 1B
|
|
ISO
|
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3 | ClinVar Annotator: match by term: CENTRAL OBESITY, TYPE 2 DIABETES, HYPERTENSION, AND EARLY-ONSET CORONARY ARTERY DISEASE | ClinVar Annotator: match by term: DYRK1B-related condition
|
OMIM ClinVar |
PMID:9536098 PMID:17576681 PMID:24827035 PMID:25741868 PMID:28492532 PMID:32041611 More...
|
|
NCBI chrNW_004936661:2,436,702...2,444,758
Ensembl chrNW_004936661:2,433,483...2,444,752
|
|
|
G
|
Adcy5
|
adenylate cyclase 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23202124 |
|
NCBI chrNW_004936725:1,751,272...1,897,937
Ensembl chrNW_004936725:1,751,266...1,897,946
|
|
G
|
Adrb1
|
adrenoceptor beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23202124 |
|
NCBI chrNW_004936486:4,400,467...4,401,588
Ensembl chrNW_004936486:4,399,915...4,403,149
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27592400 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G
|
As3mt
|
arsenite methyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26928318 |
|
NCBI chrNW_004936600:3,050,946...3,069,786
Ensembl chrNW_004936600:3,051,129...3,069,690
|
|
G
|
Cdkal1
|
CDKAL1 threonylcarbamoyladenosine tRNA methylthiotransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23202124 |
|
NCBI chrNW_004936552:5,903,042...6,347,498
Ensembl chrNW_004936552:5,833,409...6,347,017
|
|
G
|
Dhrs9
|
dehydrogenase/reductase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34200176 |
|
NCBI chrNW_004936469:10,465,701...10,487,534
Ensembl chrNW_004936469:10,465,701...10,487,534
|
|
G
|
Dlx5
|
distal-less homeobox 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31082282 |
|
NCBI chrNW_004936585:3,462,063...3,466,641
Ensembl chrNW_004936585:3,461,944...3,466,641
|
|
G
|
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23866971 |
|
NCBI chrNW_004936470:26,994,549...27,099,758
Ensembl chrNW_004936470:26,994,215...27,100,999
|
|
G
|
Hfe
|
homeostatic iron regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20659343 |
|
NCBI chrNW_004936671:1,940,079...1,947,574
Ensembl chrNW_004936671:1,940,101...1,947,580
|
|
G
|
Hmga2
|
high mobility group AT-hook 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23202124 |
|
NCBI chrNW_004936545:3,944,419...3,958,289
Ensembl chrNW_004936545:3,944,419...4,064,193
|
|
G
|
Lcorl
|
ligand dependent nuclear receptor corepressor like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23202124 |
|
NCBI chrNW_004936477:10,257,924...10,408,000
Ensembl chrNW_004936477:10,257,913...10,408,000
|
|
G
|
LOC101969148
|
cytochrome P450 1A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27592400 |
|
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G
|
Ndn
|
necdin, MAGE family member
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31082282 |
|
NCBI chrNW_004936805:849,218...850,894
Ensembl chrNW_004936805:849,345...850,322
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:39038764 |
|
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G
|
Pon1
|
paraoxonase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17237730 |
|
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
|
|
G
|
Xrcc1
|
X-ray repair cross complementing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27592400 |
|
NCBI chrNW_004936706:752,571...783,746
Ensembl chrNW_004936706:751,108...783,777
|
|
|
G
|
Lep
|
leptin
|
|
ISO
|
|
RGD |
PMID:21328617 |
RGD:5128513 |
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
|
G
|
Phf6
|
PHD finger protein 6
|
|
ISO
|
ClinVar Annotator: match by term: Borjeson-Forssman-Lehmann syndrome | ClinVar Annotator: match by term: MENTAL RETARDATION, X-LINKED, SYNDROMIC, BORJESON-FORSSMAN-LEHMANN TYPE | ClinVar Annotator: match by term: Mental deficiency, epilepsy and endocrine disorders | ClinVar Annotator: match by term: PHF6-related condition
|
OMIM ClinVar |
PMID:12415272 PMID:13871358 PMID:15241480 PMID:15466013 PMID:15580208 PMID:15994862 PMID:18414213 PMID:23906836 PMID:24092917 PMID:24728327 PMID:25099957 PMID:25741868 PMID:25741869 PMID:26467025 PMID:26648834 PMID:27633282 PMID:27698851 PMID:28492532 PMID:28539120 PMID:28554332 PMID:30403997 PMID:30630810 PMID:33772537 PMID:34041787 PMID:35662002 PMID:36008597 PMID:36999477 More...
|
|
NCBI chrNW_004936691:716,723...767,960
Ensembl chrNW_004936691:716,697...768,016
|
|
|
G
|
Atp2a1
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
|
|
ISO
|
associated with hepatocellular carcinoma
|
RGD |
PMID:23200745 |
RGD:13782066 |
NCBI chrNW_004936501:11,818,301...11,836,221
Ensembl chrNW_004936501:11,816,585...11,836,231
|
|
G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
|
ISO
|
associated with hepatocellular carcinoma
|
RGD |
PMID:23200745 |
RGD:13782066 |
NCBI chrNW_004936558:3,300,941...3,357,595
Ensembl chrNW_004936558:3,300,941...3,357,941
|
|
G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
ISO
|
associated with gastrointestinal system cancer;mRNA,protein:increased expression:subcutaneous adipose tissue:
|
RGD |
PMID:21245862 |
RGD:153350145 |
NCBI chrNW_004936543:105,983...113,475
Ensembl chrNW_004936543:105,956...114,190
|
|
G
|
Bard1
|
BRCA1 associated RING domain 1
|
|
ISO
|
associated with Carcinoma, Hepatocellular;protein:increased expression:skeletal muscle
|
RGD |
PMID:16685375 |
RGD:2315732 |
NCBI chrNW_004936586:2,200,211...2,272,781
Ensembl chrNW_004936586:2,200,205...2,273,307
|
|
G
|
Cd27
|
CD27 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17878525 |
|
NCBI chrNW_004936709:1,312,434...1,317,592
Ensembl chrNW_004936709:1,312,448...1,317,378
|
|
G
|
Cdh6
|
cadherin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17878525 |
|
NCBI chrNW_004936518:9,280,194...9,403,320
Ensembl chrNW_004936518:9,283,459...9,334,722
|
|
G
|
Coq7
|
coenzyme Q7, hydroxylase
|
susceptibility
|
ISO
|
|
RGD |
PMID:23166727 |
RGD:10402105 |
NCBI chrNW_004936501:5,035,986...5,043,864
Ensembl chrNW_004936501:5,034,224...5,043,909
|
|
G
|
Ddx42
|
DEAD-box helicase 42
|
|
ISO
|
associated with Malnutrition;mRNA:increased expression:gastrocnemius muscle (mouse) associated with Diabetes Mellitus, Experimental;mRNA:increased expression:gastrocnemius muscle (rat)
|
RGD |
PMID:14718385 |
RGD:1641826 |
NCBI chrNW_004936541:4,418,743...4,462,513
Ensembl chrNW_004936541:4,429,657...4,465,099
|
|
G
|
Gdf15
|
growth differentiation factor 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30782979 |
|
NCBI chrNW_004936596:2,854,620...2,857,018
Ensembl chrNW_004936596:2,854,841...2,857,111
|
|
G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
RGD CTD |
PMID:12576449 PMID:17347304 |
RGD:7242556 |
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G
|
Igf1
|
insulin like growth factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30782979 |
|
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
associated with Inflammation
|
RGD |
PMID:15005009 |
RGD:1626680 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
associated with Inflammation
|
RGD |
PMID:15005009 |
RGD:1626680 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G
|
Il6
|
interleukin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with Leukemia, T-Cell;protein:increased activity:plasma (rat)
|
CTD RGD |
PMID:9110147 PMID:17878525 |
RGD:11062106 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G
|
Jak2
|
Janus kinase 2
|
treatment
|
ISO
|
associated with colon adenocarcinoma
|
RGD |
PMID:28489606 |
RGD:127285673 |
NCBI chrNW_004936503:111,722...243,627
Ensembl chrNW_004936503:110,963...241,867
|
|
G
|
LOC101964975
|
interleukin-8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17878525 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
G
|
Lpin1
|
lipin 1
|
|
ISO
|
associated with Carcinoma, Hepatocellular;mRNA:increased expression:skeletal muscle
|
RGD |
PMID:14718385 |
RGD:1641826 |
NCBI chrNW_004936532:7,596,279...7,654,139
Ensembl chrNW_004936532:7,605,965...7,652,573
|
|
G
|
Lta
|
lymphotoxin alpha
|
susceptibility
|
ISO
|
associated with Breast Neoplasms;DNA:polymorphism:intron:252G>A (human)
|
RGD |
PMID:18953879 |
RGD:8548798 |
NCBI chrNW_004936727:1,940,081...1,941,022
Ensembl chrNW_004936727:1,940,081...1,941,022
|
|
G
|
Map3k7
|
mitogen-activated protein kinase kinase kinase 7
|
treatment
|
ISO
|
associated with Pulmonary Arterial Hypertension
|
RGD |
PMID:30554141 |
RGD:155791671 |
NCBI chrNW_004936510:1,772,971...1,836,075
Ensembl chrNW_004936510:1,772,971...1,837,765
|
|
G
|
Mc4r
|
melanocortin 4 receptor
|
|
ISO
|
associated with Myocardial Infarction
|
RGD |
PMID:20371568 |
RGD:6484229 |
NCBI chrNW_004936497:4,636,370...4,638,205
Ensembl chrNW_004936497:4,636,758...4,637,759
|
|
G
|
Mefv
|
MEFV innate immunity regulator, pyrin
|
|
ISO
|
ClinVar Annotator: match by term: Cachexia
|
ClinVar |
PMID:9668175 PMID:10090880 PMID:10612841 PMID:10787450 PMID:10842288 PMID:11464238 PMID:11977178 PMID:15018633 PMID:15024744 PMID:16730661 PMID:17489852 PMID:19253030 PMID:19934083 PMID:20041150 PMID:20534143 PMID:21153919 PMID:21246368 PMID:21413889 PMID:21978701 PMID:22614345 PMID:22903357 PMID:23505242 PMID:23588594 PMID:23907647 PMID:23981758 PMID:24251727 PMID:24469716 PMID:24929125 PMID:25615955 PMID:25741868 PMID:26078663 PMID:28492532 PMID:29047407 PMID:29543225 PMID:29599418 PMID:31989427 PMID:32312770 PMID:32853466 PMID:33733382 PMID:34426522 PMID:35098403 More...
|
|
NCBI chrNW_004936694:970,706...980,605
|
|
G
|
Mstn
|
myostatin
|
|
ISO
|
associated with Carcinoma, Hepatocellular;mRNA:increased expression:skeletal muscle
|
RGD |
PMID:18578694 |
RGD:2303552 |
NCBI chrNW_004936506:7,988,879...7,996,260
Ensembl chrNW_004936506:7,988,718...7,996,971
|
|
G
|
Myd88
|
MYD88 innate immune signal transduction adaptor
|
ameliorates
|
ISO
|
associated with Carcinoma, Lewis Lung
|
RGD |
PMID:31138662 |
RGD:150530282 |
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G
|
Parl
|
presenilin associated rhomboid like
|
|
ISO
|
|
RGD |
PMID:16839884 |
RGD:12902627 |
NCBI chrNW_004936578:5,945,765...5,992,972
Ensembl chrNW_004936578:5,945,635...5,993,143
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
|
ISO
|
associated with Pulmonary Disease, Chronic Obstructive (COPD, MeSH:D029424); RNA:decreased expression:skeletal muscle
|
RGD |
PMID:17459894 |
RGD:5683621 |
NCBI chrNW_004936629:3,672,445...3,725,645
Ensembl chrNW_004936629:3,672,460...3,725,626
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17878525 |
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G
|
Pthlh
|
parathyroid hormone like hormone
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17878525 |
|
NCBI chrNW_004936760:197,525...209,212
Ensembl chrNW_004936760:197,525...209,518
|
|
G
|
Slc25a4
|
solute carrier family 25 member 4
|
|
ISO
|
associated with hepatocellular carcinoma
|
RGD |
PMID:23200745 |
RGD:13782066 |
NCBI chrNW_004936554:4,130,461...4,135,046
Ensembl chrNW_004936554:4,130,459...4,135,044
|
|
G
|
Tfam
|
transcription factor A, mitochondrial
|
|
ISO
|
associated with Pulmonary Disease, Chronic Obstructive (COPD, MeSH:D029424); RNA, protein:decreased expression:skeletal muscle
|
RGD |
PMID:17459894 |
RGD:5683621 |
NCBI chrNW_004936614:4,595,973...4,605,040
Ensembl chrNW_004936614:4,596,617...4,605,104
|
|
G
|
Tgfb1
|
transforming growth factor beta 1
|
|
ISO
|
|
RGD |
PMID:2054795 |
RGD:7394820 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with hepatocellular carcinoma;mRNA:altered expression:skeletal muscle tissue, adipose tissue (rat)
|
CTD RGD |
PMID:16077938 PMID:17878525 |
RGD:1624190 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
ISO
|
CTD Direct Evidence: therapeutic associated with Carcinoma, Hepatocellular;protein, mRNA:increased expression:skeletal muscle, adipose tissue
|
CTD RGD |
PMID:16077938 PMID:18801959 |
RGD:1624190 |
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
|
|
G
|
Zfp36
|
ZFP36 ring finger protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12756304 PMID:15944294 |
|
NCBI chrNW_004936661:2,251,148...2,253,527
Ensembl chrNW_004936661:2,250,665...2,253,787
|
|
|
G
|
Aff4
|
ALF transcription elongation factor 4
|
|
ISO
|
ClinVar Annotator: match by term: AFF4-related condition | ClinVar Annotator: match by term: Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome
|
OMIM ClinVar |
PMID:9536098 PMID:17576681 PMID:25730767 PMID:25741868 PMID:28492532 PMID:29758562 PMID:31058441 PMID:34782754 More...
|
|
NCBI chrNW_004936647:2,242,476...2,342,409
Ensembl chrNW_004936647:2,242,319...2,336,532
|
|
|
G
|
Rnf135
|
ring finger protein 135
|
|
ISO
|
ClinVar Annotator: match by term: Chromosome 17q11.2 deletion syndrome, 1.4Mb | ClinVar Annotator: match by term: Macrocephaly, macrosomia, facial dysmorphism syndrome
|
ClinVar |
PMID:17632510 PMID:21681106 PMID:25741868 PMID:27535533 PMID:28135719 PMID:30665703 PMID:30763456 More...
|
|
NCBI chrNW_004936538:2,741,308...2,757,042
Ensembl chrNW_004936538:2,741,220...2,757,240
|
|
|
G
|
Nsdhl
|
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
|
|
ISO
|
ClinVar Annotator: match by term: CK syndrome | ClinVar Annotator: match by term: MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICAL MALFORMATION
|
OMIM ClinVar |
PMID:18414213 PMID:19377476 PMID:21129721 PMID:21290788 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936714:246,574...273,930
Ensembl chrNW_004936714:246,551...273,912
|
|
|
G
|
Trip12
|
thyroid hormone receptor interactor 12
|
|
ISO
|
ClinVar Annotator: match by term: Clark-Baraitser syndrome | ClinVar Annotator: match by term: TRIP12-related condition
|
OMIM ClinVar |
PMID:3812552 PMID:25363768 PMID:25741868 PMID:27848077 PMID:28251352 PMID:28492532 PMID:28660352 PMID:29758562 PMID:31814248 More...
|
|
NCBI chrNW_004936525:6,539,234...6,690,457
Ensembl chrNW_004936525:6,539,191...6,690,457
|
|
|
G
|
Ankrd46
|
ankyrin repeat domain 46
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:42,755,799...42,782,479
|
|
G
|
Atp6v1c1
|
ATPase H+ transporting V1 subunit C1
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,626,523...40,675,435
Ensembl chrNW_004936470:40,623,553...40,675,598
|
|
G
|
Azin1
|
antizyme inhibitor 1
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,801,943...40,832,543
Ensembl chrNW_004936470:40,801,943...40,834,003
|
|
G
|
Baalc
|
BAALC binder of MAP3K1 and KLF4
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,506,596...40,590,537
Ensembl chrNW_004936470:40,508,338...40,579,585
|
|
G
|
Cthrc1
|
collagen triple helix repeat containing 1
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,381,215...40,392,105
Ensembl chrNW_004936470:40,377,835...40,392,225
|
|
G
|
Dcaf13
|
DDB1 and CUL4 associated factor 13
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,321,103...40,357,001
Ensembl chrNW_004936470:40,320,073...40,356,993
|
|
G
|
Dcstamp
|
dendrocyte expressed seven transmembrane protein
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:39,664,573...39,671,532
Ensembl chrNW_004936470:39,664,511...39,671,532
|
|
G
|
Dpys
|
dihydropyrimidinase
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:39,564,431...39,637,394
Ensembl chrNW_004936470:39,564,335...39,637,544
|
|
G
|
Fbxo43
|
F-box protein 43
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:43,091,516...43,100,973
Ensembl chrNW_004936470:43,088,714...43,100,973
|
|
G
|
Fzd6
|
frizzled class receptor 6
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,416,254...40,454,717
Ensembl chrNW_004936470:40,416,014...40,454,062
|
|
G
|
Grhl2
|
grainyhead like transcription factor 2
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:41,856,683...41,961,666
Ensembl chrNW_004936470:41,859,035...42,002,844
|
|
G
|
Kcns2
|
potassium voltage-gated channel modifier subfamily S member 2
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chrNW_004936470:44,455,117...44,460,193
Ensembl chrNW_004936470:44,456,526...44,460,327
|
|
G
|
Klf10
|
KLF transcription factor 10
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,980,487...40,986,880
Ensembl chrNW_004936470:40,980,487...40,986,885
|
|
G
|
LOC101970194
|
cytochrome c oxidase subunit 6C
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:43,269,744...43,280,886
Ensembl chrNW_004936470:43,269,711...43,283,683
|
|
G
|
Lrp12
|
LDL receptor related protein 12
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:39,459,395...39,542,125
Ensembl chrNW_004936470:39,459,002...39,544,577
|
|
G
|
Myo7a
|
myosin VIIA
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:9382091 PMID:24033266 PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004936498:5,758,572...5,824,526
Ensembl chrNW_004936498:5,751,779...5,824,378
|
|
G
|
Ncald
|
neurocalcin delta
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:41,573,238...41,852,349
Ensembl chrNW_004936470:41,573,238...41,852,337
|
|
G
|
Nipal2
|
NIPA like domain containing 2
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:44,588,211...44,645,860
Ensembl chrNW_004936470:44,588,168...44,646,651
|
|
G
|
Odf1
|
outer dense fiber of sperm tails 1
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:41,069,033...41,078,020
Ensembl chrNW_004936470:41,069,033...41,078,020
|
|
G
|
Osr2
|
odd-skipped related transciption factor 2
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chrNW_004936470:44,024,497...44,032,429
Ensembl chrNW_004936470:44,024,439...44,032,429
|
|
G
|
Pabpc1
|
poly(A) binding protein cytoplasmic 1
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:42,628,890...42,670,311
Ensembl chrNW_004936470:42,628,667...42,643,347
|
|
G
|
Polr2k
|
RNA polymerase II, I and III subunit K
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:43,079,377...43,083,251
Ensembl chrNW_004936470:43,081,284...43,083,236
|
|
G
|
Pop1
|
POP1 homolog, ribonuclease P/MRP subunit
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:44,676,798...44,710,397
Ensembl chrNW_004936470:44,676,776...44,710,716
|
|
G
|
Rgs22
|
regulator of G protein signaling 22
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:43,135,410...43,225,788
Ensembl chrNW_004936470:43,122,822...43,219,279
|
|
G
|
Rims2
|
regulating synaptic membrane exocytosis 2
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:39,725,092...40,270,268
Ensembl chrNW_004936470:39,723,091...40,270,267
|
|
G
|
Rnf19a
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:42,965,790...43,007,487
Ensembl chrNW_004936470:42,965,284...43,007,487
|
|
G
|
Rrm2b
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:41,354,387...41,401,308
Ensembl chrNW_004936470:41,354,287...41,401,317
|
|
G
|
Slc25a32
|
solute carrier family 25 member 32
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:40,357,066...40,370,514
Ensembl chrNW_004936470:40,357,446...40,370,514
|
|
G
|
Snx31
|
sorting nexin 31
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:42,684,346...42,743,001
Ensembl chrNW_004936470:42,684,346...42,742,092
|
|
G
|
Spag1
|
sperm associated antigen 1
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome | ClinVar Annotator: match by term: VPS13B-related condition
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936470:43,015,688...43,078,158
Ensembl chrNW_004936470:43,016,575...43,075,239
|
|
G
|
Stk3
|
serine/threonine kinase 3
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:15141358 PMID:16648375 PMID:20461111 PMID:28492532 |
|
NCBI chrNW_004936470:44,159,449...44,436,295
Ensembl chrNW_004936470:44,159,419...44,436,330
|
|
G
|
Ubr5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:41,222,782...41,345,755
Ensembl chrNW_004936470:41,252,951...41,344,134
|
|
G
|
Vps13b
|
vacuolar protein sorting 13 homolog B
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome | ClinVar Annotator: match by term: PEPPER SYNDROME | ClinVar Annotator: match by term: Pepper syndrome | ClinVar Annotator: match by term: VPS13B-related condition
|
OMIM ClinVar |
PMID:9536098 PMID:11169562 PMID:12730828 PMID:15141358 PMID:15154116 PMID:15173253 PMID:15211651 PMID:15498460 PMID:15691367 PMID:15918062 PMID:16199547 PMID:16648375 PMID:16917849 PMID:17383910 PMID:17576681 PMID:17786118 PMID:17990063 PMID:18414213 PMID:18655112 PMID:19006247 PMID:19190672 PMID:19533689 PMID:19763152 PMID:20307669 PMID:20461111 PMID:20656880 PMID:20683995 PMID:20921020 PMID:21330571 PMID:21659346 PMID:21850686 PMID:21865173 PMID:22382802 PMID:22406018 PMID:22527104 PMID:22700954 PMID:22855652 PMID:23033978 PMID:23188044 PMID:23352163 PMID:23757202 PMID:24033266 PMID:24123366 PMID:24311531 PMID:24334746 PMID:24334764 PMID:25060287 PMID:25326635 PMID:25356970 PMID:25472526 PMID:25502226 PMID:25525159 PMID:25533962 PMID:25640679 PMID:25741868 PMID:26104215 PMID:26133662 PMID:26193622 PMID:26395554 PMID:26443248 PMID:26467025 PMID:26539891 PMID:26938784 PMID:27175599 PMID:27353947 PMID:27380831 PMID:27533158 PMID:27829003 PMID:28041643 PMID:28341476 PMID:28492532 PMID:28559085 PMID:28631888 PMID:28832562 PMID:29149870 PMID:29431110 PMID:29453417 PMID:29634382 PMID:29706646 PMID:29758347 PMID:30138938 PMID:30290665 PMID:30602132 PMID:30792901 PMID:30843084 PMID:31444703 PMID:31580008 PMID:31736247 PMID:31943017 PMID:31965297 PMID:32170714 PMID:32384097 PMID:32483926 PMID:32505691 PMID:32581362 PMID:32860008 PMID:32919079 PMID:32959227 PMID:33023636 PMID:33025479 PMID:33217554 PMID:33584783 PMID:33994118 PMID:34006472 PMID:34353225 PMID:34425733 PMID:34426522 PMID:35052368 PMID:35488281 PMID:35599849 PMID:35690661 PMID:37690893 More...
|
|
NCBI chrNW_004936470:43,281,905...43,952,523
Ensembl chrNW_004936470:43,281,469...43,951,805
|
|
G
|
Ywhaz
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:42,444,671...42,470,548
Ensembl chrNW_004936470:42,445,412...42,470,900
|
|
G
|
Zfpm2
|
zinc finger protein, FOG family member 2
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:38,432,894...38,857,656
Ensembl chrNW_004936470:38,432,897...38,857,662
|
|
G
|
Znf706
|
zinc finger protein 706
|
|
ISO
|
ClinVar Annotator: match by term: Cohen syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936470:42,245,657...42,253,492
Ensembl chrNW_004936470:42,245,765...42,251,590
|
|
|
G
|
Lep
|
leptin
|
|
ISO
|
ClinVar Annotator: match by term: LEP-related condition | ClinVar Annotator: match by term: Leptin dysfunction | ClinVar Annotator: match by term: Obesity due to congenital leptin deficiency
|
OMIM ClinVar |
PMID:9202122 PMID:9500540 PMID:9745435 PMID:12393845 PMID:15070752 PMID:15472169 PMID:15937081 PMID:19427251 PMID:20140086 PMID:20307995 PMID:25551525 PMID:25741868 PMID:26186301 PMID:27075752 PMID:28209183 PMID:28377240 PMID:28492532 PMID:32349990 PMID:37314706 More...
|
|
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Lepr
|
leptin receptor
|
|
ISO
|
ClinVar Annotator: match by term: Obesity due to congenital leptin deficiency
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
|
G
|
Irak1bp1
|
interleukin 1 receptor associated kinase 1 binding protein 1
|
|
ISO
|
ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHISM | ClinVar Annotator: match by term: PHIP-related disorder
|
ClinVar |
PMID:9536098 PMID:17576681 PMID:23033978 PMID:25741868 PMID:28492532 PMID:29209020 PMID:31167805 PMID:32801363 PMID:33004838 PMID:37961033 PMID:39825153 More...
|
|
NCBI chrNW_004936510:11,220,194...11,242,485
Ensembl chrNW_004936510:11,217,024...11,242,667
|
|
G
|
Phip
|
pleckstrin homology domain interacting protein
|
|
ISO
|
ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHISM | ClinVar Annotator: match by term: PHIP-related disorder
|
OMIM ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:23033978 PMID:25741868 PMID:27479843 PMID:27900362 PMID:28191889 PMID:28263302 PMID:28492532 PMID:29209020 PMID:30018425 PMID:30564305 PMID:31167805 PMID:32492392 PMID:32801363 PMID:33004838 PMID:34773373 PMID:37961033 PMID:39825153 More...
|
|
NCBI chrNW_004936510:11,076,790...11,198,483
Ensembl chrNW_004936510:11,076,785...11,193,689
|
|
|
G
|
Mgme1
|
mitochondrial genome maintenance exonuclease 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23313956 |
|
NCBI chrNW_004936485:2,154,446...2,167,633
Ensembl chrNW_004936485:2,153,295...2,166,908
|
|
|
G
|
Hnf4a
|
hepatocyte nuclear factor 4 alpha
|
|
ISO
|
DNA:mutations: :
|
RGD |
PMID:17407387 PMID:19435144 |
RGD:12904698 RGD:12904767 |
NCBI chrNW_004936530:2,401,053...2,425,989
Ensembl chrNW_004936530:2,401,043...2,454,466
|
|
G
|
Igf1
|
insulin like growth factor 1
|
|
ISO
|
protein:increased expression:serum:
|
RGD |
PMID:17113804 |
RGD:12743591 |
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G
|
Igfbp3
|
insulin like growth factor binding protein 3
|
|
ISO
|
protein:increased expression:serum:
|
RGD |
PMID:17113804 |
RGD:12743591 |
NCBI chrNW_004936478:20,511,490...20,518,251
Ensembl chrNW_004936478:20,510,137...20,518,306
|
|
G
|
Lipc
|
lipase C, hepatic type
|
|
ISO
|
associated with Diabetes Mellitus, Experimental; protein:increased expression:liver (rat)
|
RGD |
PMID:10600655 |
RGD:2308786 |
NCBI chrNW_004936471:19,604,083...19,733,721
Ensembl chrNW_004936471:19,703,236...19,733,686
|
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35204234 |
|
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
|
G
|
Lepr
|
leptin receptor
|
|
ISO
|
ClinVar Annotator: match by term: LEPR-related condition | ClinVar Annotator: match by term: Leptin receptor deficiency
|
OMIM ClinVar |
PMID:8666155 PMID:9144432 PMID:9175732 PMID:9287054 PMID:9537324 PMID:9860295 PMID:11354636 PMID:11380591 PMID:11443193 PMID:12006639 PMID:12646666 PMID:15585384 PMID:16284652 PMID:17229951 PMID:17785359 PMID:18212354 PMID:18490929 PMID:18703626 PMID:21393862 PMID:21744741 PMID:22331430 PMID:22810975 PMID:23616257 PMID:23760429 PMID:24319006 PMID:24611737 PMID:25741868 PMID:25751111 PMID:26094658 PMID:26467025 PMID:28432296 PMID:28492532 PMID:29970488 PMID:30926952 PMID:31237021 PMID:33221380 PMID:33660144 PMID:34097736 PMID:37140700 More...
|
|
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
G
|
Leprot
|
leptin receptor overlapping transcript
|
|
ISO
|
ClinVar Annotator: match by term: Leptin receptor deficiency
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936692:2,840,461...2,850,756
Ensembl chrNW_004936692:2,840,332...2,894,726
|
|
|
G
|
Eif2s3
|
eukaryotic translation initiation factor 2 subunit gamma
|
|
ISO
|
ClinVar Annotator: match by term: EIF2S3-related condition | ClinVar Annotator: match by term: MEHMO syndrome
|
OMIM ClinVar |
PMID:23063529 PMID:25741868 PMID:25741869 PMID:27333055 PMID:28055140 PMID:28492532 PMID:30878599 More...
|
|
NCBI chrNW_004936624:516,206...535,749
Ensembl chrNW_004936624:515,864...535,981
|
|
|
G
|
Acss2
|
acyl-CoA synthetase short chain family member 2
|
treatment
|
ISO
|
|
RGD |
PMID:22384010 |
RGD:13831306 |
NCBI chrNW_004936561:5,794,685...5,842,619
Ensembl chrNW_004936561:5,795,077...5,842,676
|
|
G
|
Adcy3
|
adenylate cyclase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29311637 |
|
NCBI chrNW_004936493:7,250,194...7,333,433
Ensembl chrNW_004936493:7,250,194...7,335,691
|
|
G
|
Ager
|
advanced glycosylation end-product specific receptor
|
treatment
|
ISO
|
|
RGD |
PMID:22828946 |
RGD:7243249 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G
|
Apln
|
apelin
|
|
ISO
|
protein:increased expression:plasma associated with Diabetes Mellitus, Non-Insulin-Dependent
|
RGD |
PMID:15970339 PMID:19756893 |
RGD:1600932 RGD:2313938 |
NCBI chrNW_004936479:1,889,930...1,899,811
Ensembl chrNW_004936479:1,890,229...1,899,730
|
|
G
|
Aqp7
|
aquaporin 7
|
|
ISO
|
mRNA:decreased expression:subcutaneous adipose tissue
|
RGD |
PMID:17566090 |
RGD:1626289 |
NCBI chrNW_004936524:1,898,635...1,915,078
|
|
G
|
Bbs4
|
Bardet-Biedl syndrome 4
|
susceptibility
|
ISO
|
DNA:SNPs
|
RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chrNW_004936471:31,962,500...32,019,516
Ensembl chrNW_004936471:31,962,336...32,020,712
|
|
G
|
Bdnf
|
brain derived neurotrophic factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21708048 |
|
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
|
|
G
|
Cck
|
cholecystokinin
|
|
ISO
|
protein:decreased expression:plasma:associated with Metabolic Syndrome X (MeSH:D024821)
|
RGD |
PMID:17443025 |
RGD:1625798 |
NCBI chrNW_004936695:2,776,705...2,782,280
Ensembl chrNW_004936695:2,776,831...2,782,061
|
|
G
|
Cpe
|
carboxypeptidase E
|
|
ISO
|
mRNA:increased expression:visceral abdominal fat:significantly higher expression in visceral fat than subcutaneous fat of morbidly obese subjects
|
RGD |
PMID:12530526 |
RGD:1626182 |
NCBI chrNW_004936555:531,842...641,905
Ensembl chrNW_004936555:530,307...641,905
|
|
G
|
Ctnnbl1
|
catenin beta like 1
|
no_association susceptibility
|
ISO
|
DNA:snps:introns:IVS7+3134G>T, IVS7-79A>G (rs6013029, rs6020846) (human)
|
RGD |
PMID:19228371 PMID:19245693 |
RGD:9850251 RGD:9850253 |
NCBI chrNW_004936561:3,434,232...3,589,341
Ensembl chrNW_004936561:3,434,731...3,589,341
|
|
G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
|
ISO
|
|
RGD |
PMID:19188925 |
RGD:2313745 |
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
ISO
|
mRNA:increased expression:subcutaneous adipose tissue
|
RGD |
PMID:16046292 |
RGD:1626320 |
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:11889184 |
RGD:1626666 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21708048 |
|
NCBI chrNW_004936521:2,000,113...2,706,010
Ensembl chrNW_004936521:2,000,109...2,705,365
|
|
G
|
Ksr2
|
kinase suppressor of ras 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936558:4,786,148...5,146,062
Ensembl chrNW_004936558:4,785,718...5,141,609
|
|
G
|
Lep
|
leptin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:9500540 PMID:15070752 |
|
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Lepr
|
leptin receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9537324 |
|
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
G
|
LOC101973029
|
cytochrome P450 2E1
|
|
ISO
|
protein:increased activity::3x higher activity in morbidly obese subjects compared to non-obese, activity decreased proportionally with weight loss, activity measured as total oral chlorzoxazone clearance
|
RGD |
PMID:12883487 |
RGD:1626305 |
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G
|
Lpin1
|
lipin 1
|
|
ISO
|
|
RGD |
PMID:17563064 |
RGD:1641822 |
NCBI chrNW_004936532:7,596,279...7,654,139
Ensembl chrNW_004936532:7,605,965...7,652,573
|
|
G
|
Mc4r
|
melanocortin 4 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11443223 PMID:12588803 PMID:29273807 PMID:29311635 |
RGD:1600750 RGD:1600755 |
NCBI chrNW_004936497:4,636,370...4,638,205
Ensembl chrNW_004936497:4,636,758...4,637,759
|
|
G
|
Mchr1
|
melanin concentrating hormone receptor 1
|
onset
|
ISO
|
DNA:SNP:promoter
|
RGD |
PMID:16186414 |
RGD:1624359 |
NCBI chrNW_004936492:1,153,895...1,156,980
Ensembl chrNW_004936492:1,153,651...1,157,142
|
|
G
|
Nppb
|
natriuretic peptide B
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:17273651 |
RGD:1642195 |
NCBI chrNW_004936474:683,325...684,662
Ensembl chrNW_004936474:683,325...684,665
|
|
G
|
Npy2r
|
neuropeptide Y receptor Y2
|
|
ISO
|
DNA:SNP:CDS:NCBI refSNP IDs=rs1047214, rs2880415 coding for silent Ile variants; Pima Indians, males only
|
RGD |
PMID:15855352 |
RGD:1642381 |
NCBI chrNW_004936576:1,932,526...1,939,560
Ensembl chrNW_004936576:1,932,870...1,938,703
|
|
G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
onset
|
ISO
|
protein:substitution:Y722C;severe early-onset
|
RGD |
PMID:16702999 |
RGD:1626135 |
NCBI chrNW_004936680:267,850...621,467
Ensembl chrNW_004936680:267,596...615,928
|
|
G
|
Pparg
|
peroxisome proliferator activated receptor gamma
|
|
ISO
|
ClinVar Annotator: match by term: Morbid obesity
|
ClinVar |
PMID:9753710 PMID:10690291 PMID:25157153 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G
|
Ucp3
|
uncoupling protein 3
|
|
ISO
|
ClinVar Annotator: match by term: OBESITY, SEVERE
|
ClinVar |
PMID:9769326 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936498:3,082,575...3,095,739
Ensembl chrNW_004936498:3,082,575...3,095,737
|
|
|
G
|
Cep19
|
centrosomal protein 19
|
|
ISO
|
ClinVar Annotator: match by term: CEP19-related condition | ClinVar Annotator: match by term: Morbid obesity and spermatogenic failure
|
OMIM ClinVar |
PMID:24268657 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936784:1,284,215...1,289,362
Ensembl chrNW_004936784:1,283,886...1,289,965
|
|
|
G
|
Inpp5e
|
inositol polyphosphate-5-phosphatase E
|
|
ISO
|
ClinVar Annotator: match by term: INPP5E-related condition | ClinVar Annotator: match by term: MORM syndrome
|
OMIM ClinVar |
PMID:9536098 PMID:15786477 PMID:17576681 PMID:19668215 PMID:19668216 PMID:23034536 PMID:23386033 PMID:23847139 PMID:25741868 PMID:25818971 PMID:25999675 PMID:26075876 PMID:26092869 PMID:26748598 PMID:27081510 PMID:27353947 PMID:27401686 PMID:28125082 PMID:28454995 PMID:28492532 PMID:28497568 PMID:28559085 PMID:28771248 PMID:29052317 PMID:29186038 PMID:29230161 PMID:29555955 PMID:29915382 PMID:29987673 PMID:30202406 PMID:32483926 PMID:33749171 PMID:34188062 PMID:34234304 PMID:34906470 PMID:36460718 PMID:36909829 More...
|
|
NCBI chrNW_004936669:1,377,005...1,385,287
|
|
|
G
|
Aacs
|
acetoacetyl-CoA synthetase
|
|
ISO
|
mRNA:altered expression:thalamus, hypothalamus (rat)
|
RGD |
PMID:19219059 |
RGD:2326191 |
NCBI chrNW_004936558:327,822...373,474
Ensembl chrNW_004936558:327,407...373,683
|
|
G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
disease_progression susceptibility
|
ISO
|
mRNA:increased expression:liver (rat) DNA:SNP:exon:p.R230C (rs9282541) (human)
|
RGD |
PMID:17287470 PMID:25612518 |
RGD:15045599 RGD:1601092 |
NCBI chrNW_004936559:7,177,887...7,312,660
Ensembl chrNW_004936559:7,177,904...7,312,741
|
|
G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
|
ISO
|
|
RGD |
PMID:21726512 |
RGD:14688050 |
NCBI chrNW_004936469:10,521,576...10,599,005
Ensembl chrNW_004936469:10,521,576...10,599,005
|
|
G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (rat)
|
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chrNW_004936508:8,093,804...8,117,467
Ensembl chrNW_004936508:8,093,804...8,116,877
|
|
G
|
Abcg8
|
ATP binding cassette subfamily G member 8
|
|
ISO
|
|
RGD |
PMID:15331430 |
RGD:1601095 |
NCBI chrNW_004936508:8,074,697...8,093,424
Ensembl chrNW_004936508:8,074,674...8,093,550
|
|
G
|
Acacb
|
acetyl-CoA carboxylase beta
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:increased expression:left ventricle myocardium (rat)
|
CTD RGD |
PMID:20882379 PMID:33310031 |
RGD:329955450 |
NCBI chrNW_004936769:950,970...1,053,671
Ensembl chrNW_004936769:950,845...1,051,887
|
|
G
|
Acadm
|
acyl-CoA dehydrogenase medium chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936571:2,761,254...2,797,045
|
|
G
|
Ache
|
acetylcholinesterase (Cartwright blood group)
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
|
|
G
|
Acly
|
ATP citrate lyase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936490:16,758,001...16,798,152
Ensembl chrNW_004936490:16,757,985...16,798,237
|
|
G
|
Acox1
|
acyl-CoA oxidase 1
|
treatment
|
ISO
|
|
RGD |
PMID:30298849 |
RGD:401960083 |
NCBI chrNW_004936594:1,115,607...1,140,085
Ensembl chrNW_004936594:1,112,565...1,140,228
|
|
G
|
Acp1
|
acid phosphatase 1
|
severity
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent
|
RGD |
PMID:2373509 PMID:9198310 |
RGD:1625289 RGD:2313187 |
NCBI chrNW_004936532:130,799...145,285
Ensembl chrNW_004936532:132,350...145,285
|
|
G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936659:1,598,252...1,642,615
Ensembl chrNW_004936659:1,598,177...1,600,262
|
|
G
|
Acsl1
|
acyl-CoA synthetase long chain family member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:subcutaneous adipose tissue mRNA, protein:increased expression:adipose tissue, liver
|
CTD RGD |
PMID:1543733 PMID:16788709 PMID:20882379 |
RGD:1625735 RGD:1625737 |
NCBI chrNW_004936554:4,425,518...4,484,853
Ensembl chrNW_004936554:4,425,495...4,484,887
|
|
G
|
Ada
|
adenosine deaminase
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:16501670 |
RGD:1624289 |
NCBI chrNW_004936530:2,217,713...2,224,070
|
|
G
|
Adarb1
|
adenosine deaminase RNA specific B1
|
|
ISO
|
associated with Hyperphagia
|
RGD |
PMID:17567573 |
RGD:10450894 |
NCBI chrNW_004936778:1,056,259...1,137,772
Ensembl chrNW_004936778:1,053,871...1,137,828
|
|
G
|
Adcy3
|
adenylate cyclase 3
|
treatment
|
ISO
|
ClinVar Annotator: match by term: ADCY3-related condition | ClinVar Annotator: match by term: Monogenic Obesity
|
ClinVar RGD |
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 PMID:30568259 |
RGD:407550184 |
NCBI chrNW_004936493:7,250,194...7,333,433
Ensembl chrNW_004936493:7,250,194...7,335,691
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
treatment
|
ISO
|
associated with myocardial infarction; protein:decreased expression:plasma associated with Pulmonary Disease, Chronic Obstructive; protein:decreased expression:plasma associated with Diabetes Mellitus, Type 2 CTD Direct Evidence: marker/mechanism|therapeutic
|
RGD CTD |
PMID:10092513 PMID:14617771 PMID:16092047 PMID:18303100 PMID:18651432 PMID:19606374 PMID:23731386 PMID:28843383 More...
|
RGD:14975146 RGD:1599149 RGD:2313239 RGD:5686809 RGD:5686813 RGD:8695927 |
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G
|
Adipor1
|
adiponectin receptor 1
|
|
ISO
|
mRNA:decreased expression:lymphocyte mRNA:increased expression:liver
|
RGD |
PMID:16483885 PMID:17391161 |
RGD:1625761 RGD:1625763 |
NCBI chrNW_004936567:1,658,405...1,674,794
Ensembl chrNW_004936567:1,658,383...1,676,199
|
|
G
|
Adipor2
|
adiponectin receptor 2
|
severity treatment
|
ISO
|
mRNA:decreased expression:liver (rat) mRNA:increased expression:liver associated with non-alcoholic fatty liver disease
|
RGD |
PMID:16483885 PMID:23838384 PMID:30131158 PMID:30225267 |
RGD:1625763 RGD:21406435 RGD:25824942 RGD:8695926 |
NCBI chrNW_004936606:1,911,104...2,007,109
Ensembl chrNW_004936606:1,948,743...2,007,163
|
|
G
|
Adm
|
adrenomedullin
|
|
ISO
|
mRNA, protein:increased expression:adipose tissue
|
RGD |
PMID:16793965 |
RGD:1625297 |
NCBI chrNW_004936528:8,005,223...8,007,586
Ensembl chrNW_004936528:8,005,189...8,007,643
|
|
G
|
Adora1
|
adenosine A1 receptor
|
|
ISO
|
protein:increased expression:visceral adipose tissue:increased density of ligand binding sites on VAT in African American women compared to Caucasian women
|
RGD |
PMID:16507638 |
RGD:1625369 |
NCBI chrNW_004936567:1,430,128...1,508,626
Ensembl chrNW_004936567:1,429,817...1,462,532
|
|
G
|
Adra2b
|
adrenoceptor alpha 2B
|
|
ISO
|
|
RGD |
PMID:10404816 |
RGD:1300265 |
NCBI chrNW_004936744:249,673...253,040
Ensembl chrNW_004936744:251,467...252,816
|
|
G
|
Adrb1
|
adrenoceptor beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12032746 |
|
NCBI chrNW_004936486:4,400,467...4,401,588
Ensembl chrNW_004936486:4,399,915...4,403,149
|
|
G
|
Adrb2
|
adrenoceptor beta 2
|
no_association susceptibility
|
ISO
|
DNA:polymorphisms: :p.R16G, p.Q27E CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:12161655 PMID:15687340 PMID:17027833 PMID:17221209 |
RGD:1601119 RGD:1601122 RGD:737773 |
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
|
|
G
|
Adrb3
|
adrenoceptor beta 3
|
no_association susceptibility
|
ISO
|
DNA:missense mutation:cds:p.W64R rs4994 (human) ClinVar Annotator: match by term: Obesity
|
RGD OMIM ClinVar |
PMID:7609750 PMID:7609752 PMID:8903328 PMID:8954053 PMID:9054940 PMID:9100608 PMID:9112025 PMID:9449691 PMID:9709965 PMID:9814483 PMID:9892244 PMID:10323390 PMID:10323402 PMID:10999801 PMID:11095426 PMID:11882399 PMID:15472194 PMID:25741868 More...
|
RGD:5684409 |
NCBI chrNW_004936710:1,410,589...1,413,279
Ensembl chrNW_004936710:1,411,446...1,413,098
|
|
G
|
Aff4
|
ALF transcription elongation factor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25730767 |
|
NCBI chrNW_004936647:2,242,476...2,342,409
Ensembl chrNW_004936647:2,242,319...2,336,532
|
|
G
|
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
ISO
|
|
RGD |
PMID:20068140 |
RGD:13838849 |
NCBI chrNW_004936646:1,865,154...1,881,614
Ensembl chrNW_004936646:1,865,395...1,876,453
|
|
G
|
Ager
|
advanced glycosylation end-product specific receptor
|
|
ISO
|
protein:decreased expression:plasma (human)
|
RGD |
PMID:22761461 PMID:23046363 |
RGD:7243247 RGD:7243250 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G
|
Agrp
|
agouti related neuropeptide
|
|
ISO
|
ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, late-onset
|
OMIM ClinVar |
PMID:11602360 PMID:12213871 PMID:15054840 PMID:25741868 |
|
NCBI chrNW_004936475:17,927,991...17,929,377
Ensembl chrNW_004936475:17,927,985...17,937,147
|
|
G
|
Agt
|
angiotensinogen
|
susceptibility
|
ISO
|
DNA:polymorphism: :p.M235T DNA:polymorphism: :p.T174M
|
RGD |
PMID:16514903 PMID:16713443 |
RGD:1601142 RGD:1601143 |
NCBI chrNW_004936484:19,713,299...19,721,144
Ensembl chrNW_004936484:19,716,165...19,721,261
|
|
G
|
Agtr2
|
angiotensin II receptor type 2
|
|
ISO
|
|
RGD |
PMID:15793237 |
RGD:2313554 |
NCBI chrNW_004936479:13,252,678...13,255,570
Ensembl chrNW_004936479:13,252,678...13,255,570
|
|
G
|
Ahi1
|
Abelson helper integration site 1
|
|
ISO
|
mRNA:increased expression:vastus lateralis
|
RGD |
PMID:20045148 |
RGD:11537398 |
NCBI chrNW_004936560:2,881,631...3,057,256
Ensembl chrNW_004936560:2,881,977...3,038,725
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27020609 PMID:30813227 PMID:31306034 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G
|
Ahsg
|
alpha 2-HS glycoprotein
|
susceptibility
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:17011519 PMID:19228823 |
RGD:1625793 RGD:2313809 |
NCBI chrNW_004936578:3,332,934...3,339,903
Ensembl chrNW_004936578:3,332,934...3,339,903
|
|
G
|
Ak1
|
adenylate kinase 1
|
|
ISO
|
protein:increased expression:skeletal muscle
|
RGD |
PMID:15855311 |
RGD:1601154 |
NCBI chrNW_004936487:15,507,663...15,517,401
Ensembl chrNW_004936487:15,507,498...15,517,469
|
|
G
|
Akap1
|
A-kinase anchoring protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20975297 |
|
NCBI chrNW_004936490:5,829,728...5,842,217
Ensembl chrNW_004936490:5,830,973...5,845,441
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased phosphorylation:aorta
|
CTD RGD |
PMID:19293429 PMID:23954404 |
RGD:408364952 |
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
|
|
G
|
Akt2
|
AKT serine/threonine kinase 2
|
|
ISO
|
protein:decreased expression:plantaris (rat) protein:decreased activity:rectus abdominis (human)
|
RGD |
PMID:12663464 PMID:17923673 PMID:18508911 |
RGD:2313320 RGD:2313406 RGD:2313409 |
NCBI chrNW_004936661:2,652,568...2,694,039
Ensembl chrNW_004936661:2,652,566...2,694,086
|
|
G
|
Aldh1l1
|
aldehyde dehydrogenase 1 family member L1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936898:456,299...484,681
Ensembl chrNW_004936898:456,521...484,282
|
|
G
|
Aldh6a1
|
aldehyde dehydrogenase 6 family member A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936488:3,320,357...3,340,463
Ensembl chrNW_004936488:3,318,422...3,340,626
|
|
G
|
Alms1
|
ALMS1 centrosome and basal body associated protein
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936491:17,152,759...17,342,648
|
|
G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
|
ISO
|
mRNA:increased expression:adipose tissue (mouse) mRNA:increased expression:peripheral blood mononuclear cell (human)
|
RGD |
PMID:17379835 PMID:19596146 |
RGD:2313884 RGD:2313913 |
NCBI chrNW_004936472:25,477,094...25,502,823
Ensembl chrNW_004936472:25,477,010...25,502,840
|
|
G
|
Amh
|
anti-Mullerian hormone
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:17109858 |
RGD:1601182 |
NCBI chrNW_004936588:1,342,791...1,345,746
Ensembl chrNW_004936588:1,343,085...1,345,654
|
|
G
|
Ang
|
angiogenin
|
|
ISO
|
protein:increased expression:adipose tissue
|
RGD |
PMID:22748184 |
RGD:6892722 |
NCBI chrNW_004936880:39,372...40,070
|
|
G
|
Angptl4
|
angiopoietin like 4
|
resistance
|
ISO
|
CTD Direct Evidence: therapeutic
|
RGD CTD |
PMID:17210919 PMID:28842503 |
RGD:1625353 |
NCBI chrNW_004936588:5,188,866...5,194,924
Ensembl chrNW_004936588:5,188,850...5,194,931
|
|
G
|
Angptl6
|
angiopoietin like 6
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936659:491,330...499,409
Ensembl chrNW_004936659:487,983...499,448
|
|
G
|
Apcdd1
|
APC down-regulated 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28242765 |
|
NCBI chrNW_004936626:1,217,240...1,237,741
Ensembl chrNW_004936626:1,216,323...1,237,792
|
|
G
|
Apln
|
apelin
|
|
ISO
|
mRNA:increased expression:subcutaneous adipose tissue
|
RGD |
PMID:17594060 |
RGD:1626170 |
NCBI chrNW_004936479:1,889,930...1,899,811
Ensembl chrNW_004936479:1,890,229...1,899,730
|
|
G
|
Apoa1
|
apolipoprotein A1
|
|
ISO
|
protein:decreased expression
|
RGD |
PMID:9933608 PMID:12725089 |
RGD:1601185 RGD:2313959 |
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G
|
Apoa2
|
apolipoprotein A2
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:9002300 PMID:9933608 |
RGD:1601191 RGD:2313959 |
NCBI chrNW_004936903:520,420...521,726
Ensembl chrNW_004936903:520,650...521,910
|
|
G
|
Apoa5
|
apolipoprotein A5
|
|
ISO
|
DNA:SNP: :rs662799 (human)
|
RGD |
PMID:25606423 |
RGD:329901774 |
NCBI chrNW_004936542:2,069,683...2,071,344
Ensembl chrNW_004936542:2,069,683...2,071,353
|
|
G
|
Apob
|
apolipoprotein B
|
|
ISO
|
associated with Insulin Resistance;protein:increased expression:plasma
|
RGD |
PMID:16752182 PMID:19592617 |
RGD:1601202 RGD:2313974 |
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
|
|
G
|
Apobec1
|
apolipoprotein B mRNA editing enzyme catalytic subunit 1
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:8781289 |
RGD:1626278 |
NCBI chrNW_004939393:628...6,234
Ensembl chrNW_004939393:628...6,201
|
|
G
|
Apoc1
|
apolipoprotein C1
|
|
ISO
|
|
RGD |
PMID:11723061 |
RGD:2313951 |
NCBI chrNW_004936706:1,519,248...1,520,102
|
|
G
|
Apoc2
|
apolipoprotein C2
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:9002300 |
RGD:1601191 |
NCBI chrNW_004936706:1,531,219...1,531,921
|
|
G
|
Apoc3
|
apolipoprotein C3
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:9002300 |
RGD:1601191 |
NCBI chrNW_004936542:2,106,927...2,108,412
Ensembl chrNW_004936542:2,106,318...2,108,603
|
|
G
|
Apod
|
apolipoprotein D
|
|
ISO
|
DNA:polymorphism
|
RGD |
PMID:7913935 |
RGD:2311179 |
NCBI chrNW_004936833:260,798...277,060
Ensembl chrNW_004936833:259,660...277,246
|
|
G
|
Apoe
|
apolipoprotein E
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
|
CTD RGD |
PMID:9002300 PMID:17192461 PMID:20975297 |
RGD:1601191 RGD:1601230 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G
|
App
|
amyloid beta precursor protein
|
treatment
|
ISO
|
mRNA,protein:increased expression:adipocyte,plasma:
|
RGD |
PMID:19672057 |
RGD:10054260 |
NCBI chrNW_004936640:1,549,977...1,787,436
Ensembl chrNW_004936640:1,550,167...1,787,286
|
|
G
|
Aqp7
|
aquaporin 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16325777 |
|
NCBI chrNW_004936524:1,898,635...1,915,078
|
|
G
|
Ar
|
androgen receptor
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:repeat: :CAG DNA:repeats: :GGN, CAG OMIM:601665
|
RGD MouseDO |
PMID:12532157 PMID:18805913 |
RGD:1601246 RGD:2306771 |
NCBI chrNW_004936635:485,903...647,820
Ensembl chrNW_004936635:485,903...647,932
|
|
G
|
Arl13b
|
ARF like GTPase 13B
|
|
ISO
|
protein:decreased expression:hypothalamus, cilium (mouse)
|
RGD |
PMID:22581473 |
RGD:11553936 |
NCBI chrNW_004936666:115,964...179,639
Ensembl chrNW_004936666:116,264...177,989
|
|
G
|
Asip
|
agouti signaling protein
|
susceptibility
|
ISO
|
DNA, mRNA:deletion, insertions, increased expression: multiple organs CTD Direct Evidence: marker/mechanism OMIM:601665
|
RGD CTD MouseDO |
PMID:1473152 PMID:7987393 PMID:8146154 PMID:25447408 PMID:25448685 PMID:32937126 More...
|
RGD:1625724 |
NCBI chrNW_004936561:6,341,667...6,346,440
Ensembl chrNW_004936561:6,341,623...6,346,458
|
|
G
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2
|
susceptibility
|
ISO
|
|
RGD |
PMID:16286513 |
RGD:1601250 |
NCBI chrNW_004936740:489,357...514,235
Ensembl chrNW_004936740:488,154...514,308
|
|
G
|
Atp4b
|
ATPase H+/K+ transporting subunit beta
|
treatment
|
ISO
|
|
RGD |
PMID:25822172 |
RGD:14696745 |
NCBI chrNW_004936472:168,745...173,996
Ensembl chrNW_004936472:168,750...173,968
|
|
G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
treatment
|
ISO
|
|
RGD |
PMID:26880535 |
RGD:13782133 |
NCBI chrNW_004936646:951,236...958,907
Ensembl chrNW_004936646:951,009...959,516
|
|
G
|
Atp5f1c
|
ATP synthase F1 subunit gamma
|
|
ISO
|
|
RGD |
PMID:19549744 |
RGD:14696798 |
NCBI chrNW_004936484:7,016,049...7,031,060
|
|
G
|
Atp5f1d
|
ATP synthase F1 subunit delta
|
treatment
|
ISO
|
|
RGD |
PMID:27874268 |
RGD:13792665 |
NCBI chrNW_004936588:612,255...614,894
Ensembl chrNW_004936588:611,725...617,782
|
|
G
|
Atp5mc2
|
ATP synthase membrane subunit c locus 2
|
|
ISO
|
|
RGD |
PMID:26709097 |
RGD:11535661 |
NCBI chrNW_004936512:10,908,915...10,918,445
Ensembl chrNW_004936512:10,908,881...10,918,445
|
|
G
|
Atpaf1
|
ATP synthase mitochondrial F1 complex assembly factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936474:27,638,637...27,663,348
Ensembl chrNW_004936474:27,637,833...27,663,382
|
|
G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
ISO
|
mRNA, protein:decreased expression:fat pad, liver,plasma associated with colorectal cancer; protein:decreased expression:subcutaneous white adipose tissue protein:decreased expression:plasma mRNA:decreased expression:fat pad
|
RGD |
PMID:19934249 PMID:21136593 PMID:29755407 |
RGD:153350147 RGD:153350156 RGD:153350157 |
NCBI chrNW_004936543:105,983...113,475
Ensembl chrNW_004936543:105,956...114,190
|
|
G
|
B2m
|
beta-2-microglobulin
|
|
ISO
|
protein:increased expression:urine
|
RGD |
PMID:15517379 |
RGD:1601309 |
NCBI chrNW_004936471:7,646,504...7,655,656
Ensembl chrNW_004936471:7,646,373...7,655,778
|
|
G
|
Bad
|
BCL2 associated agonist of cell death
|
|
ISO
|
protein:increased expression:heart left ventricle
|
RGD |
PMID:18070754 |
RGD:2292682 |
NCBI chrNW_004936599:4,924,349...4,933,683
Ensembl chrNW_004936599:4,924,789...4,933,368
|
|
G
|
Bambi
|
BMP and activin membrane bound inhibitor
|
|
ISO
|
mRNA:decreased expression:adipose tissue
|
RGD |
PMID:22187378 |
RGD:14390162 |
NCBI chrNW_004936613:3,098,549...3,103,868
Ensembl chrNW_004936613:3,098,159...3,103,868
|
|
G
|
Bbs1
|
Bardet-Biedl syndrome 1
|
no_association
|
ISO
|
DNA:mutation: :p.M390R (human) OMIM:601665
|
RGD MouseDO |
PMID:14993910 PMID:33722691 |
RGD:1601314 RGD:243065268 |
NCBI chrNW_004936599:3,059,274...3,076,853
Ensembl chrNW_004936599:3,059,148...3,076,299
|
|
G
|
Bbs2
|
Bardet-Biedl syndrome 2
|
susceptibility
|
ISO
|
DNA:SNPs
|
RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chrNW_004936475:8,785,914...8,810,490
Ensembl chrNW_004936475:8,785,154...8,810,541
|
|
G
|
Bbs4
|
Bardet-Biedl syndrome 4
|
onset
|
ISO
|
DNA:SNPs OMIM:601665
|
RGD MouseDO |
PMID:17003356 |
RGD:1601311 |
NCBI chrNW_004936471:31,962,500...32,019,516
Ensembl chrNW_004936471:31,962,336...32,020,712
|
|
G
|
Bche
|
butyrylcholinesterase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:18452903 PMID:23000450 PMID:23073171 PMID:27163854 |
|
NCBI chrNW_004936707:1,784,338...1,913,401
Ensembl chrNW_004936707:1,854,444...1,913,460
|
|
G
|
Bcl2
|
BCL2 apoptosis regulator
|
|
ISO
|
mRNA, protein:decreased expression:heart left ventricle
|
RGD |
PMID:18202171 |
RGD:2293027 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G
|
Bdkrb1
|
bradykinin receptor B1
|
|
ISO
|
ob/ob mice mRNA:decreased expression:brown adipose tissue, heart mRNA:increased expression:white adipose tissue, hypothalamus
|
RGD |
PMID:17184856 |
RGD:1625733 |
NCBI chrNW_004936604:551,774...567,014
|
|
G
|
Bdnf
|
brain derived neurotrophic factor
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:11840487 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
|
ISO
|
|
RGD |
PMID:18070754 |
RGD:2292682 |
NCBI chrNW_004936486:18,449,371...18,460,435
Ensembl chrNW_004936486:18,448,494...18,455,927
|
|
G
|
Brd2
|
bromodomain containing 2
|
|
ISO
|
|
RGD |
PMID:19883376 |
RGD:9586446 |
NCBI chrNW_004936476:25,807,179...25,818,914
Ensembl chrNW_004936476:25,807,163...25,818,899
|
|
G
|
Brs3
|
bombesin receptor subtype 3
|
|
ISO
|
|
RGD |
PMID:9367152 |
RGD:734661 |
NCBI chrNW_004936513:10,784,181...10,788,679
Ensembl chrNW_004936513:10,784,181...10,788,680
|
|
G
|
C3
|
complement C3
|
treatment
|
ISO
|
|
RGD |
PMID:23118029 |
RGD:7411625 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G
|
C5ar1
|
complement C5a receptor 1
|
treatment
|
ISO
|
|
RGD |
PMID:23118029 |
RGD:7411625 |
NCBI chrNW_004936664:1,026,216...1,033,438
Ensembl chrNW_004936664:1,032,304...1,033,374
|
|
G
|
Ca3
|
carbonic anhydrase 3
|
|
ISO
|
protein:decreased expression:adipocyte CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:8476041 PMID:20882379 |
RGD:408426009 |
NCBI chrNW_004936544:337,437...347,760
Ensembl chrNW_004936544:337,382...348,462
|
|
G
|
Cadm2
|
cell adhesion molecule 2
|
|
ISO
|
DNA:SNP: :rs13078807 (human)
|
RGD |
PMID:31341224 |
RGD:15092077 |
NCBI chrNW_004936610:3,304,556...4,297,745
Ensembl chrNW_004936610:3,305,551...3,598,837
|
|
G
|
Canx
|
calnexin
|
|
ISO
|
protein:increased expression:subcutaneous adipose tissue
|
RGD |
PMID:18567819 |
RGD:2314284 |
NCBI chrNW_004936739:1,051,853...1,085,658
Ensembl chrNW_004936739:1,051,240...1,086,405
|
|
G
|
Capn10
|
calpain 10
|
|
ISO
|
DNA:SNPs
|
RGD |
PMID:16752174 |
RGD:1625047 |
NCBI chrNW_004936745:1,029,514...1,039,524
|
|
G
|
Cartpt
|
CART prepropeptide
|
no_association susceptibility
|
ISO
|
DNA:deletion, substitution: :1457delA, 1475A>G (human) DNA:polymorphism:3' utr (human) ClinVar Annotator: match by term: Obesity
|
RGD OMIM ClinVar |
PMID:10574510 PMID:10805512 PMID:11522684 PMID:15326462 PMID:25741868 |
RGD:2313633 RGD:2313634 |
NCBI chrNW_004936549:4,717,337...4,719,523
Ensembl chrNW_004936549:4,717,771...4,719,395
|
|
G
|
Cast
|
calpastatin
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity ClinVar Annotator: match by term: Body mass index quantitative trait locus 12 | ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency
|
ClinVar |
PMID:18604207 PMID:22210313 PMID:23383060 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G
|
Cav1
|
caveolin 1
|
|
ISO
|
|
RGD |
PMID:22492718 |
RGD:6784520 |
NCBI chrNW_004936589:2,504,235...2,536,778
Ensembl chrNW_004936589:2,504,224...2,537,170
|
|
G
|
Cav2
|
caveolin 2
|
|
ISO
|
|
RGD |
PMID:22492718 |
RGD:6784520 |
NCBI chrNW_004936589:2,553,932...2,561,186
Ensembl chrNW_004936589:2,552,477...2,561,569
|
|
G
|
Cckar
|
cholecystokinin A receptor
|
|
ISO
|
DNA:deletion
|
RGD |
PMID:9192855 PMID:9530226 |
RGD:7257724 RGD:734711 |
NCBI chrNW_004936477:3,306,898...3,314,659
Ensembl chrNW_004936477:3,306,874...3,314,714
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:18469848 |
RGD:2307038 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G
|
Ccr3
|
C-C motif chemokine receptor 3
|
|
ISO
|
mRNA:increased expression:adipose tissue
|
RGD |
PMID:18492752 |
RGD:6483834 |
NCBI chrNW_004936596:223,660...224,739
Ensembl chrNW_004936596:223,660...224,739
|
|
G
|
Cd36
|
CD36 molecule (CD36 blood group)
|
|
ISO
|
protein:increased expression:skeletal muscle, T-tubule mRNA, protein:increased expression:liver, gastrocnemius
|
RGD |
PMID:20435456 PMID:22615812 PMID:23743348 PMID:25477422 |
RGD:11041118 RGD:11041132 RGD:6893497 RGD:6893542 |
NCBI chrNW_004936810:791,823...838,303
Ensembl chrNW_004936810:758,182...838,365
|
|
G
|
Cd40
|
CD40 molecule
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:21670556 PMID:29035695 |
RGD:7248753 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G
|
Cd40lg
|
CD40 ligand
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:20660932 PMID:21817098 |
RGD:5490592 RGD:5490970 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G
|
Cd68
|
CD68 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29035695 |
|
NCBI chrNW_004936595:858,289...861,131
|
|
G
|
Cdk4
|
cyclin dependent kinase 4
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism:intron:IVS4-40G>A (human)
|
RGD |
PMID:19634152 |
RGD:2314609 |
NCBI chrNW_004936646:1,886,262...1,889,260
|
|
G
|
Cdkal1
|
CDKAL1 threonylcarbamoyladenosine tRNA methylthiotransferase
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936552:5,903,042...6,347,498
Ensembl chrNW_004936552:5,833,409...6,347,017
|
|
G
|
Cdkn1b
|
cyclin dependent kinase inhibitor 1B
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:23357529 |
RGD:10045356 |
NCBI chrNW_004936587:4,573,166...4,578,480
Ensembl chrNW_004936587:4,572,728...4,578,461
|
|
G
|
Cdo1
|
cysteine dioxygenase type 1
|
|
ISO
|
|
RGD |
PMID:16627576 |
RGD:2301355 |
NCBI chrNW_004936742:981,863...993,271
Ensembl chrNW_004936742:979,368...993,257
|
|
G
|
Cebpa
|
CCAAT enhancer binding protein alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28242765 |
|
NCBI chrNW_004936570:2,513,561...2,516,213
|
|
G
|
Cenpo
|
centromere protein O
|
|
ISO
|
ClinVar Annotator: match by term: ADCY3-related condition | ClinVar Annotator: match by term: Monogenic Obesity
|
ClinVar |
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936493:7,333,387...7,351,368
Ensembl chrNW_004936493:7,334,617...7,352,421
|
|
G
|
Cers1
|
ceramide synthase 1
|
|
ISO
|
mRNA:increased expression:skeletal muscle cell
|
RGD |
PMID:30605666 |
RGD:156431060 |
NCBI chrNW_004936596:2,442,978...2,467,184
Ensembl chrNW_004936596:2,442,991...2,467,184
|
|
G
|
Cfd
|
complement factor D
|
|
ISO
|
mRNA, protein:decreased expression:adipocyte, serum
|
RGD |
PMID:2197880 PMID:14564690 |
RGD:1624324 RGD:1624327 |
NCBI chrNW_004936588:350,925...352,732
Ensembl chrNW_004936588:350,921...355,582
|
|
G
|
Cidea
|
cell death inducing DFFA like effector a
|
|
ISO
|
protein:amino acid substitution:V115F CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16186410 PMID:20975297 |
RGD:1625390 |
NCBI chrNW_004936626:230,372...246,893
Ensembl chrNW_004936626:230,329...246,893
|
|
G
|
Cnr1
|
cannabinoid receptor 1
|
no_association
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :1256C>A, 1419+1G>C (human) DNA:polymorphism:exon:3813A>G (human) DNA, mRNA:hypermethylation, increased expression:promoter, hypothalamus DNA:hypermethylation:promoter, peripheral blood mononuclear cell
|
CTD RGD |
PMID:17292652 PMID:17405839 PMID:18722357 PMID:19325539 PMID:19530697 PMID:31258545 More...
|
RGD:1626325 RGD:1626326 RGD:2314629 RGD:2314630 RGD:401827956 |
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
|
|
G
|
Cntf
|
ciliary neurotrophic factor
|
no_association
|
ISO
|
DNA:point mutation:intron:G>A
|
RGD |
PMID:12404108 PMID:14747836 |
RGD:1626113 RGD:1626114 |
NCBI chrNW_004936581:3,710,171...3,715,753
Ensembl chrNW_004936581:3,710,160...3,715,638
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
|
ISO
|
mRNA:increased expression:kidney (rat)
|
RGD |
PMID:28746409 |
RGD:401965413 |
NCBI chrNW_004936490:11,448,552...11,465,836
Ensembl chrNW_004936490:11,448,654...11,464,444
|
|
G
|
Col3a1
|
collagen type III alpha 1 chain
|
|
ISO
|
mRNA:increased expression:kidney (rat)
|
RGD |
PMID:28746409 |
RGD:401965413 |
NCBI chrNW_004936506:8,886,494...8,923,921
Ensembl chrNW_004936506:8,886,494...8,923,930
|
|
G
|
Col4a1
|
collagen type IV alpha 1 chain
|
|
ISO
|
mRNA:increased expression:kidney (rat)
|
RGD |
PMID:28746409 |
RGD:401965413 |
NCBI chrNW_004936472:2,416,043...2,543,561
Ensembl chrNW_004936472:2,416,566...2,542,814
|
|
G
|
Comt
|
catechol-O-methyltransferase
|
susceptibility
|
ISO
|
DNA:polymorphism:exon
|
RGD |
PMID:17497175 |
RGD:2289713 |
NCBI chrNW_004936619:3,847,059...3,883,866
Ensembl chrNW_004936619:3,876,299...3,882,747
|
|
G
|
Cpb2
|
carboxypeptidase B2
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression, increased activity:plasma CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:11836301 PMID:16959692 |
RGD:2313645 |
NCBI chrNW_004936857:577,067...609,855
Ensembl chrNW_004936857:577,585...626,267
|
|
G
|
Cpe
|
carboxypeptidase E
|
no_association
|
ISO
|
DNA:SNP:intron (rs1946816, rs4481204) (human) CTD Direct Evidence: marker/mechanism no association between obesity or diabetes and three SNPs (-53G>T, -144G>A, 219G>A) in Japanese patients DNA:transition:CDS:729T>C, amino acid S202P; decreased activity results in decrease in processing of proinsulin OMIM:601665
|
RGD CTD MouseDO |
PMID:7663508 PMID:9662053 PMID:15358678 PMID:23434795 PMID:23900445 |
RGD:1626181 RGD:1626184 RGD:405650675 |
NCBI chrNW_004936555:531,842...641,905
Ensembl chrNW_004936555:530,307...641,905
|
|
G
|
Cps1
|
carbamoyl-phosphate synthase 1
|
|
ISO
|
|
RGD |
PMID:15481768 |
RGD:2303517 |
NCBI chrNW_004936586:5,739,038...5,850,317
Ensembl chrNW_004936586:5,739,337...5,850,312
|
|
G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
treatment
|
ISO
|
mRNA:decreased expression:liver mRNA:decreased expression:left ventricle myocardium (rat)
|
RGD |
PMID:16751799 PMID:33310031 |
RGD:2311345 RGD:329955450 |
NCBI chrNW_004936599:1,491,934...1,535,101
Ensembl chrNW_004936599:1,482,172...1,535,119
|
|
G
|
Crh
|
corticotropin releasing hormone
|
|
ISO
|
|
RGD |
PMID:11564446 |
RGD:5508830 |
NCBI chrNW_004936496:7,759,656...7,761,555
Ensembl chrNW_004936496:7,760,532...7,761,122
|
|
G
|
Crhbp
|
corticotropin releasing hormone binding protein
|
|
ISO
|
mRNA:decreased expression:anterior pituitary gland (rat)
|
RGD |
PMID:10600923 |
RGD:5508840 |
NCBI chrNW_004936549:64,866...78,272
Ensembl chrNW_004936549:64,866...78,272
|
|
G
|
Crhr1
|
corticotropin releasing hormone receptor 1
|
|
ISO
|
DNA:SNP:CDS:861C>T (human)
|
RGD |
PMID:14724656 |
RGD:1626226 |
NCBI chrNW_004936541:2,288,847...2,333,129
Ensembl chrNW_004936541:2,288,841...2,331,689
|
|
G
|
Crp
|
C-reactive protein
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (rat) protein:increased expression:serum CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:20660932 PMID:24042701 PMID:25612518 |
RGD:15045599 RGD:5490970 |
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G
|
Cs
|
citrate synthase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936646:676,926...704,988
Ensembl chrNW_004936646:678,307...692,777
|
|
G
|
Ctf1
|
cardiotrophin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21803294 |
|
NCBI chrNW_004936501:13,286,821...13,291,280
|
|
G
|
Ctsc
|
cathepsin C
|
|
ISO
|
|
RGD |
PMID:3705543 |
RGD:1599645 |
NCBI chrNW_004936736:1,201,343...1,240,311
|
|
G
|
Ctss
|
cathepsin S
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21156398 |
|
NCBI chrNW_004936580:963,176...991,732
Ensembl chrNW_004936580:963,153...991,442
|
|
G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
|
ISO
|
DNA:SNP: :p.T280M (human)
|
RGD |
PMID:20523302 |
RGD:4891903 |
NCBI chrNW_004936473:28,508,726...28,535,640
Ensembl chrNW_004936473:28,510,523...28,535,627
|
|
G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
|
ISO
|
|
RGD |
PMID:25016030 |
RGD:13673852 |
NCBI chrNW_004936469:39,794,613...39,798,448
Ensembl chrNW_004936469:39,794,584...39,798,459
|
|
G
|
Dcn
|
decorin
|
|
ISO
|
|
RGD |
PMID:17244723 |
RGD:1600551 |
NCBI chrNW_004936507:7,887,259...7,923,055
Ensembl chrNW_004936507:7,884,654...7,922,961
|
|
G
|
Ddhd2
|
DDHD domain containing 2
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:23176823 PMID:24337409 PMID:24517879 PMID:25417924 PMID:25741868 PMID:28492532 PMID:31302745 PMID:32488064 PMID:37420318 More...
|
|
NCBI chrNW_004936710:1,593,899...1,616,572
Ensembl chrNW_004936710:1,593,946...1,618,828
|
|
G
|
Ddit3
|
DNA damage inducible transcript 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26655953 |
|
NCBI chrNW_004936646:1,665,019...1,669,212
|
|
G
|
Deaf1
|
DEAF1 transcription factor
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936888:473,651...497,152
Ensembl chrNW_004936888:473,974...497,158
|
|
G
|
Defb1
|
defensin beta 1
|
|
ISO
|
mRNA:decreased expression:kidney
|
RGD |
PMID:11340353 |
RGD:4892260 |
NCBI chrNW_004936615:4,780,229...4,790,516
|
|
G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
treatment no_association
|
ISO
|
DNA:polymorphism:C97T
|
RGD |
PMID:10802663 PMID:14569040 PMID:18183944 |
RGD:10401058 RGD:1625597 RGD:734536 |
NCBI chrNW_004936470:7,916,438...7,926,089
Ensembl chrNW_004936470:7,916,438...7,926,088
|
|
G
|
Dio2
|
iodothyronine deiodinase 2
|
no_association
|
ISO
|
protein:substitution:Thr92Ala
|
RGD |
PMID:17077128 |
RGD:1626439 |
NCBI chrNW_004936488:8,769,555...8,783,157
|
|
G
|
Dip2c
|
disco interacting protein 2 homolog C
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936484:13,587,541...13,752,361
Ensembl chrNW_004936484:13,578,941...13,755,108
|
|
G
|
Dixdc1
|
DIX domain containing 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936612:2,440,357...2,518,596
Ensembl chrNW_004936612:2,443,525...2,517,114
|
|
G
|
Dnm1l
|
dynamin 1 like
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:26825290 PMID:27328748 PMID:28492532 |
|
NCBI chrNW_004936607:3,576,357...3,632,423
Ensembl chrNW_004936607:3,576,392...3,632,554
|
|
G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:24614070 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936493:6,963,406...7,013,256
Ensembl chrNW_004936493:6,935,386...7,007,610
|
|
G
|
Dpyd
|
dihydropyrimidine dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936537:1,660,461...2,439,305
Ensembl chrNW_004936537:1,660,477...2,439,273
|
|
G
|
Drd1
|
dopamine receptor D1
|
treatment
|
ISO
|
protein:increased serine phosphorylation:renal proximal tubule, membrane (rat)
|
RGD |
PMID:15983225 PMID:17191082 |
RGD:7248449 RGD:7248552 |
NCBI chrNW_004936609:790,647...795,187
Ensembl chrNW_004936609:792,276...793,613
|
|
G
|
Drd2
|
dopamine receptor D2
|
|
ISO
|
mRNA:decreased expression:ventral tegmental area (rat) DNA:polymorphism DNA:polymorphisms, haplotype:enhancer, promoter, intron:multiple
|
RGD |
PMID:15939106 PMID:17108814 PMID:18477764 |
RGD:1600904 RGD:1600905 RGD:2311581 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G
|
Drd4
|
dopamine receptor D4
|
|
ISO
|
protein:decreased expression:kidney (rat)
|
RGD |
PMID:20810614 |
RGD:7248616 |
NCBI chrNW_004936888:468,334...471,254
Ensembl chrNW_004936888:468,403...471,205
|
|
G
|
Dusp1
|
dual specificity phosphatase 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:16814733 |
RGD:2298673 |
NCBI chrNW_004936609:2,688,170...2,691,057
Ensembl chrNW_004936609:2,688,181...2,690,408
|
|
G
|
Ech1
|
enoyl-CoA hydratase 1
|
treatment
|
ISO
|
|
RGD |
PMID:31961704 |
RGD:21408561 |
NCBI chrNW_004936661:1,780,706...1,785,864
|
|
G
|
Echs1
|
enoyl-CoA hydratase, short chain 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936486:19,488,619...19,496,583
Ensembl chrNW_004936486:19,488,554...19,496,575
|
|
G
|
Edn1
|
endothelin 1
|
|
ISO
|
DNA:polymorphism:exon:p.K198N (human)
|
RGD |
PMID:17444275 |
RGD:1625065 |
NCBI chrNW_004936534:885,489...892,292
Ensembl chrNW_004936534:885,287...891,772
|
|
G
|
Efnb1
|
ephrin B1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24098442 |
|
NCBI chrNW_004936777:434,729...447,778
Ensembl chrNW_004936777:434,692...447,780
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
|
ISO
|
protein:decreased phosphorylation:liver (mouse)
|
RGD |
PMID:3624263 |
RGD:5131534 |
NCBI chrNW_004936678:365,005...560,546
Ensembl chrNW_004936678:365,834...436,528
|
|
G
|
Ehd1
|
EH domain containing 1
|
|
ISO
|
|
RGD |
PMID:21365757 |
RGD:8661255 |
NCBI chrNW_004936599:4,451,207...4,473,078
Ensembl chrNW_004936599:4,450,188...4,473,738
|
|
G
|
Elovl6
|
ELOVL fatty acid elongase 6
|
|
ISO
|
mRNA,protein:increased expression:liver:
|
RGD |
PMID:31988048 |
RGD:21403676 |
NCBI chrNW_004936563:1,224,392...1,344,707
Ensembl chrNW_004936563:1,221,233...1,344,810
|
|
G
|
Emc1
|
ER membrane protein complex subunit 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:26572623 PMID:26942288 PMID:28492532 PMID:29271071 |
|
NCBI chrNW_004936474:5,512,100...5,539,198
Ensembl chrNW_004936474:5,511,661...5,539,237
|
|
G
|
Enpp1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder
|
OMIM ClinVar |
PMID:8960499 PMID:9662402 PMID:10453738 PMID:10480624 PMID:11739459 PMID:11771660 PMID:12881724 PMID:14671192 PMID:14988267 PMID:15001634 PMID:15126519 PMID:15605415 PMID:15677494 PMID:16025115 PMID:16315058 PMID:16369898 PMID:16607460 PMID:16609882 PMID:16968801 PMID:18950909 PMID:20016754 PMID:20137773 PMID:20981035 PMID:22539483 PMID:24033266 PMID:25741868 PMID:27238374 PMID:27467858 PMID:28377967 PMID:28492532 PMID:28973083 PMID:29244957 PMID:29979387 PMID:33005041 PMID:35738466 More...
|
|
NCBI chrNW_004937067:194,375...246,607
|
|
G
|
Entpd6
|
ectonucleoside triphosphate diphosphohydrolase 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936620:598,677...627,766
Ensembl chrNW_004936620:598,592...627,822
|
|
G
|
Ep300
|
E1A binding protein p300
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26441656 |
|
NCBI chrNW_004936492:696,982...778,132
Ensembl chrNW_004936492:696,960...778,138
|
|
G
|
Esr1
|
estrogen receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:11095962 PMID:20667977 PMID:22230815 |
RGD:8553065 RGD:8553199 |
NCBI chrNW_004936489:4,616,839...4,887,179
Ensembl chrNW_004936489:4,614,754...4,887,171
|
|
G
|
Esr2
|
estrogen receptor 2
|
|
ISO
|
|
RGD |
PMID:22230815 |
RGD:8553199 |
NCBI chrNW_004936495:7,956,168...8,018,356
Ensembl chrNW_004936495:7,956,766...8,004,357
|
|
G
|
Esrra
|
estrogen related receptor alpha
|
no_association
|
ISO
|
|
RGD |
PMID:16755280 |
RGD:1625637 |
NCBI chrNW_004936599:4,898,534...4,922,758
Ensembl chrNW_004936599:4,897,066...4,904,886
|
|
G
|
Etfdh
|
electron transfer flavoprotein dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936576:5,140,577...5,165,527
Ensembl chrNW_004936576:5,140,577...5,165,527
|
|
G
|
F2
|
coagulation factor II, thrombin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:21210148 PMID:22841818 PMID:23628972 |
RGD:5147773 RGD:7387310 |
NCBI chrNW_004936562:2,371,725...2,388,617
Ensembl chrNW_004936562:2,372,044...2,388,650
|
|
G
|
F7
|
coagulation factor VII
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent protein:increased activity:plasma (human) associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human)
|
RGD |
PMID:9258277 PMID:14513073 PMID:16739871 PMID:19329212 |
RGD:1625710 RGD:2312379 RGD:2312395 RGD:2312404 |
NCBI chrNW_004936472:505,751...515,375
Ensembl chrNW_004936472:505,751...514,339
|
|
G
|
Faah
|
fatty acid amide hydrolase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:polymorphism
|
CTD RGD |
PMID:15809662 PMID:19103437 PMID:20716455 |
RGD:1625726 |
NCBI chrNW_004936474:27,419,211...27,441,061
Ensembl chrNW_004936474:27,419,078...27,441,039
|
|
G
|
Fabp1
|
fatty acid binding protein 1
|
|
ISO
|
Western diet-induced obesity; DNA:mutation::Fabp1 knockout mice
|
RGD |
PMID:17058218 |
RGD:1626440 |
NCBI chrNW_004936712:738,361...743,073
Ensembl chrNW_004936712:738,348...743,955
|
|
G
|
Fabp2
|
fatty acid binding protein 2
|
onset no_association
|
ISO
|
DNA:polymorphism:CDS:p.A54T (human) Early onset of obesity and resistance to reducing visceral white adipose tissue; DNA:polymorphism:CDS:amino acid A54T, in Japanese women with a BMI > 25 DNA:polymorphism:CDS:amino acid A54T, in Chilean Aymara and Mapuche ethnic groups
|
RGD |
PMID:14981227 PMID:15620432 PMID:17211557 |
RGD:1578458 RGD:1626400 RGD:1626407 |
NCBI chrNW_004936869:146,567...149,929
Ensembl chrNW_004936869:146,844...149,902
|
|
G
|
Fabp3
|
fatty acid binding protein 3
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;mRNA:decreased expression:skeletal muscle
|
RGD |
PMID:17515913 |
RGD:2307328 |
NCBI chrNW_004936474:14,576,582...14,584,362
Ensembl chrNW_004936474:14,574,891...14,585,706
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
|
ISO
|
|
RGD |
PMID:8910278 |
RGD:737747 |
NCBI chrNW_004936656:2,722,970...2,727,383
Ensembl chrNW_004936656:2,722,713...2,729,046
|
|
G
|
Fadd
|
Fas associated via death domain
|
|
ISO
|
protein:increased expression:heart left ventricle
|
RGD |
PMID:18202171 |
RGD:2293027 |
NCBI chrNW_004936599:633,501...639,412
Ensembl chrNW_004936599:633,330...639,456
|
|
G
|
Fads1
|
fatty acid desaturase 1
|
|
ISO
|
protein:decreased expression:microsomes, liver
|
RGD |
PMID:8446010 |
RGD:1625421 |
NCBI chrNW_004936581:1,312,199...1,327,046
Ensembl chrNW_004936581:1,312,183...1,327,998
|
|
G
|
Fanca
|
FA complementation group A
|
|
ISO
|
|
RGD |
PMID:22482891 |
RGD:11046266 |
NCBI chrNW_004936641:281,119...319,796
Ensembl chrNW_004936641:281,073...324,053
|
|
G
|
Fancc
|
FA complementation group C
|
|
ISO
|
|
RGD |
PMID:22482891 |
RGD:11046266 |
NCBI chrNW_004936626:3,980,311...4,147,042
Ensembl chrNW_004936626:3,982,647...4,159,976
|
|
G
|
Fasn
|
fatty acid synthase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936594:5,591,785...5,609,886
Ensembl chrNW_004936594:5,592,609...5,608,972
|
|
G
|
Fbxo11
|
F-box protein 11
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936508:4,622,695...4,708,694
Ensembl chrNW_004936508:4,685,595...4,708,694
|
|
G
|
Fgf21
|
fibroblast growth factor 21
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:24184811 PMID:26797127 |
|
NCBI chrNW_004936664:2,826,823...2,828,330
Ensembl chrNW_004936664:2,826,823...2,828,330
|
|
G
|
Fgfr1
|
fibroblast growth factor receptor 1
|
|
ISO
|
mRNA:increased expression:adipose tissue: mRNA:increased expression:hypothalamus:
|
RGD |
PMID:21430024 |
RGD:10402094 |
NCBI chrNW_004936710:1,760,365...1,815,269
Ensembl chrNW_004936710:1,760,089...1,815,508
|
|
G
|
Fgg
|
fibrinogen gamma chain
|
|
ISO
|
protein:decreased expression:plasma
|
RGD |
PMID:22134356 |
RGD:11352709 |
NCBI chrNW_004936576:1,343,657...1,352,085
Ensembl chrNW_004936576:1,343,661...1,352,143
|
|
G
|
Fggy
|
FGGY carbohydrate kinase domain containing
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29220483 |
|
NCBI chrNW_004936522:2,196,664...2,589,311
Ensembl chrNW_004936522:2,196,015...2,589,296
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27071101 |
|
NCBI chrNW_004936488:4,384,710...4,388,118
Ensembl chrNW_004936488:4,384,705...4,388,122
|
|
G
|
Foxa2
|
forkhead box A2
|
|
ISO
|
|
RGD |
PMID:12865419 |
RGD:1627574 |
NCBI chrNW_004936620:2,966,341...2,969,349
Ensembl chrNW_004936620:2,966,341...2,969,349
|
|
G
|
Foxc2
|
forkhead box C2
|
|
ISO
|
DNA:polymorphism:5'ut:-512C>T(human)
|
RGD |
PMID:15601967 |
RGD:1601218 |
NCBI chrNW_004936641:2,236,224...2,238,501
Ensembl chrNW_004936641:2,236,873...2,238,375
|
|
G
|
Foxo3
|
forkhead box O3
|
|
ISO
|
protein:increased expression:myocardium: CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16467659 PMID:23954404 |
RGD:10402201 |
NCBI chrNW_004936564:4,788,036...4,907,600
Ensembl chrNW_004936564:4,787,992...4,903,837
|
|
G
|
Ftl
|
ferritin light chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936664:2,976,325...2,977,878
Ensembl chrNW_004936664:2,976,314...2,977,877
|
|
G
|
Fto
|
FTO alpha-ketoglutarate dependent dioxygenase
|
severity
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs3751812 (human) mRNA:increased expression:pancreas DNA:SNPs: :rs9939609, rs1421085, rs17817449 (human) DNA:SNP:intron:rs17817449 (human) DNA:SNP:intron:rs9939609 (human) mRNA, protein:increased expression:liver DNA:SNP: :rs9939609 (human)
|
RGD CTD |
PMID:17496892 PMID:19079260 PMID:19079261 PMID:19151714 PMID:19918250 PMID:21076408 PMID:21919686 PMID:23111453 PMID:23134754 PMID:25606423 PMID:29540276 PMID:31801409 PMID:32420297 PMID:35945320 More...
|
RGD:329812007 RGD:329812010 RGD:329812016 RGD:329812040 RGD:329845887 RGD:329901774 RGD:329951013 RGD:329951016 |
NCBI chrNW_004936475:6,321,725...6,689,410
Ensembl chrNW_004936475:6,321,711...6,689,588
|
|
G
|
Fxn
|
frataxin
|
|
ISO
|
DNA:deletion:exon (mouse)
|
RGD |
PMID:17404227 |
RGD:2307045 |
NCBI chrNW_004936503:5,323,206...5,343,228
|
|
G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:liver mRNA, protein:increased expression:white fat
|
RGD |
PMID:15923630 PMID:19230846 |
RGD:2307340 RGD:2307347 |
NCBI chrNW_004936809:1,269,900...1,285,853
Ensembl chrNW_004936809:1,269,914...1,285,889
|
|
G
|
Gabra6
|
gamma-aminobutyric acid type A receptor subunit alpha6
|
|
ISO
|
DNA:polymorphism:3' utr:1519T>C, abdominal obesity and hypercortisolism
|
RGD |
PMID:12080446 |
RGD:1626491 |
NCBI chrNW_004936515:1,982,415...1,997,740
Ensembl chrNW_004936515:1,980,824...1,998,053
|
|
G
|
Gal
|
galanin and GMAP prepropeptide
|
no_association
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:11220530 PMID:15930442 |
RGD:1624334 RGD:1625748 |
NCBI chrNW_004936599:1,563,270...1,567,618
Ensembl chrNW_004936599:1,563,270...1,566,158
|
|
G
|
Galr1
|
galanin receptor 1
|
no_association
|
ISO
|
|
RGD |
PMID:15930442 |
RGD:1625748 |
NCBI chrNW_004936616:2,007,339...2,020,737
Ensembl chrNW_004936616:2,007,352...2,020,737
|
|
G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
treatment
|
ISO
|
|
RGD |
PMID:27987997 |
RGD:13792668 |
NCBI chrNW_004936709:1,243,149...1,247,782
Ensembl chrNW_004936709:1,243,147...1,247,903
|
|
G
|
Gas7
|
growth arrest specific 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19270708 |
|
NCBI chrNW_004936595:2,890,336...3,011,314
Ensembl chrNW_004936595:2,894,643...2,993,545
|
|
G
|
Gcg
|
glucagon
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:20065960 |
|
NCBI chrNW_004936469:16,906,658...16,916,045
Ensembl chrNW_004936469:16,906,658...16,916,045
|
|
G
|
Gck
|
glucokinase
|
|
ISO
|
DNA, mRNA, protein:hypermethylation, increased expression:liver
|
RGD |
PMID:21239437 |
RGD:7488967 |
NCBI chrNW_004936478:19,104,477...19,118,915
Ensembl chrNW_004936478:19,105,361...19,158,733
|
|
G
|
Gckr
|
glucokinase regulator
|
no_association
|
ISO
|
DNA:mutations:CDS:no association with mutations P446L, R590Y, R227X or R518Q in obese French patients despite localization of gene within a QTL for obesity-related phenotypes
|
RGD |
PMID:12739015 |
RGD:1626607 |
NCBI chrNW_004936493:5,080,517...5,101,892
Ensembl chrNW_004936493:5,080,559...5,101,892
|
|
G
|
Gfpt1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11118009 PMID:20882379 |
RGD:1625423 |
NCBI chrNW_004936491:13,603,256...13,665,298
Ensembl chrNW_004936491:13,603,256...13,665,275
|
|
G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, age at onset of
|
OMIM ClinVar |
PMID:11502844 PMID:12050239 PMID:12161552 PMID:16204371 PMID:25741868 |
|
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G
|
Ghsr
|
growth hormone secretagogue receptor
|
|
ISO
|
DNA:point mutation:exon:F279L
|
RGD |
PMID:16511600 |
RGD:1625270 |
NCBI chrNW_004936593:268,736...273,623
Ensembl chrNW_004936593:268,350...277,229
|
|
G
|
Gip
|
gastric inhibitory polypeptide
|
|
ISO
|
associated with Polycystic Ovary Syndrome; protein:increased expression:plasma (human) protein:increased expression:plasma (rat)
|
RGD |
PMID:3546047 PMID:18063845 PMID:19375579 |
RGD:2312547 RGD:2312551 RGD:2312588 |
NCBI chrNW_004936490:12,487,025...12,492,214
Ensembl chrNW_004936490:12,487,025...12,492,214
|
|
G
|
Gipr
|
gastric inhibitory polypeptide receptor
|
susceptibility
|
ISO
|
mRNA:reduced expression:fat tissue (human) DNA:polymorphism:intron 1 C>A (rs2302382) (human) mRNA:splice variant:pancreatic islet (mouse)
|
RGD |
PMID:12068290 PMID:17395281 PMID:17971513 PMID:19254363 |
RGD:2312612 RGD:2312615 RGD:2312616 RGD:737714 |
NCBI chrNW_004936706:2,052,069...2,062,722
Ensembl chrNW_004936706:2,053,433...2,061,241
|
|
G
|
Gja5
|
gap junction protein alpha 5
|
|
ISO
|
mRNA, protein:decreased expression:mesenteric artery
|
RGD |
PMID:18324386 |
RGD:7207466 |
NCBI chrNW_004936867:269,477...279,549
|
|
G
|
Gldc
|
glycine decarboxylase
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:10873393 PMID:11286506 PMID:12126939 PMID:15670722 PMID:15791207 PMID:17361008 PMID:20301531 PMID:25741868 PMID:26179960 PMID:27362913 PMID:28492532 More...
|
|
NCBI chrNW_004936539:1,008,340...1,095,044
Ensembl chrNW_004936539:1,007,820...1,095,054
|
|
G
|
Glp1r
|
glucagon like peptide 1 receptor
|
|
ISO
|
DNA:SNP:intron (rs2268641) (human) mRNA:decreased expression:hypothalamus medial zone
|
RGD |
PMID:15279492 PMID:23900445 |
RGD:1624351 RGD:405650675 |
NCBI chrNW_004936476:20,541,812...20,580,454
Ensembl chrNW_004936476:20,541,775...20,567,188
|
|
G
|
Glrx
|
glutaredoxin
|
|
ISO
|
protein:increased expression:renal visceral adipose:
|
RGD |
PMID:23404913 |
RGD:9686064 |
NCBI chrNW_004936523:7,535,650...7,544,339
Ensembl chrNW_004936523:7,535,857...7,541,864
|
|
G
|
Glul
|
glutamate-ammonia ligase
|
|
ISO
|
protein:increased activity:skeletal muscle:activity is increased in Zucker fa/fa genetically obese but not dietary obese (fa/?) rats vs non-obese (fa/?) rats CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:15481771 PMID:20882379 |
RGD:2301479 |
NCBI chrNW_004936481:7,293,301...7,301,416
Ensembl chrNW_004936481:7,293,091...7,306,202
|
|
G
|
Gnb3
|
G protein subunit beta 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15961981 PMID:16141801 |
|
NCBI chrNW_004936709:970,169...977,059
Ensembl chrNW_004936709:970,172...976,863
|
|
G
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
ISO
|
mRNA:increased expression:pancreatic islet
|
RGD |
PMID:9032096 |
RGD:2313659 |
NCBI chrNW_004936486:2,754,753...2,823,600
Ensembl chrNW_004936486:2,754,751...2,823,665
|
|
G
|
Gpr12
|
G protein-coupled receptor 12
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936472:22,115,933...22,119,674
Ensembl chrNW_004936472:22,117,254...22,119,668
|
|
G
|
Gpr17
|
G protein-coupled receptor 17
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34144038 |
|
NCBI chrNW_004936469:43,652,244...43,656,661
Ensembl chrNW_004936469:43,653,481...43,654,497
|
|
G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
|
ISO
|
protein:increased expression, activity:liver:
|
RGD |
PMID:25865565 |
RGD:11342811 |
NCBI chrNW_004936475:262,558...299,766
Ensembl chrNW_004936475:262,920...297,459
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15184668 PMID:30298849 |
RGD:401960083 |
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G
|
Gpx3
|
glutathione peroxidase 3
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:decreased expression, activity:plasma (mouse) mRNA:decreased expression:adipose tissue (rat) protein:decreased expression:plasma mRNA:decreased expression:embryo, blastocyst
|
CTD RGD |
PMID:11328671 PMID:18562625 PMID:19212806 PMID:19270708 PMID:21535898 PMID:21862610 PMID:31791316 More...
|
RGD:2307430 RGD:2312633 RGD:401827913 RGD:401827923 RGD:5683906 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G
|
Gria4
|
glutamate ionotropic receptor AMPA type subunit 4
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936551:2,426,840...2,760,042
Ensembl chrNW_004936551:2,425,080...2,760,189
|
|
G
|
Gucy2c
|
guanylate cyclase 2C
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936587:2,742,911...2,811,139
Ensembl chrNW_004936587:2,742,911...2,810,969
|
|
G
|
Hadh
|
hydroxyacyl-CoA dehydrogenase
|
|
ISO
|
protein:increased expression:skeletal muscle CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16088331 PMID:20882379 |
RGD:2302228 |
NCBI chrNW_004936818:575,272...623,496
Ensembl chrNW_004936818:575,023...623,568
|
|
G
|
Hcrt
|
hypocretin neuropeptide precursor
|
|
ISO
|
mRNA:increased expression:perifornical nucleus protein:decreased expression:plasma:orexin A NOT orexin B polypeptide, expression inversely related to degree of obesity protein:increased expression:plasma:fasting patients, no change after weight loss due to gastric banding CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:12560202 PMID:15970339 PMID:16135994 PMID:27071101 |
RGD:1358428 RGD:1600932 RGD:1600933 |
NCBI chrNW_004936490:17,007,001...17,008,363
Ensembl chrNW_004936490:17,006,997...17,008,369
|
|
G
|
Hdac4
|
histone deacetylase 4
|
|
ISO
|
mRNA,protein:decreased expression:mononuclear cell, adipose tissue:
|
RGD |
PMID:24086512 |
RGD:9681453 |
NCBI chrNW_004936745:1,730,743...1,942,071
Ensembl chrNW_004936745:1,730,694...1,942,074
|
|
G
|
Hfe
|
homeostatic iron regulator
|
|
ISO
|
associated with Diabetes Mellitus, Type 2;DNA:missense mutations:CDS:p.C282Y, p.H63D (human)
|
RGD |
PMID:10705106 |
RGD:1601449 |
NCBI chrNW_004936671:1,940,079...1,947,574
Ensembl chrNW_004936671:1,940,101...1,947,580
|
|
G
|
Hgf
|
hepatocyte growth factor
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:12706940 |
RGD:1642704 |
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
ISO
|
associated with hepatocellular carcinoma;RNA:decreased expression:liver:
|
RGD |
PMID:31321740 |
RGD:155882550 |
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G
|
Hk1
|
hexokinase 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:131232 PMID:12524468 |
RGD:1601527 RGD:1601528 |
NCBI chrNW_004936521:9,067,062...9,139,112
Ensembl chrNW_004936521:9,066,999...9,159,793
|
|
G
|
Hk2
|
hexokinase 2
|
|
ISO
|
mRNA:increased expression:gastrocnemius CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:11319725 PMID:16555472 PMID:20882379 |
RGD:1624365 RGD:2313227 |
NCBI chrNW_004936556:1,054,143...1,113,425
Ensembl chrNW_004936556:1,054,021...1,113,450
|
|
G
|
Hmga2
|
high mobility group AT-hook 2
|
|
ISO
|
|
RGD |
PMID:10742101 |
RGD:1601569 |
NCBI chrNW_004936545:3,944,419...3,958,289
Ensembl chrNW_004936545:3,944,419...4,064,193
|
|
G
|
Hmgb2
|
high mobility group box 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936516:4,536,664...4,539,331
Ensembl chrNW_004936516:4,534,306...4,539,387
|
|
G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
|
ISO
|
protein:decreased activity:liver (rat)
|
RGD |
PMID:1685984 |
RGD:2326155 |
NCBI chrNW_004936480:18,862,288...18,882,614
Ensembl chrNW_004936480:18,862,238...18,882,616
|
|
G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18334666 PMID:18375438 PMID:19171794 |
|
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G
|
Hoxb5
|
homeobox B5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22484627 |
|
NCBI chrNW_004936490:12,793,485...12,796,219
Ensembl chrNW_004936490:12,793,485...12,796,219
|
|
G
|
Hrh3
|
histamine receptor H3
|
|
ISO
|
|
RGD |
PMID:17189541 |
RGD:1626405 |
NCBI chrNW_004936514:9,862,104...9,865,614
Ensembl chrNW_004936514:9,862,523...9,873,159
|
|
G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:increased expression:adipose tissue:13-fold higher in obese subjects than controls, protein expression also increased
|
CTD RGD |
PMID:15131764 PMID:16612591 PMID:16914598 PMID:17628001 PMID:21786805 |
RGD:1625071 RGD:1625072 RGD:1625073 |
NCBI chrNW_004936557:3,358,809...3,403,461
Ensembl chrNW_004936557:3,357,016...3,403,714
|
|
G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
resistance
|
ISO
|
transgenic mice expressing human HSD11B2 mRNA:increased expression:adipose tissue:subcutaneous not retroperitoneal fat
|
RGD |
PMID:15793240 PMID:17208436 |
RGD:1625081 RGD:1625083 |
NCBI chrNW_004936475:17,882,663...17,888,708
Ensembl chrNW_004936475:17,882,575...17,887,748
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26655953 |
|
NCBI chrNW_004936487:13,348,465...13,352,717
Ensembl chrNW_004936487:13,348,465...13,352,717
|
|
G
|
Htr1b
|
5-hydroxytryptamine receptor 1B
|
|
ISO
|
protein:increase expression:arcuate nucleus
|
RGD |
PMID:10564740 |
RGD:1626450 |
NCBI chrNW_004936890:154,252...157,044
Ensembl chrNW_004936890:155,233...156,408
|
|
G
|
Htr2a
|
5-hydroxytryptamine receptor 2A
|
no_association susceptibility
|
ISO
|
DNA:SNP:intron (rs912127) (human) DNA:polymorphism:promoter:-1438G>A CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16328014 PMID:16491645 PMID:17097612 PMID:23900445 |
RGD:1624369 RGD:1624370 RGD:405650675 |
NCBI chrNW_004936565:335,238...394,683
Ensembl chrNW_004936565:334,393...394,715
|
|
G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:-759C>T CTD Direct Evidence: marker/mechanism associated with Schizophrenia and Psychotic Disorders;DNA:polymorphisms:promoter:multiple
|
RGD CTD |
PMID:15048662 PMID:17016522 PMID:17702092 PMID:19142110 |
RGD:1624982 RGD:1624991 |
NCBI chrNW_004936499:1,002,083...1,109,446
Ensembl chrNW_004936499:1,004,732...1,109,377
|
|
G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
protein:increased secretion:plasma (human) protein:increased expression:submandibular gland (rat) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:11782876 PMID:20004360 PMID:20973827 |
RGD:4145329 RGD:4145463 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
ISO
|
|
RGD |
PMID:14969338 |
RGD:1626475 |
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G
|
Ido1
|
indoleamine 2,3-dioxygenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27020609 |
|
NCBI chrNW_004936843:658,058...672,662
Ensembl chrNW_004936843:657,979...672,700
|
|
G
|
Ifng
|
interferon gamma
|
|
ISO
|
associated with Asthma;protein:increased expression:serum
|
RGD |
PMID:19575934 |
RGD:2311494 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G
|
Igf1r
|
insulin like growth factor 1 receptor
|
|
ISO
|
mRNA:decreased expression:heart (rat)
|
RGD |
PMID:11009458 |
RGD:12904882 |
NCBI chrNW_004936483:4,563,995...4,860,231
Ensembl chrNW_004936483:4,564,512...4,852,925
|
|
G
|
Igf2
|
insulin like growth factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11528401 |
|
NCBI chrNW_004936816:972,902...981,232
Ensembl chrNW_004936816:972,282...979,167
|
|
G
|
Igfbp2
|
insulin like growth factor binding protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17259371 PMID:17426323 PMID:22537059 |
RGD:1626478 RGD:1626479 |
NCBI chrNW_004936586:671,760...696,783
Ensembl chrNW_004936586:672,091...696,692
|
|
G
|
Igfbp3
|
insulin like growth factor binding protein 3
|
|
ISO
|
mRNA, protein:decreased expression:pancreatic fat pad
|
RGD |
PMID:22067319 |
RGD:10402755 |
NCBI chrNW_004936478:20,511,490...20,518,251
Ensembl chrNW_004936478:20,510,137...20,518,306
|
|
G
|
Igfbp6
|
insulin like growth factor binding protein 6
|
|
ISO
|
human transgene overexpressed in mouse brain
|
RGD |
PMID:15889232 |
RGD:2301717 |
NCBI chrNW_004936512:10,415,004...10,419,698
Ensembl chrNW_004936512:10,414,807...10,419,741
|
|
G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:15685173 |
RGD:10045952 |
NCBI chrNW_004936785:358,128...406,751
Ensembl chrNW_004936785:356,168...406,773
|
|
G
|
Il10
|
interleukin 10
|
|
ISO
|
protein:increase expression:serum
|
RGD |
PMID:18787467 PMID:28843383 |
RGD:14975146 RGD:2308945 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G
|
Il15
|
interleukin 15
|
|
ISO
|
mRNA, protein:altered expression:skeletal muscle, plasma
|
RGD |
PMID:18697873 |
RGD:2313573 |
NCBI chrNW_004936535:6,344,348...6,358,803
Ensembl chrNW_004936535:6,344,395...6,350,197
|
|
G
|
Il18
|
interleukin 18
|
treatment
|
ISO
|
|
RGD |
PMID:16732281 PMID:20490358 |
RGD:14695532 RGD:7175343 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G
|
Il1b
|
interleukin 1 beta
|
treatment
|
ISO
|
protein:increased expression:plasma (mouse) protein:increased expression:kidney (rat)
|
RGD |
PMID:16567518 PMID:20490358 PMID:23150506 PMID:24146106 PMID:28843383 |
RGD:10450599 RGD:14975146 RGD:1626637 RGD:7175086 RGD:7175343 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
mRNA, protein:increased expression:adipose tissue
|
RGD |
PMID:12716739 PMID:12975454 |
RGD:1626664 RGD:1626665 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G
|
Il3
|
interleukin 3
|
|
ISO
|
protein: decreased expression: plasma
|
RGD |
PMID:21203453 |
RGD:5686875 |
NCBI chrNW_004936647:3,102,922...3,104,758
|
|
G
|
Il6
|
interleukin 6
|
|
ISO
|
DNA:polymorphism>promoter:174G>C associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human) mRNA:increased expression:islet of Langerhans CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16493118 PMID:19228869 PMID:20141834 PMID:21826222 PMID:24042701 |
RGD:10402828 RGD:1601582 RGD:2307257 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G
|
Il6r
|
interleukin 6 receptor
|
susceptibility
|
ISO
|
DNA:SNP, haplotypes:promoter:-208G>A (rs4845617) (human) protein:increased expression:serum DNA:duplication DNA:polymorphism: :p.D358A
|
RGD |
PMID:12917504 PMID:16817825 PMID:17434052 PMID:17984249 |
RGD:10402807 RGD:1625428 RGD:1625429 RGD:1625430 |
NCBI chrNW_004936580:4,055,438...4,081,876
Ensembl chrNW_004936580:4,057,771...4,081,885
|
|
G
|
Il7
|
interleukin 7
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:20376352 |
|
NCBI chrNW_004936702:110,625...162,957
Ensembl chrNW_004936702:111,211...162,322
|
|
G
|
Inpp5e
|
inositol polyphosphate-5-phosphatase E
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:skeletal muscle, white adipose tissue
|
RGD CTD |
PMID:19668215 PMID:23349329 |
RGD:12911211 |
NCBI chrNW_004936669:1,377,005...1,385,287
|
|
G
|
Inppl1
|
inositol polyphosphate phosphatase like 1
|
|
ISO
|
DNA:SNPs: :rs2276047,snp8,rs9886(human)
|
RGD |
PMID:15220217 |
RGD:1626127 |
NCBI chrNW_004936498:1,524,128...1,539,680
Ensembl chrNW_004936498:1,524,128...1,540,578
|
|
G
|
Ins
|
insulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:2777199 PMID:8923850 PMID:11528401 PMID:29035695 |
|
NCBI chrNW_004936816:1,002,137...1,003,357
Ensembl chrNW_004936816:1,002,137...1,003,357
|
|
G
|
Irs1
|
insulin receptor substrate 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:decreased tyrosine phosphorylation, increased serine phosphorylation:skeletal muscle
|
CTD RGD |
PMID:22982470 PMID:23954404 |
RGD:7207062 |
NCBI chrNW_004936525:9,064,442...9,125,972
Ensembl chrNW_004936525:9,064,466...9,122,635
|
|
G
|
Itgam
|
integrin subunit alpha M
|
|
ISO
|
protein:increased expression:monocyte (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:21446916 PMID:29035695 |
RGD:329901665 |
NCBI chrNW_004936543:8,460,526...8,508,524
Ensembl chrNW_004936543:8,461,307...8,508,524
|
|
G
|
Itih4
|
inter-alpha-trypsin inhibitor heavy chain 4
|
|
ISO
|
|
RGD |
PMID:22134356 |
RGD:11352709 |
NCBI chrNW_004936473:3,573,282...3,589,345
Ensembl chrNW_004936473:3,573,384...3,589,345
|
|
G
|
Jak2
|
Janus kinase 2
|
|
ISO
|
protein:decreased expression:hypothalamus mRNA:decreased expression:omental adipose tissue:by microarray
|
RGD |
PMID:14630696 PMID:23397595 |
RGD:10411893 RGD:1627661 |
NCBI chrNW_004936503:111,722...243,627
Ensembl chrNW_004936503:110,963...241,867
|
|
G
|
Kcnh2
|
potassium voltage-gated channel subfamily H member 2
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:7889573 PMID:9024139 PMID:9927399 PMID:10753933 PMID:10973849 PMID:11113008 PMID:11468227 PMID:11668638 PMID:11854117 PMID:12354768 PMID:15051636 PMID:15840476 PMID:16432067 PMID:17160940 PMID:17445409 PMID:18441445 PMID:18593567 PMID:19716085 PMID:19841300 PMID:22581653 PMID:22949429 PMID:23303164 PMID:24606995 PMID:24623279 PMID:24667783 PMID:25741868 PMID:26847485 PMID:28492532 PMID:29672598 PMID:30246897 More...
|
|
NCBI chrNW_004936527:6,380,222...6,412,390
Ensembl chrNW_004936527:6,379,669...6,412,390
|
|
G
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27605626 |
|
NCBI chrNW_004936521:2,000,113...2,706,010
Ensembl chrNW_004936521:2,000,109...2,705,365
|
|
G
|
Kctd15
|
potassium channel tetramerization domain containing 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19079261 |
|
NCBI chrNW_004936570:2,080,549...2,096,929
Ensembl chrNW_004936570:2,080,547...2,096,929
|
|
G
|
Kdm3a
|
lysine demethylase 3A
|
|
ISO
|
OMIM:601665
|
RGD MouseDO |
PMID:19875498 |
RGD:9590220 |
NCBI chrNW_004936712:1,053,210...1,097,845
Ensembl chrNW_004936712:1,053,210...1,096,961
|
|
G
|
Kif4a
|
kinesin family member 4A
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936762:1,062,570...1,194,192
Ensembl chrNW_004936762:1,061,526...1,187,863
|
|
G
|
Kitlg
|
KIT ligand
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23954404 |
|
NCBI chrNW_004936507:5,566,144...5,650,412
Ensembl chrNW_004936507:5,565,821...5,650,828
|
|
G
|
Lactb
|
lactamase beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18344982 |
|
NCBI chrNW_004936471:23,713,144...23,732,214
Ensembl chrNW_004936471:23,713,100...23,732,216
|
|
G
|
Lbp
|
lipopolysaccharide binding protein
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:19917068 PMID:23349936 |
RGD:9685197 |
NCBI chrNW_004936561:3,017,471...3,035,481
Ensembl chrNW_004936561:3,016,926...3,035,552
|
|
G
|
Lcn2
|
lipocalin 2
|
|
ISO
|
mRNA:decreased expression:ovary, testicle protein:increased expression:serum mRNA:increased expression:epididymal fat pad, adipose cell (rat)
|
RGD |
PMID:18292240 PMID:21143924 PMID:32627017 |
RGD:126790490 RGD:126790530 RGD:2316514 |
NCBI chrNW_004936487:15,721,752...15,725,396
Ensembl chrNW_004936487:15,721,684...15,728,221
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25554529 |
|
NCBI chrNW_004936659:1,259,405...1,300,545
Ensembl chrNW_004936659:1,259,369...1,302,294
|
|
G
|
Lep
|
leptin
|
treatment no_association
|
ISO
|
mouse protein in a rat model in a US Caucasian population ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity
|
RGD ClinVar |
PMID:10029567 PMID:15910756 PMID:23793169 PMID:25741868 PMID:28492532 |
RGD:10053612 RGD:10053638 RGD:1643130 |
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Lepr
|
leptin receptor
|
disease_progression sexual_dimorphism no_association treatment susceptibility
|
ISO
|
compared to BN DNA:polymorphism:exon:p.Q223R (human) ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder
|
RGD ClinVar |
PMID:8666155 PMID:9545018 PMID:11354636 PMID:11380591 PMID:11443193 PMID:12006639 PMID:16284652 PMID:17785359 PMID:18204169 PMID:18490929 PMID:20159938 PMID:21393862 PMID:21744741 PMID:22331430 PMID:25741868 PMID:26467025 PMID:27465994 PMID:28492532 PMID:33568522 More...
|
RGD:10412018 RGD:10412023 RGD:12911217 RGD:401965412 RGD:5128855 RGD:7365117 |
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
G
|
Leprot
|
leptin receptor overlapping transcript
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936692:2,840,461...2,850,756
Ensembl chrNW_004936692:2,840,332...2,894,726
|
|
G
|
Lipc
|
lipase C, hepatic type
|
|
ISO
|
protein:altered expression:liver, plasma (rat) associated with Diabetes Mellitus, Insulin-Dependent; protein:increased expression:plasma (human)
|
RGD |
PMID:11544558 PMID:12843191 |
RGD:2308784 RGD:2308835 |
NCBI chrNW_004936471:19,604,083...19,733,721
Ensembl chrNW_004936471:19,703,236...19,733,686
|
|
G
|
Lipe
|
lipase E, hormone sensitive type
|
|
ISO
|
mRNA:decreased expression:white fat
|
RGD |
PMID:17712951 |
RGD:2313580 |
NCBI chrNW_004936706:122,939...139,506
Ensembl chrNW_004936706:128,133...141,276
|
|
G
|
Lipg
|
lipase G, endothelial type
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:16772345 |
RGD:1641819 |
NCBI chrNW_004936497:13,406,402...13,429,833
Ensembl chrNW_004936497:13,406,357...13,429,890
|
|
G
|
LOC101955831
|
heat shock 70 kDa protein 1
|
|
ISO
|
DNA:SNP:CDS:homozygous P2/P2 allele at position 1267 (p<0.000001)
|
RGD |
PMID:11319647 |
RGD:1626642 |
NCBI chrNW_004936727:1,718,952...1,721,691
|
|
G
|
LOC101960314
|
cytochrome b5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936616:4,176,576...4,210,276
|
|
G
|
LOC101961000
|
cytochrome c oxidase subunit 7C, mitochondrial
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936469:5,337,331...5,339,716
Ensembl chrNW_004936469:5,337,333...5,342,174
|
|
G
|
LOC101967786
|
L-xylulose reductase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936594:5,532,264...5,534,129
Ensembl chrNW_004936594:5,531,560...5,538,105
|
|
G
|
LOC101968793
|
glucosamine-6-phosphate isomerase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19079261 |
|
NCBI chrNW_004936482:11,382,358...11,423,823
Ensembl chrNW_004936482:11,397,322...11,423,885 Ensembl chrNW_004936482:11,397,322...11,423,885
|
|
G
|
LOC101968921
|
angiotensin-converting enzyme
|
no_association
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:17164796 PMID:19361967 |
RGD:1601115 RGD:2325227 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G
|
LOC101969021
|
somatotropin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8923850 |
|
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G
|
LOC101970101
|
cytochrome P450 1B1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:27036855 |
|
NCBI chrNW_004936663:345,021...355,188
Ensembl chrNW_004936663:348,368...355,191
|
|
G
|
LOC101970551
|
inhibitor of carbonic anhydrase
|
|
ISO
|
|
RGD |
PMID:16267817 |
RGD:1601520 |
NCBI chrNW_004936529:6,856,042...6,895,989
|
|
G
|
LOC101970831
|
serotransferrin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936529:6,917,762...6,947,512
Ensembl chrNW_004936529:6,855,958...6,947,394
|
|
G
|
LOC101971027
|
neuroendocrine secretory protein 55
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:11784876 PMID:12970262 PMID:21525160 PMID:23281139 PMID:23796510 PMID:25741868 PMID:25802881 PMID:28492532 PMID:29059381 More...
|
|
NCBI chrNW_004936530:1,353,432...1,407,437
|
|
G
|
LOC101972957
|
vitamin D 25-hydroxylase
|
|
ISO
|
associated with hypertension:DNA:SNP:CDS: rs12794714 (human)
|
RGD |
PMID:34906413 |
RGD:401900724 |
NCBI chrNW_004936528:3,881,630...3,897,613
Ensembl chrNW_004936528:3,881,087...3,900,302
|
|
G
|
LOC101973029
|
cytochrome P450 2E1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased activity:liver,fat
|
CTD RGD |
PMID:17049493 PMID:23954404 |
RGD:1626307 |
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G
|
LOC101973421
|
amine oxidase copper containing 3
|
|
ISO
|
|
RGD |
PMID:17977742 |
RGD:2313916 |
NCBI chrNW_004936490:17,549,836...17,564,867
|
|
G
|
LOC101973430
|
cytochrome b-c1 complex subunit 2, mitochondrial
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936501:6,947,985...6,968,846
Ensembl chrNW_004936501:6,947,985...6,970,254
|
|
G
|
LOC101973720
|
rap guanine nucleotide exchange factor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936512:5,636,197...5,659,606
Ensembl chrNW_004936512:5,636,758...5,659,300 Ensembl chrNW_004936512:5,636,758...5,659,300
|
|
G
|
LOC101975674
|
cytochrome P450 26B1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936491:16,010,394...16,028,852
Ensembl chrNW_004936491:16,010,070...16,028,895
|
|
G
|
LOC101976500
|
haptoglobin
|
treatment
|
ISO
|
protein:increased expression:serum mRNA:increased expression:white fat
|
RGD |
PMID:11807829 PMID:15181041 PMID:17161237 PMID:19917068 |
RGD:1626339 RGD:1626346 RGD:1626349 RGD:9685197 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G
|
LOC101978323
|
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphisms:promoter, intron:g.-1260C>A, g.2838T>C (human)
|
RGD |
PMID:17223345 |
RGD:2307312 |
NCBI chrNW_004936646:1,899,686...1,904,104
Ensembl chrNW_004936646:1,900,259...1,904,104
|
|
G
|
Lpl
|
lipoprotein lipase
|
treatment
|
ISO
|
mRNA:increased expression:white fat CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17712951 PMID:18344982 PMID:18952837 PMID:27160499 PMID:28514832 |
RGD:13793401 RGD:13794378 RGD:2313300 RGD:2313580 |
NCBI chrNW_004936555:4,084,099...4,108,219
Ensembl chrNW_004936555:4,084,099...4,108,365
|
|
G
|
Mapk1
|
mitogen-activated protein kinase 1
|
|
ISO
|
protein:increased phosphorylation:endometrium (human)
|
RGD |
PMID:20074784 |
RGD:13782055 |
NCBI chrNW_004936619:1,889,841...1,932,646
Ensembl chrNW_004936619:1,889,708...1,932,646
|
|
G
|
Mapk3
|
mitogen-activated protein kinase 3
|
|
ISO
|
protein:increased phosphorylation:endometrium (human)
|
RGD |
PMID:20074784 |
RGD:13782055 |
NCBI chrNW_004936501:12,342,670...12,390,650
Ensembl chrNW_004936501:12,384,804...12,392,180
|
|
G
|
Mapt
|
microtubule associated protein tau
|
|
ISO
|
|
RGD |
PMID:25257559 |
RGD:13800921 |
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G
|
Mc3r
|
melanocortin 3 receptor
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: Obesity DNA:missense mutations:cds:p.T6K, p.V81I (human)
|
ClinVar RGD |
PMID:16123355 |
RGD:6484587 |
NCBI chrNW_004936875:172,764...174,446
Ensembl chrNW_004936875:172,862...173,830
|
|
G
|
Mc4r
|
melanocortin 4 receptor
|
|
ISO
|
ClinVar Annotator: match by term: ADCY3-related condition | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity due to melanocortin 4 receptor deficiency | ClinVar Annotator: match by term: Obesity, autosomal dominant | ClinVar Annotator: match by term: SIM1-related condition ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, autosomal dominant ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, autosomal dominant | ClinVar Annotator: match by term: SIM1-related condition
|
ClinVar |
PMID:8392067 PMID:9267995 PMID:10078568 PMID:10199800 PMID:10577903 PMID:10585465 PMID:10592235 PMID:10903341 PMID:10903343 PMID:11443223 PMID:11487744 PMID:12032748 PMID:12364414 PMID:12364415 PMID:12499395 PMID:12588803 PMID:12629567 PMID:12646665 PMID:12646666 PMID:12690102 PMID:12815165 PMID:12851297 PMID:12959994 PMID:12970296 PMID:14633862 PMID:14764812 PMID:14764818 PMID:14973783 PMID:15037865 PMID:15126516 PMID:15448103 PMID:15466016 PMID:15486053 PMID:15585384 PMID:15805150 PMID:15975705 PMID:16030156 PMID:16032553 PMID:16083993 PMID:16094248 PMID:16231025 PMID:16274851 PMID:16289450 PMID:16469222 PMID:16492696 PMID:16507637 PMID:16611215 PMID:16614075 PMID:16616374 PMID:16710097 PMID:16752916 PMID:16886960 PMID:16960181 PMID:17185898 PMID:17286227 PMID:17306938 PMID:17356525 PMID:17357083 PMID:17418015 PMID:17492953 PMID:17517246 PMID:17519222 PMID:17579204 PMID:17587397 PMID:17590021 PMID:17628007 PMID:17668051 PMID:17986382 PMID:18559663 PMID:18801902 PMID:18835933 PMID:18997677 PMID:19011902 PMID:19091795 PMID:19179454 PMID:19184404 PMID:19244934 PMID:19284607 PMID:19298524 PMID:19301229 PMID:19400288 PMID:19417090 PMID:19696756 PMID:19766264 PMID:19889825 PMID:20462274 PMID:20631012 PMID:20696697 PMID:20826565 PMID:20966905 PMID:20975296 PMID:21085626 PMID:21404042 PMID:22106157 PMID:22447289 PMID:22463805 PMID:22688572 PMID:22822657 PMID:23146882 PMID:23251400 PMID:23505181 PMID:23791567 PMID:24248383 PMID:24276017 PMID:24385306 PMID:24426828 PMID:24512492 PMID:24611737 PMID:24705671 PMID:24780838 PMID:24890885 PMID:25076858 PMID:25136332 PMID:25332687 PMID:25741868 PMID:25741869 PMID:26047380 PMID:26179253 PMID:26238496 PMID:26244670 PMID:26467025 PMID:26588347 PMID:26666384 PMID:26782456 PMID:26788538 PMID:27222505 PMID:27654141 PMID:28166811 PMID:28218067 PMID:28492532 PMID:29031731 PMID:29273807 PMID:29311635 PMID:29679223 PMID:29758564 PMID:29861388 PMID:29970488 PMID:30048591 PMID:30068297 PMID:30586318 PMID:30719650 PMID:30811542 PMID:30926952 PMID:30991789 PMID:31002796 PMID:31118516 PMID:31841602 PMID:31947684 PMID:32185475 PMID:32534219 PMID:32916307 PMID:32952152 PMID:32971154 PMID:33761344 PMID:33889637 PMID:35562395 PMID:36775011 PMID:38528040 More...
|
|
NCBI chrNW_004936497:4,636,370...4,638,205
Ensembl chrNW_004936497:4,636,758...4,637,759
|
|
G
|
Mchr1
|
melanin concentrating hormone receptor 1
|
|
ISO
|
mRNA:increased expression:hypothalamus
|
RGD |
PMID:15363890 |
RGD:1624360 |
NCBI chrNW_004936492:1,153,895...1,156,980
Ensembl chrNW_004936492:1,153,651...1,157,142
|
|
G
|
Me1
|
malic enzyme 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19270708 |
|
NCBI chrNW_004936510:7,425,983...7,571,090
Ensembl chrNW_004936510:7,426,347...7,571,553
|
|
G
|
Mfn2
|
mitofusin 2
|
|
ISO
|
mRNA:decreased expression:skeletal muscle tissue (human) mRNA:decreased expression:liver (rat)
|
RGD |
PMID:12598526 PMID:25336449 |
RGD:12880438 RGD:1601412 |
NCBI chrNW_004936474:767,754...795,258
Ensembl chrNW_004936474:767,671...796,556
|
|
G
|
Mgrn1
|
mahogunin ring finger 1
|
|
ISO
|
|
RGD |
PMID:16638826 |
RGD:1641947 |
NCBI chrNW_004936530:4,647,550...4,693,143
Ensembl chrNW_004936530:4,652,464...4,693,999
|
|
G
|
Mif
|
macrophage migration inhibitory factor
|
|
ISO
|
DNA:polymorphisms:promoter mRNA, protein:increased expression:mononuclear cell, plasma
|
RGD |
PMID:15472203 PMID:16247506 |
RGD:1641950 RGD:1641953 |
NCBI chrNW_004936619:1,207,058...1,208,010
Ensembl chrNW_004936619:1,203,746...1,208,442
|
|
G
|
Mkks
|
MKKS centrosomal shuttling protein
|
no_association
|
ISO
|
protein:substitution:A242S possible contribution unlikely to play a major role in the pathogenesis of nonsyndromic obesity OMIM:601665
|
RGD MouseDO |
PMID:10973251 PMID:15483080 |
RGD:1581208 RGD:1601414 |
NCBI chrNW_004936485:9,089,118...9,114,396
Ensembl chrNW_004936485:9,088,963...9,115,175
|
|
G
|
Mmp19
|
matrix metallopeptidase 19
|
|
ISO
|
mRNA:increased expression:adipose tissue
|
RGD |
PMID:12529376 PMID:15169894 |
RGD:1642022 RGD:1642023 |
NCBI chrNW_004936646:298,854...304,479
Ensembl chrNW_004936646:299,059...304,430
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17512313 PMID:21156398 |
RGD:1642026 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G
|
Mmut
|
methylmalonyl-CoA mutase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936476:11,208,251...11,241,648
Ensembl chrNW_004936476:11,208,267...11,241,648
|
|
G
|
Mrap2
|
melanocortin 2 receptor accessory protein 2
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936510:6,905,870...6,945,583
Ensembl chrNW_004936510:6,904,795...6,945,626
|
|
G
|
Mrc1
|
mannose receptor C-type 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29035695 |
|
NCBI chrNW_004936520:9,463,007...9,547,321
Ensembl chrNW_004936520:9,463,007...9,547,257
|
|
G
|
Mt3
|
metallothionein 3
|
|
ISO
|
|
RGD |
PMID:21726645 |
RGD:6480475 |
NCBI chrNW_004936475:8,864,512...8,866,516
Ensembl chrNW_004936475:8,864,675...8,866,506
|
|
G
|
Mtch2
|
mitochondrial carrier 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19079261 |
|
NCBI chrNW_004936562:1,622,341...1,644,191
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
|
ISO
|
mRNA, protein:decreased expression:hypothalamus
|
RGD |
PMID:25807795 |
RGD:11570513 |
NCBI chrNW_004936474:158,376...282,310
Ensembl chrNW_004936474:157,590...282,342
|
|
G
|
Mttp
|
microsomal triglyceride transfer protein
|
susceptibility
|
ISO
|
DNA:polymorphisms
|
RGD |
PMID:15635487 |
RGD:1625486 |
NCBI chrNW_004936520:3,337,726...3,417,818
Ensembl chrNW_004936520:3,338,881...3,381,627
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
|
ISO
|
mRNA:decreased expression:pancreas (rat)
|
RGD |
PMID:22421529 |
RGD:7240547 |
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
|
|
G
|
Myh10
|
myosin heavy chain 10
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936595:1,697,283...1,832,571
Ensembl chrNW_004936595:1,694,102...1,832,364
|
|
G
|
Myh9
|
myosin heavy chain 9
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 PMID:31064749 |
|
NCBI chrNW_004936492:4,384,215...4,466,229
Ensembl chrNW_004936492:4,384,215...4,466,262
|
|
G
|
Myod1
|
myogenic differentiation 1
|
|
ISO
|
mRNA:decreased expression:plantaris
|
RGD |
PMID:18508911 PMID:22349736 |
RGD:2313320 RGD:9686079 |
NCBI chrNW_004936528:1,407,187...1,409,683
Ensembl chrNW_004936528:1,407,661...1,409,573
|
|
G
|
Myog
|
myogenin
|
|
ISO
|
mRNA:decreased expression:plantaris
|
RGD |
PMID:18508911 |
RGD:2313320 |
NCBI chrNW_004936567:1,507,042...1,509,814
Ensembl chrNW_004936567:1,507,042...1,509,815
|
|
G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
|
CTD RGD |
PMID:17618961 PMID:23834033 |
RGD:1642336 |
NCBI chrNW_004936479:17,682,070...17,716,713
Ensembl chrNW_004936479:17,682,201...17,716,661
|
|
G
|
Ncf2
|
neutrophil cytosolic factor 2
|
|
ISO
|
protein:increased expression:artery
|
RGD |
PMID:17515452 |
RGD:2314435 |
NCBI chrNW_004936481:6,300,894...6,325,878
Ensembl chrNW_004936481:6,301,012...6,324,787
|
|
G
|
Ncoa1
|
nuclear receptor coactivator 1
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936493:7,368,393...7,605,754
Ensembl chrNW_004936493:7,368,462...7,465,615
|
|
G
|
Ncoa3
|
nuclear receptor coactivator 3
|
|
ISO
|
DNA:polymorphism:CDS:C-terminus polyglutamine repeat, combination of long polyglutamine repeat in NCOA3 and homozygous A1/A1 Progesterone Receptor genotype associated with obesity in 301 postmenopausal women with breast cancer
|
RGD |
PMID:14557830 |
RGD:1642050 |
NCBI chrNW_004936514:5,900,135...5,967,862
Ensembl chrNW_004936514:5,901,601...5,967,865
|
|
G
|
Ndufb6
|
NADH:ubiquinone oxidoreductase subunit B6
|
|
ISO
|
mRNA:decreased expression:epididymal fat pad
|
RGD |
PMID:20559011 |
RGD:13822707 |
NCBI chrNW_004936524:1,231,744...1,243,783
Ensembl chrNW_004936524:1,231,852...1,243,659
|
|
G
|
Negr1
|
neuronal growth regulator 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19079261 |
|
NCBI chrNW_004936591:112,864...903,598
Ensembl chrNW_004936591:113,013...899,271
|
|
G
|
Neil1
|
nei like DNA glycosylase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism OMIM:601665
|
CTD MouseDO |
PMID:16446448 PMID:21285402 |
|
NCBI chrNW_004936471:34,184,273...34,192,675
Ensembl chrNW_004936471:34,186,729...34,192,501
|
|
G
|
Neurod1
|
neuronal differentiation 1
|
|
ISO
|
mRNA:increased expression:pancreas
|
RGD |
PMID:15979049 |
RGD:1625044 |
NCBI chrNW_004936509:10,421,821...10,425,927
Ensembl chrNW_004936509:10,423,126...10,424,196
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
|
ISO
|
protein:decreased expression:hepatocyte: protein:decreased expression:liver macrophage:
|
RGD |
PMID:32102936 |
RGD:21201281 |
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G
|
Nhlh2
|
nescient helix-loop-helix 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20808804 |
|
NCBI chrNW_004936627:1,130,064...1,135,092
Ensembl chrNW_004936627:1,131,807...1,135,012
|
|
G
|
Nmb
|
neuromedin B
|
susceptibility
|
ISO
|
DNA:polymorphism:CDS:217C>A, amino acid P73T, associated with disinhibition toward food (p=0.03), susceptibility to hunger (p=0.01) and increased percent body fat (p<0.05) DNA:polymorphism:CDS:401G>A, silent mutation in stop codon, associated with body weight (p=0.02) protein:increased expression:central hypothalamus:concentrations higher in obese (fa/fa) than in lean (Fa/?) male Zucker rats, not affected by weight loss
|
RGD |
PMID:1709601 PMID:11194934 PMID:15585758 |
RGD:1642059 RGD:1642062 RGD:1642063 |
NCBI chrNW_004936483:16,712,382...16,715,397
Ensembl chrNW_004936483:16,712,363...16,715,749
|
|
G
|
Nmu
|
neuromedin U
|
susceptibility
|
ISO
|
DNA:polymorphisms:cds:p.R165W,p.A19E
|
RGD |
PMID:15448684 PMID:16984985 PMID:17706946 |
RGD:1642093 RGD:1642094 RGD:1642095 |
Ensembl chrNW_004936482:17,936,467...17,961,711
|
|
G
|
Nnt
|
nicotinamide nucleotide transhydrogenase
|
|
ISO
|
protein:decreased expression:gastrocnemius, soleus
|
RGD |
PMID:25761734 |
RGD:13513980 |
NCBI chrNW_004936480:18,599,037...18,692,097
Ensembl chrNW_004936480:18,598,481...18,691,859
|
|
G
|
Nos1
|
nitric oxide synthase 1
|
|
ISO
|
|
RGD |
PMID:16316351 |
RGD:1642132 |
NCBI chrNW_004936558:5,162,471...5,302,488
Ensembl chrNW_004936558:5,233,459...5,301,414
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
protein:increased expression:liver, gastrocnemius muscle, adipose tissue (mouse) protein:increased expression:sputum
|
RGD |
PMID:18098375 PMID:21896669 |
RGD:4891935 RGD:5509059 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
ISO
|
protein:decreased expression:artery
|
RGD |
PMID:17623751 PMID:29180887 |
RGD:13504728 RGD:2292133 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G
|
Nox4
|
NADPH oxidase 4
|
treatment
|
ISO
|
|
RGD |
PMID:30298849 |
RGD:401960083 |
NCBI chrNW_004936736:230,465...394,859
Ensembl chrNW_004936736:230,476...396,708
|
|
G
|
Npc1
|
NPC intracellular cholesterol transporter 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19151714 |
|
NCBI chrNW_004936550:2,983,172...3,032,222
Ensembl chrNW_004936550:2,980,442...3,032,229
|
|
G
|
Nppa
|
natriuretic peptide A
|
|
ISO
|
associated with Heart Failure;
|
RGD |
PMID:23566312 |
RGD:7247714 |
NCBI chrNW_004936474:671,362...673,610
|
|
G
|
Nppb
|
natriuretic peptide B
|
treatment
|
ISO
|
associated with Diabetes Mellitus, Type 2 mRNA:decreased expression:heart associated with hypoxia; protein:increased expression:blood serum (rat)
|
RGD |
PMID:21959345 PMID:24009719 PMID:33310031 |
RGD:329955450 RGD:5685647 RGD:7327171 |
NCBI chrNW_004936474:683,325...684,662
Ensembl chrNW_004936474:683,325...684,665
|
|
G
|
Npy
|
neuropeptide Y
|
|
ISO
|
mRNA, protein:increased expression:hypothalamus
|
RGD |
PMID:17447163 |
RGD:10448938 |
NCBI chrNW_004936478:1,289,437...1,296,819
Ensembl chrNW_004936478:1,290,505...1,296,874
|
|
G
|
Npy1r
|
neuropeptide Y receptor Y1
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with Hyperinsulinemia mRNA:increased expression:hypothalamus OMIM:601665
|
CTD RGD MouseDO |
PMID:9861026 PMID:17447163 PMID:20975297 |
RGD:10448938 RGD:1642306 |
NCBI chrNW_004936555:2,267,727...2,276,673
Ensembl chrNW_004936555:2,267,669...2,276,778
|
|
G
|
Npy2r
|
neuropeptide Y receptor Y2
|
|
ISO
|
DNA:SNP:promoter:−4448C>A, NCBI refSNP ID=rs12649641; Danish white subjects mRNA:increased expression:hypothalamus
|
RGD |
PMID:17019604 PMID:17447163 |
RGD:10448938 RGD:1642379 |
NCBI chrNW_004936576:1,932,526...1,939,560
Ensembl chrNW_004936576:1,932,870...1,938,703
|
|
G
|
Npy5r
|
neuropeptide Y receptor Y5
|
susceptibility
|
ISO
|
DNA:SNP:utr (Y5R1c52) (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:hypothalamus DNA:polymorphisms
|
RGD CTD |
PMID:10849579 PMID:17447163 PMID:23900445 |
RGD:10448938 RGD:1625493 RGD:405650675 |
NCBI chrNW_004936555:2,248,699...2,252,637
Ensembl chrNW_004936555:2,248,699...2,252,637
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17405841 |
|
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G
|
Nr0b2
|
nuclear receptor subfamily 0 group B member 2
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: NR0B2-related condition | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, mild, early-onset
|
OMIM ClinVar |
PMID:2716767 PMID:11136233 PMID:15459958 PMID:20233523 PMID:25741868 PMID:28492532 PMID:33094510 PMID:35460704 More...
|
|
NCBI chrNW_004936474:11,316,857...11,319,669
Ensembl chrNW_004936474:11,316,700...11,319,669
|
|
G
|
Nr1h2
|
nuclear receptor subfamily 1 group H member 2
|
disease_progression
|
ISO
|
DNA:polymorphism:multiple mRNA:increased expression:liver (rat)
|
RGD |
PMID:17108812 PMID:20939869 PMID:25612518 |
RGD:13506790 RGD:15045599 RGD:1626248 |
NCBI chrNW_004936889:223,137...229,968
Ensembl chrNW_004936889:223,101...229,990
|
|
G
|
Nr1h3
|
nuclear receptor subfamily 1 group H member 3
|
disease_progression
|
ISO
|
DNA:polymorphism:multiple mRNA:increased expression:liver (rat)
|
RGD |
PMID:17108812 PMID:25612518 |
RGD:15045599 RGD:1626248 |
NCBI chrNW_004936562:1,937,665...1,946,680
Ensembl chrNW_004936562:1,937,667...1,946,669
|
|
G
|
Nr1h4
|
nuclear receptor subfamily 1 group H member 4
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (rat)
|
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chrNW_004936492:13,315,265...13,365,186
Ensembl chrNW_004936492:13,315,265...13,374,034
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1 group I member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20869355 |
|
NCBI chrNW_004936536:6,691,590...6,726,421
Ensembl chrNW_004936536:6,691,590...6,726,704
|
|
G
|
Nr1i3
|
nuclear receptor subfamily 1 group I member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20869355 |
|
NCBI chrNW_004936903:527,838...533,930
Ensembl chrNW_004936903:527,871...533,790
|
|
G
|
Nr3c1
|
nuclear receptor subfamily 3 group C member 1
|
no_association
|
ISO
|
associated with Depressive Disorder, Major;DNA:SNP:intron:IVS2+646C>G (human) protein:polymorphism:N363S
|
RGD |
PMID:16725041 PMID:18246526 PMID:20723946 |
RGD:1601498 RGD:4892206 RGD:7174717 |
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
|
|
G
|
Nr3c2
|
nuclear receptor subfamily 3 group C member 2
|
treatment
|
ISO
|
|
RGD |
PMID:30298849 |
RGD:401960083 |
NCBI chrNW_004936535:1,139,687...1,467,469
Ensembl chrNW_004936535:1,140,178...1,467,471
|
|
G
|
Nrf1
|
nuclear respiratory factor 1
|
treatment
|
ISO
|
mRNA:decreased expression:left ventricle myocardium (rat)
|
RGD |
PMID:33310031 |
RGD:329955450 |
NCBI chrNW_004936579:5,424,049...5,560,355
Ensembl chrNW_004936579:5,423,773...5,561,003
|
|
G
|
Nrxn1
|
neurexin 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936508:1,889,640...2,954,039
|
|
G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936680:267,850...621,467
Ensembl chrNW_004936680:267,596...615,928
|
|
G
|
Nucb2
|
nucleobindin 2
|
|
ISO
|
protein:increased expression:adipose tissue:
|
RGD |
PMID:22641054 |
RGD:9831187 |
NCBI chrNW_004936528:1,726,879...1,763,483
Ensembl chrNW_004936528:1,717,049...1,763,536
|
|
G
|
Nudc
|
nuclear distribution C, dynein complex regulator
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: NR0B2-related condition | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, mild, early-onset | ClinVar Annotator: match by term: UCP3-related condition
|
ClinVar |
PMID:2716767 PMID:11136233 PMID:15459958 PMID:20233523 PMID:25741868 PMID:28492532 PMID:33094510 PMID:35460704 More...
|
|
NCBI chrNW_004936474:11,327,986...11,341,357
Ensembl chrNW_004936474:11,327,942...11,343,672
|
|
G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29709520 |
|
NCBI chrNW_004936602:3,411,106...3,418,826
Ensembl chrNW_004936602:3,413,282...3,418,831
|
|
G
|
Oprm1
|
opioid receptor mu 1
|
treatment
|
ISO
|
DNA:hypermethylation:promoter, peripheral blood mononuclear cell DNA, mRNA:hypermethylation, increased expression:promoter, hypothalamus
|
RGD |
PMID:16876155 PMID:31258545 |
RGD:401827956 RGD:401842391 |
NCBI chrNW_004936489:6,506,207...6,567,136
Ensembl chrNW_004936489:6,506,207...6,548,946
|
|
G
|
Otc
|
ornithine transcarbamylase
|
|
ISO
|
protein:increased activity:liver (rat)
|
RGD |
PMID:1330956 |
RGD:4144087 |
NCBI chrNW_004936502:5,234,253...5,291,891
Ensembl chrNW_004936502:5,234,253...5,291,891
|
|
G
|
Oxct1
|
3-oxoacid CoA-transferase 1
|
|
ISO
|
mRNA:decreased expression:thalamus (rat)
|
RGD |
PMID:19219059 |
RGD:2326191 |
NCBI chrNW_004936518:924,840...1,057,201
|
|
G
|
Pacs1
|
phosphofurin acidic cluster sorting protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23563609 |
|
NCBI chrNW_004936599:3,345,242...3,379,634
Ensembl chrNW_004936599:3,344,037...3,379,671
|
|
G
|
Parp1
|
poly(ADP-ribose) polymerase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20561897 |
|
NCBI chrNW_004936526:3,102,468...3,147,601
Ensembl chrNW_004936526:3,102,039...3,147,642
|
|
G
|
Pax8
|
paired box 8
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936783:1,523,658...1,553,464
Ensembl chrNW_004936783:1,523,661...1,576,568
|
|
G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936530:361,872...367,005
Ensembl chrNW_004936530:361,872...367,005
|
|
G
|
Pcsk1
|
proprotein convertase subtilisin/kexin type 1
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder | ClinVar Annotator: match by term: SIM1-related condition
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936523:7,009,966...7,050,300
Ensembl chrNW_004936523:7,010,068...7,050,468
|
|
G
|
Pcsk1n
|
proprotein convertase subtilisin/kexin type 1 inhibitor
|
|
ISO
|
protein:increased expression:brainstem
|
RGD |
PMID:11680901 PMID:15012590 |
RGD:1642350 RGD:1642351 |
NCBI chrNW_004936721:783,973...787,712
Ensembl chrNW_004936721:782,032...787,952
|
|
G
|
Pde3a
|
phosphodiesterase 3A
|
|
ISO
|
mRNA:decreased expression:heart
|
RGD |
PMID:9648839 |
RGD:2300415 |
NCBI chrNW_004936548:5,758,634...6,072,195
Ensembl chrNW_004936548:5,762,507...6,070,576
|
|
G
|
Pde9a
|
phosphodiesterase 9A
|
treatment
|
ISO
|
|
RGD |
PMID:34618683 |
RGD:242170038 |
NCBI chrNW_004936500:1,201,843...1,266,818
Ensembl chrNW_004936500:1,203,437...1,267,095
|
|
G
|
Pdp1
|
pyruvate dehydrogenase phosphatase catalytic subunit 1
|
|
ISO
|
protein:decreased activity:circulating lymphocytes
|
RGD |
PMID:15897476 |
RGD:1642637 |
NCBI chrNW_004936544:7,008,882...7,017,446
Ensembl chrNW_004936544:7,009,486...7,018,859
|
|
G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
|
ISO
|
mRNA:increased expression:exocrine pancreas (human)
|
RGD |
PMID:15979049 |
RGD:1625044 |
NCBI chrNW_004936472:23,102,534...23,107,127
Ensembl chrNW_004936472:23,102,534...23,107,127
|
|
G
|
Pex11a
|
peroxisomal biogenesis factor 11 alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30585412 |
|
NCBI chrNW_004936483:15,474,484...15,480,527
Ensembl chrNW_004936483:15,472,949...15,480,648
|
|
G
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936484:8,356,523...8,434,529
Ensembl chrNW_004936484:8,356,487...8,434,925
|
|
G
|
Pgf
|
placental growth factor
|
|
ISO
|
associated with pancreatic cancer;protein:increased expression:plasma (human) associated with Pre-eclampsia;protein:increased expression:serum
|
RGD |
PMID:16020476 PMID:16769024 PMID:26861455 |
RGD:14349030 RGD:1642384 RGD:1642385 |
NCBI chrNW_004936488:4,098,187...4,111,108
Ensembl chrNW_004936488:4,098,225...4,111,142
|
|
G
|
Pgr
|
progesterone receptor
|
|
ISO
|
DNA:polymorphism:CDS:PROGINS polymorphism, combination of long polyglutamine repeat in NCOA3 and homozygous A1/A1 PGR PROGINS genotype associated with obesity in 301 postmenopausal women with breast cancer
|
RGD |
PMID:14557830 |
RGD:1642050 |
NCBI chrNW_004936551:6,498,553...6,573,212
Ensembl chrNW_004936551:6,498,553...6,573,222
|
|
G
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
|
|
ISO
|
|
RGD |
PMID:21949398 |
RGD:6482700 |
NCBI chrNW_004936479:17,084,006...17,112,264
Ensembl chrNW_004936479:17,084,920...17,112,258
|
|
G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
|
ISO
|
protein:decreased expression:soleus protein:decreased tyrosine phosphorylation:skeletal muscle, liver
|
RGD |
PMID:9399964 PMID:16123202 |
RGD:1625218 RGD:1625220 |
NCBI chrNW_004936480:1,188,408...1,273,210
Ensembl chrNW_004936480:1,188,183...1,273,537
|
|
G
|
Pklr
|
pyruvate kinase L/R
|
|
ISO
|
mRNA, protein:decreased expression:liver
|
RGD |
PMID:12958186 |
RGD:1625583 |
NCBI chrNW_004936580:4,770,977...4,799,316
Ensembl chrNW_004936580:4,767,109...4,779,916
|
|
G
|
Plat
|
plasminogen activator, tissue type
|
|
ISO
|
|
RGD |
PMID:12818410 |
RGD:2311677 |
NCBI chrNW_004936785:476,200...503,371
Ensembl chrNW_004936785:476,078...503,321
|
|
G
|
Plaur
|
plasminogen activator, urokinase receptor
|
|
ISO
|
|
RGD |
PMID:21372607 |
RGD:6484121 |
NCBI chrNW_004936706:840,968...855,552
|
|
G
|
Plin1
|
perilipin 1
|
susceptibility
|
ISO
|
DNA:snp:intron:g.11482G>A (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:11371650 PMID:15001633 PMID:15985482 |
RGD:1581041 RGD:737723 |
NCBI chrNW_004936483:15,457,299...15,470,674
Ensembl chrNW_004936483:15,457,297...15,470,350
|
|
G
|
Plscr3
|
phospholipid scramblase 3
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936595:674,754...679,979
Ensembl chrNW_004936595:672,642...679,622
|
|
G
|
Pmch
|
pro-melanin concentrating hormone
|
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with Hyperphagia;protein:increased expression:hypothalamus
|
CTD RGD |
PMID:12355323 PMID:12453827 PMID:15363890 |
RGD:1624360 RGD:1642486 |
NCBI chrNW_004936492:11,947,489...11,948,896
Ensembl chrNW_004936492:11,947,489...11,948,896
|
|
G
|
Pnpla3
|
patatin like domain 3, 1-acylglycerol-3-phosphate O-acyltransferase
|
|
ISO
|
|
RGD |
PMID:11431482 |
RGD:14985224 |
NCBI chrNW_004936718:1,620,034...1,638,315
Ensembl chrNW_004936718:1,619,948...1,638,317
|
|
G
|
Pogz
|
pogo transposable element derived with ZNF domain
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936580:1,613,425...1,650,849
Ensembl chrNW_004936580:1,615,713...1,650,874
|
|
G
|
Pomc
|
proopiomelanocortin
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity, early-onset, susceptibility to ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder
|
ClinVar OMIM |
PMID:8302318 PMID:9620771 PMID:9768693 PMID:10193875 PMID:11941477 PMID:12165561 PMID:14557433 PMID:16459314 PMID:18091355 PMID:18697863 PMID:19221669 PMID:20349035 PMID:23293326 PMID:23649472 PMID:25741868 PMID:27906547 PMID:28492532 PMID:29970488 More...
|
|
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
G
|
Pon2
|
paraoxonase 2
|
|
ISO
|
protein:increased expression:white adipose tissue
|
RGD |
PMID:21365757 |
RGD:8661255 |
NCBI chrNW_004936585:4,862,378...4,894,061
Ensembl chrNW_004936585:4,862,364...4,895,323
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:left ventricle myocardium (rat)
|
CTD RGD |
PMID:11089532 PMID:30738174 PMID:33310031 |
RGD:329955450 |
NCBI chrNW_004936629:3,672,445...3,725,645
Ensembl chrNW_004936629:3,672,460...3,725,626
|
|
G
|
Ppard
|
peroxisome proliferator activated receptor delta
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16168052 PMID:20176998 |
|
NCBI chrNW_004936476:23,799,285...23,886,606
Ensembl chrNW_004936476:23,811,641...23,828,176
|
|
G
|
Pparg
|
peroxisome proliferator activated receptor gamma
|
susceptibility treatment
|
ISO
|
DNA:polymorphism ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder
|
OMIM RGD ClinVar |
PMID:9467001 PMID:9792554 PMID:10381354 PMID:10523018 PMID:10622252 PMID:10690291 PMID:10851250 PMID:14569127 PMID:14616762 PMID:14671186 PMID:15254591 PMID:18683148 PMID:22461176 PMID:25157153 PMID:25741868 PMID:28492532 PMID:30298849 More...
|
RGD:2301847 RGD:401960083 |
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
treatment
|
ISO
|
mRNA:increased expression:retroperitoneal fat pad (rat) mRNA:decreased expression:left ventricle myocardium (rat)
|
RGD |
PMID:22401878 PMID:23180161 PMID:23256146 PMID:33310031 |
RGD:329955450 RGD:7241848 RGD:7242011 RGD:7242183 |
NCBI chrNW_004936477:4,881,230...5,488,208
Ensembl chrNW_004936477:5,199,881...5,488,226
|
|
G
|
Ppargc1b
|
PPARG coactivator 1 beta
|
resistance
|
ISO
|
DNA:polymorphism: :p.A203P ClinVar Annotator: match by term: Obesity, variation in
|
RGD ClinVar |
PMID:15863669 |
RGD:1642501 |
NCBI chrNW_004936504:5,099,334...5,198,279
Ensembl chrNW_004936504:5,099,470...5,198,584
|
|
G
|
Ppia
|
peptidylprolyl isomerase A
|
|
ISO
|
mRNA:increased expression:blood (human)
|
RGD |
PMID:32496587 |
RGD:150383342 |
NCBI chrNW_004936478:19,669,727...19,673,355
Ensembl chrNW_004936478:19,669,506...19,673,398
|
|
G
|
Ppm1l
|
protein phosphatase, Mg2+/Mn2+ dependent 1L
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18344982 |
|
NCBI chrNW_004936708:724,878...1,006,405
Ensembl chrNW_004936708:727,610...996,607
|
|
G
|
Prg2
|
proteoglycan 2, pro eosinophil major basic protein
|
|
ISO
|
mRNA:decreased expression:placenta (human)
|
RGD |
PMID:28125591 |
RGD:40902990 |
NCBI chrNW_004936581:5,101,041...5,103,175
Ensembl chrNW_004936581:5,100,623...5,102,857
|
|
G
|
Prkar1a
|
protein kinase cAMP-dependent type I regulatory subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29367455 |
|
NCBI chrNW_004936541:7,845,876...7,863,677
Ensembl chrNW_004936541:7,845,676...7,863,709
|
|
G
|
Prkar2b
|
protein kinase cAMP-dependent type II regulatory subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20975297 |
|
NCBI chrNW_004936479:16,894,068...16,988,879
Ensembl chrNW_004936479:16,894,068...16,988,885
|
|
G
|
Prkcb
|
protein kinase C beta
|
|
ISO
|
mRNA, protein:increased expression:mononuclear cell
|
RGD |
PMID:17180352 |
RGD:1625512 |
NCBI chrNW_004936501:8,410,273...8,729,238
Ensembl chrNW_004936501:8,437,715...8,728,716
|
|
G
|
Prkcd
|
protein kinase C delta
|
|
ISO
|
protein:decreased expression:heart ventricle
|
RGD |
PMID:11478406 |
RGD:1642533 |
NCBI chrNW_004936473:3,892,625...3,923,467
Ensembl chrNW_004936473:3,892,366...3,923,515
|
|
G
|
Prkch
|
protein kinase C eta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23563609 |
|
NCBI chrNW_004936495:5,426,243...5,638,250
Ensembl chrNW_004936495:5,426,243...5,638,245
|
|
G
|
Prkci
|
protein kinase C iota
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936593:2,170,539...2,236,904
Ensembl chrNW_004936593:2,170,808...2,236,673
|
|
G
|
Prkg1
|
protein kinase cGMP-dependent 1
|
|
ISO
|
protein:increased expression:kidney, glomerulus
|
RGD |
PMID:23454089 |
RGD:7777114 |
NCBI chrNW_004936787:330,390...1,491,994
Ensembl chrNW_004936787:332,342...1,491,285
|
|
G
|
Prl
|
prolactin
|
|
ISO
|
|
RGD |
PMID:8388614 |
RGD:1642559 |
NCBI chrNW_004936552:7,204,298...7,212,632
|
|
G
|
Prlh
|
prolactin releasing hormone
|
|
ISO
|
OMIM:601665
|
RGD MouseDO |
PMID:15854142 |
RGD:1641829 |
Ensembl chrNW_004936525:770,177...770,863
|
|
G
|
Prlhr
|
prolactin releasing hormone receptor
|
|
ISO
|
|
RGD |
PMID:15854142 |
RGD:1641829 |
NCBI chrNW_004936486:8,177,111...8,181,663
Ensembl chrNW_004936486:8,180,436...8,181,548
|
|
G
|
Prmt7
|
protein arginine methyltransferase 7
|
|
ISO
|
ClinVar Annotator: match by term: Obesity disorder
|
ClinVar |
PMID:25741868 PMID:26437029 PMID:27718516 PMID:28492532 PMID:28902392 |
|
NCBI chrNW_004936475:18,632,022...18,667,515
Ensembl chrNW_004936475:18,632,052...18,672,247
|
|
G
|
Prox1
|
prospero homeobox 1
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936628:4,185,712...4,240,680
Ensembl chrNW_004936628:4,185,706...4,238,451
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
|
CTD RGD |
PMID:21156398 PMID:21978752 |
RGD:5508307 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G
|
Ptpn1
|
protein tyrosine phosphatase non-receptor type 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10744717 PMID:20075852 |
|
NCBI chrNW_004936514:4,065,455...4,083,847
Ensembl chrNW_004936514:4,068,238...4,084,009
|
|
G
|
Ptprf
|
protein tyrosine phosphatase receptor type F
|
|
ISO
|
protein:increased expression:skeletal muscle:increased 42% in insulin-resistant obese (fa/fa) and 50% in diabetic (ZDF/Drt-fa/fa) Zucker rats (P<0.05) protein:increased expression, increased activity:subcutaneous adipose tissue:2.03-fold higher activity in obese than lean individuals (P < 0.001) protein:increased activity, increased expression:skeletal muscle:activity increased to 140-170% of control in insulin-resistant obese (BMI>30) nondiabetic subjects (p<0.05); activity decreased to 39% in obese NIDDM subjects (p<0.05)
|
RGD |
PMID:7666792 PMID:7769120 PMID:9218523 |
RGD:1642727 RGD:1642732 RGD:1642733 |
NCBI chrNW_004936474:24,908,103...24,984,678
Ensembl chrNW_004936474:24,908,120...24,983,330
|
|
G
|
Pyy
|
peptide YY
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:10898754 PMID:11825645 PMID:16368708 |
|
NCBI chrNW_004936541:470,806...471,518
Ensembl chrNW_004936541:470,966...471,518
|
|
G
|
Rab21
|
RAB21, member RAS oncogene family
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936568:814,647...846,426
Ensembl chrNW_004936568:814,656...846,206
|
|
G
|
Rai1
|
retinoic acid induced 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15459175 PMID:19116176 |
|
NCBI chrNW_004936741:1,332,353...1,408,116
Ensembl chrNW_004936741:1,332,339...1,406,628
|
|
G
|
Rarres2
|
retinoic acid receptor responder 2
|
|
ISO
|
protein:increased expression:serum:
|
RGD |
PMID:30873215 PMID:31284705 |
RGD:15036824 RGD:15036825 |
NCBI chrNW_004936527:5,949,161...5,952,367
Ensembl chrNW_004936527:5,947,960...5,952,579
|
|
G
|
Rb1
|
RB transcriptional corepressor 1
|
|
ISO
|
mRNA:decreased expression:adipose tissue
|
RGD |
PMID:23315497 |
RGD:8547988 |
NCBI chrNW_004936565:1,596,227...1,746,706
Ensembl chrNW_004936565:1,597,593...1,746,846
|
|
G
|
Rbp4
|
retinol binding protein 4
|
ameliorates disease_progression
|
ISO
|
mRNA, protein:decreased expression:adipose tissue, serum protein:increased expression:blood serum (human)
|
RGD |
PMID:17292720 PMID:18401839 PMID:21585349 |
RGD:2302016 RGD:329845862 RGD:329853312 |
NCBI chrNW_004936601:1,401,215...1,410,195
Ensembl chrNW_004936601:1,402,691...1,410,208
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
|
ISO
|
|
RGD |
PMID:18356846 |
RGD:2298856 |
NCBI chrNW_004936599:3,800,142...3,810,583
Ensembl chrNW_004936599:3,801,636...3,809,813
|
|
G
|
Ren
|
renin
|
|
ISO
|
mRNA:increased expression:abdomen, subcutaneous adipose tissue, mesenchymal stem cell (human)
|
RGD |
PMID:22648117 |
RGD:6784503 |
NCBI chrNW_004936567:598,044...607,628
Ensembl chrNW_004936567:598,048...607,497
|
|
G
|
Retn
|
resistin
|
|
ISO
|
mRNA, protein:increased expression:subcutaneous adipose tissue, serum DNA:SNP:promoter:-420C>G (human)
|
RGD |
PMID:11201732 PMID:17598818 PMID:22816026 |
RGD:7207072 RGD:7207155 RGD:7207158 |
NCBI chrNW_004936588:4,705,295...4,706,653
Ensembl chrNW_004936588:4,705,119...4,706,656
|
|
G
|
Rhoa
|
ras homolog family member A
|
|
ISO
|
protein:increased expression:membrane, aorta, skeletal muscle
|
RGD |
PMID:16267124 |
RGD:2298881 |
NCBI chrNW_004936529:1,000,050...1,045,655
Ensembl chrNW_004936529:999,935...1,045,681
|
|
G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
|
ISO
|
protein:increased phosphorylation:skeletal muscle
|
RGD |
PMID:15604215 |
RGD:1642978 |
NCBI chrNW_004936490:3,441,046...3,492,917
Ensembl chrNW_004936490:3,441,055...3,492,917
|
|
G
|
Rspo1
|
R-spondin 1
|
|
ISO
|
mRNA:decreased expression:ventromedial nucleus of hypothalamus
|
RGD |
PMID:30649980 |
RGD:597830031 |
NCBI chrNW_004936474:19,826,808...19,846,453
Ensembl chrNW_004936474:19,827,669...19,842,726
|
|
G
|
Rsrc2
|
arginine and serine rich coiled-coil 2
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936558:2,024,414...2,042,550
Ensembl chrNW_004936558:2,024,387...2,043,087
|
|
G
|
Rxra
|
retinoid X receptor alpha
|
susceptibility
|
ISO
|
|
RGD |
PMID:15936932 |
RGD:1643104 |
NCBI chrNW_004936669:2,735,111...2,763,060
Ensembl chrNW_004936669:2,738,448...2,763,070
|
|
G
|
Ryr1
|
ryanodine receptor 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity disorder
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936801:1,185,615...1,298,416
Ensembl chrNW_004936801:1,185,733...1,298,289
|
|
G
|
Sat1
|
spermidine/spermine N1-acetyltransferase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936624:756,761...759,979
Ensembl chrNW_004936624:756,712...759,983
|
|
G
|
Scaper
|
S-phase cyclin A associated protein in the ER
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 PMID:30723319 |
|
NCBI chrNW_004936471:35,414,507...35,834,438
Ensembl chrNW_004936471:35,416,571...35,835,048
|
|
G
|
Sdc1
|
syndecan 1
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:11522680 |
RGD:1643129 |
NCBI chrNW_004936493:11,177,804...11,199,678
Ensembl chrNW_004936493:11,177,708...11,199,804
|
|
G
|
Sdc3
|
syndecan 3
|
|
ISO
|
ClinVar Annotator: match by term: Obesity, association with
|
OMIM ClinVar |
PMID:17018662 |
|
NCBI chrNW_004936474:14,203,322...14,209,187
Ensembl chrNW_004936474:14,204,118...14,233,635
|
|
G
|
Selp
|
selectin P
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:altered localization:platelet
|
RGD |
PMID:19228864 |
RGD:2312291 |
NCBI chrNW_004936481:17,076,660...17,112,501
Ensembl chrNW_004936481:17,076,536...17,107,963
|
|
G
|
Serpina12
|
serpin family A member 12
|
treatment
|
ISO
|
|
RGD |
PMID:16030142 |
RGD:1547845 |
NCBI chrNW_004936846:83,727...92,392
Ensembl chrNW_004936846:83,727...92,398
|
|
G
|
Serpine1
|
serpin family E member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23819014 |
|
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G
|
Serpinf1
|
serpin family F member 1
|
|
ISO
|
protein:increased expression:serum (rat)
|
RGD |
PMID:17491674 PMID:24424059 |
RGD:2312347 RGD:8633067 |
NCBI chrNW_004936538:7,885,816...7,898,308
Ensembl chrNW_004936538:7,885,475...7,899,113
|
|
G
|
Sftpb
|
surfactant protein B
|
|
ISO
|
protein:increased expression:lung
|
RGD |
PMID:15136884 |
RGD:4143472 |
NCBI chrNW_004936712:1,614,979...1,621,207
Ensembl chrNW_004936712:1,614,979...1,622,466
|
|
G
|
Sh2b1
|
SH2B adaptor protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19079261 |
|
NCBI chrNW_004936501:11,840,227...11,849,742
Ensembl chrNW_004936501:11,840,190...11,848,780
|
|
G
|
Sim1
|
SIM bHLH transcription factor 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency | ClinVar Annotator: match by term: SIM1-related condition | ClinVar Annotator: match by term: UCP3-related condition ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder | ClinVar Annotator: match by term: Obesity due to SIM1 deficiency | ClinVar Annotator: match by term: SIM1-related condition
|
ClinVar |
PMID:2152513 PMID:16924270 PMID:19401419 PMID:21512513 PMID:23778136 PMID:23778139 PMID:24097297 PMID:25234154 PMID:25741868 PMID:26795956 PMID:28492532 PMID:29216354 PMID:30926952 PMID:30991789 PMID:33434169 More...
|
|
NCBI chrNW_004936651:1,841,040...1,911,944
Ensembl chrNW_004936651:1,841,054...1,911,944
|
|
G
|
Sirt1
|
sirtuin 1
|
treatment
|
ISO
|
CTD Direct Evidence: therapeutic protein:decreased expression:ovary
|
CTD RGD |
PMID:24135502 PMID:24184811 PMID:24773342 |
RGD:9585762 RGD:9586064 |
NCBI chrNW_004936521:10,296,097...10,316,673
Ensembl chrNW_004936521:10,296,097...10,322,215
|
|
G
|
Sirt3
|
sirtuin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:21901160 PMID:23956348 |
RGD:9586047 |
NCBI chrNW_004936888:63,131...78,536
Ensembl chrNW_004936888:63,546...77,950
|
|
G
|
Sirt6
|
sirtuin 6
|
|
ISO
|
protein:decreased expression:ovary
|
RGD |
PMID:24135502 |
RGD:9586064 |
NCBI chrNW_004936588:2,387,162...2,394,066
Ensembl chrNW_004936588:2,386,977...2,394,096
|
|
G
|
Slc10a1
|
solute carrier family 10 member 1
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (rat)
|
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chrNW_004936495:12,958,983...12,975,755
Ensembl chrNW_004936495:12,959,077...12,975,755
|
|
G
|
Slc16a7
|
solute carrier family 16 member 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936646:3,482,148...3,647,466
Ensembl chrNW_004936646:3,533,590...3,642,526
|
|
G
|
Slc22a1
|
solute carrier family 22 member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20956498 |
|
NCBI chrNW_004936489:11,534,095...11,556,759
Ensembl chrNW_004936489:11,534,095...11,556,745
|
|
G
|
Slc22a2
|
solute carrier family 22 member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27401566 |
|
NCBI chrNW_004936489:11,605,403...11,627,786
Ensembl chrNW_004936489:11,594,480...11,627,786
|
|
G
|
Slc22a3
|
solute carrier family 22 member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27401566 |
|
NCBI chrNW_004936489:11,693,755...11,774,380
Ensembl chrNW_004936489:11,693,755...11,772,628
|
|
G
|
Slc27a1
|
solute carrier family 27 member 1
|
susceptibility
|
ISO
|
DNA:gene knockout::Slc27a1-/- mice resistant to diet-induced obesity and metabolic syndrome protein:increased expression:soleus muscle, protein:decreased expression:gastrocnemius muscle
|
RGD |
PMID:15281014 PMID:16611988 |
RGD:1642790 RGD:1642794 |
NCBI chrNW_004936596:3,426,807...3,451,259
Ensembl chrNW_004936596:3,427,874...3,449,489
|
|
G
|
Slc27a4
|
solute carrier family 27 member 4
|
|
ISO
|
mRNA:increased expression:subcutaneous adipose tissue
|
RGD |
PMID:15168018 |
RGD:1625638 |
NCBI chrNW_004936487:15,877,075...15,905,752
Ensembl chrNW_004936487:15,876,606...15,906,003 Ensembl chrNW_004936487:15,876,606...15,906,003
|
|
G
|
Slc2a1
|
solute carrier family 2 member 1
|
treatment
|
ISO
|
associated with Polycystic Ovary Syndrome
|
RGD |
PMID:24842895 |
RGD:12879503 |
NCBI chrNW_004936474:24,205,878...24,236,611
Ensembl chrNW_004936474:24,206,644...24,236,713
|
|
G
|
Slc32a1
|
solute carrier family 32 member 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936561:2,709,580...2,714,313
Ensembl chrNW_004936561:2,709,463...2,714,313
|
|
G
|
Slc6a1
|
solute carrier family 6 member 1
|
|
ISO
|
|
RGD |
PMID:11191352 |
RGD:1643191 |
NCBI chrNW_004936602:2,359,151...2,397,346
Ensembl chrNW_004936602:2,357,607...2,379,061
|
|
G
|
Slc6a14
|
solute carrier family 6 member 14
|
susceptibility
|
ISO
|
DNA:SNPs
|
RGD |
PMID:15331564 |
RGD:1625271 |
NCBI chrNW_004936479:13,024,831...13,051,908
|
|
G
|
Slc6a3
|
solute carrier family 6 member 3
|
no_association susceptibility
|
ISO
|
DNA:polymorphism
|
RGD |
PMID:12490667 PMID:16674552 |
RGD:1625653 RGD:1625655 |
NCBI chrNW_004936815:359,775...400,690
Ensembl chrNW_004936815:359,775...400,690
|
|
G
|
Slc9a3
|
solute carrier family 9 member A3
|
|
ISO
|
protein:decreased expression:kidney cortex
|
RGD |
PMID:16757903 |
RGD:1625672 |
NCBI chrNW_004936815:963,715...999,280
Ensembl chrNW_004936815:963,715...999,280
|
|
G
|
Smarca4
|
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936659:1,152,846...1,246,718
Ensembl chrNW_004936659:1,169,792...1,249,213
|
|
G
|
Snap25
|
synaptosome associated protein 25
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936485:9,198,744...9,279,854
Ensembl chrNW_004936485:9,195,110...9,279,920
|
|
G
|
Socs1
|
suppressor of cytokine signaling 1
|
|
ISO
|
mRNA, protein:increased expression:white fat
|
RGD |
PMID:11027633 |
RGD:2298920 |
NCBI chrNW_004936530:9,312,965...9,315,593
Ensembl chrNW_004936530:9,312,965...9,316,165
|
|
G
|
Socs3
|
suppressor of cytokine signaling 3
|
|
ISO
|
DNA:SNP:utr (rs4969170) (human) mRNA:altered expression:skeletal muscle, subcutaneous adipose tissue mRNA:decreased expression:subcutaneous adipose tissue mRNA, protein:increased expression:white fat
|
RGD |
PMID:11027633 PMID:15331532 PMID:16920065 PMID:23900445 |
RGD:1625676 RGD:2298920 RGD:2313790 RGD:405650675 |
NCBI chrNW_004936594:2,932,297...2,935,358
Ensembl chrNW_004936594:2,933,747...2,934,451
|
|
G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24042701 |
|
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
|
|
G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16317704 PMID:23956348 PMID:30738174 |
|
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G
|
Sorbs1
|
sorbin and SH3 domain containing 1
|
|
ISO
|
DNA:SNP: :p.T228A (human)
|
RGD |
PMID:11532984 |
RGD:1642744 |
NCBI chrNW_004936636:3,834,887...4,066,293
Ensembl chrNW_004936636:3,948,733...4,066,293
|
|
G
|
Sparc
|
secreted protein acidic and cysteine rich
|
|
ISO
|
mRNA:increased expression:adipose tissue
|
RGD |
PMID:11294850 |
RGD:2300062 |
NCBI chrNW_004936515:11,026,156...11,046,812
Ensembl chrNW_004936515:11,025,724...11,046,849
|
|
G
|
Sqle
|
squalene epoxidase
|
|
ISO
|
|
RGD |
PMID:15556298 |
RGD:1581399 |
NCBI chrNW_004936470:22,726,793...22,752,429
Ensembl chrNW_004936470:22,725,888...22,752,500
|
|
G
|
Srd5a1
|
steroid 5 alpha-reductase 1
|
|
ISO
|
mRNA:increased expression:liver (rat)
|
RGD |
PMID:20098742 |
RGD:4891511 |
NCBI chrNW_004936634:758,231...798,809
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936741:1,408,669...1,419,717
Ensembl chrNW_004936741:1,406,521...1,419,776
|
|
G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
|
ISO
|
protein:increased expression:fat cell, nucleus
|
RGD |
PMID:9786926 |
RGD:2308843 |
NCBI chrNW_004936492:115,923...174,614
Ensembl chrNW_004936492:115,821...174,775
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
|
ISO
|
DNA:SNP:rs4796793 (human) protein:decreased phosphorylation:hypothalamus
|
RGD |
PMID:23397595 PMID:23900445 |
RGD:10411893 RGD:405650675 |
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G
|
Stat4
|
signal transducer and activator of transcription 4
|
treatment
|
ISO
|
|
RGD |
PMID:20978234 |
RGD:5509594 |
NCBI chrNW_004936506:7,091,982...7,185,938
Ensembl chrNW_004936506:7,095,009...7,184,689
|
|
G
|
Stk11
|
serine/threonine kinase 11
|
|
ISO
|
protein:decreased expression:gastrocnemius
|
RGD |
PMID:16352671 |
RGD:1601389 |
NCBI chrNW_004936588:579,816...601,033
Ensembl chrNW_004936588:579,816...603,654
|
|
G
|
Sts
|
steroid sulfatase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:24497646 |
|
NCBI chrNW_004936644:1,328,327...1,395,856
Ensembl chrNW_004936644:1,325,713...1,395,923
|
|
G
|
Sucla2
|
succinate-CoA ligase ADP-forming subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936565:1,313,150...1,355,693
Ensembl chrNW_004936565:1,313,150...1,355,693
|
|
G
|
Suclg2
|
succinate-CoA ligase GDP-forming subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20882379 |
|
NCBI chrNW_004936603:243,113...378,526
Ensembl chrNW_004936603:243,113...378,528
|
|
G
|
Szt2
|
SZT2 subunit of KICSTOR complex
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936474:24,788,175...24,837,471
Ensembl chrNW_004936474:24,788,195...24,837,395
|
|
G
|
Tbc1d1
|
TBC1 domain family member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16893906 PMID:18325908 PMID:18931681 |
|
NCBI chrNW_004936482:5,874,358...6,087,474
Ensembl chrNW_004936482:5,885,498...6,087,191
|
|
G
|
Tbx3
|
T-box transcription factor 3
|
|
ISO
|
ClinVar Annotator: match by term: Obesity disorder
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936558:7,230,361...7,243,651
Ensembl chrNW_004936558:7,230,668...7,244,361
|
|
G
|
Tbxa2r
|
thromboxane A2 receptor
|
|
ISO
|
mRNA:increased expression:carotid artery
|
RGD |
PMID:12409963 |
RGD:1601447 |
NCBI chrNW_004936588:2,040,712...2,044,635
Ensembl chrNW_004936588:2,040,630...2,045,110
|
|
G
|
Tfam
|
transcription factor A, mitochondrial
|
treatment
|
ISO
|
mRNA:decreased expression:left ventricle myocardium (rat)
|
RGD |
PMID:21862610 PMID:33310031 |
RGD:329955450 RGD:5683906 |
NCBI chrNW_004936614:4,595,973...4,605,040
Ensembl chrNW_004936614:4,596,617...4,605,104
|
|
G
|
Tfrc
|
transferrin receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17062801 PMID:20882379 |
|
NCBI chrNW_004936784:696,738...728,385
Ensembl chrNW_004936784:696,713...728,543
|
|
G
|
Tgfb1
|
transforming growth factor beta 1
|
severity
|
ISO
|
protein:increased expression:platelet associated with hypertension;protein:increased expression:blood protein:increased expression:adipose tissue
|
RGD |
PMID:15944724 PMID:16253647 PMID:16477387 |
RGD:1601561 RGD:1601563 RGD:1601579 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G
|
Th
|
tyrosine hydroxylase
|
resistance
|
ISO
|
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
|
RGD |
PMID:16251897 |
RGD:1601632 |
NCBI chrNW_004936794:478,651...486,887
Ensembl chrNW_004936794:478,614...487,061
|
|
G
|
Thbd
|
thrombomodulin
|
severity
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:16651309 |
RGD:1601640 |
NCBI chrNW_004936620:2,563,900...2,568,117
|
|
G
|
Thbs1
|
thrombospondin 1
|
|
ISO
|
mRNA,protein:increased expression:mononuclear cell, adipose tissue:
|
RGD |
PMID:24086512 |
RGD:9681453 |
NCBI chrNW_004936471:3,064,466...3,081,125
Ensembl chrNW_004936471:3,064,422...3,081,949
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:17512313 |
RGD:1642026 |
NCBI chrNW_004936502:13,345,936...13,350,170
Ensembl chrNW_004936502:13,345,832...13,350,248
|
|
G
|
Tlr2
|
toll like receptor 2
|
|
ISO
|
|
RGD |
PMID:18787058 |
RGD:2312681 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G
|
Tlr4
|
toll like receptor 4
|
susceptibility
|
ISO
|
|
RGD |
PMID:17053832 PMID:19144836 |
RGD:1620653 RGD:2312510 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G
|
Tmem18
|
transmembrane protein 18
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19079261 |
|
NCBI chrNW_004936532:369,794...374,936
Ensembl chrNW_004936532:370,262...374,931
|
|
G
|
Tnf
|
tumor necrosis factor
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:9502777 PMID:11328671 PMID:20141834 PMID:24146106 PMID:28843383 PMID:29035695 More...
|
RGD:10450599 RGD:14975146 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:12935365 |
RGD:1624179 |
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
|
|
G
|
Tnfrsf1b
|
TNF receptor superfamily member 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11782876 |
|
NCBI chrNW_004936474:908,414...935,765
Ensembl chrNW_004936474:908,485...934,177
|
|
G
|
Trpv1
|
transient receptor potential cation channel subfamily V member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17347480 |
|
NCBI chrNW_004936677:277,304...326,907
Ensembl chrNW_004936677:276,994...327,025
|
|
G
|
Tsc1
|
TSC complex subunit 1
|
|
ISO
|
DNA:hypermethylation:promoter
|
RGD |
PMID:25807795 |
RGD:11570513 |
NCBI chrNW_004936487:19,331,183...19,386,841
Ensembl chrNW_004936487:19,331,194...19,386,892
|
|
G
|
Tub
|
TUB bipartite transcription factor
|
susceptibility no_association
|
ISO
|
DNA:splice-site mutation OMIM:601665
|
RGD MouseDO |
PMID:8612280 PMID:8772727 |
RGD:1625564 RGD:1625565 |
NCBI chrNW_004936528:9,829,889...9,912,645
Ensembl chrNW_004936528:9,834,954...9,855,080
|
|
G
|
Tyk2
|
tyrosine kinase 2
|
|
ISO
|
OMIM:601665
|
MouseDO |
|
|
NCBI chrNW_004936659:681,463...704,484
Ensembl chrNW_004936659:681,310...702,962
|
|
G
|
Ucn
|
urocortin
|
treatment
|
ISO
|
|
RGD |
PMID:17932219 |
RGD:1642774 |
NCBI chrNW_004936493:5,258,574...5,260,692
Ensembl chrNW_004936493:5,260,219...5,260,602
|
|
G
|
Ucp1
|
uncoupling protein 1
|
no_association
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic DNA:polymorphism: :-3826A>G (human)
|
CTD RGD |
PMID:8968850 PMID:15592485 |
RGD:1624977 |
NCBI chrNW_004936535:7,258,146...7,265,475
Ensembl chrNW_004936535:7,258,343...7,265,398
|
|
G
|
Ucp2
|
uncoupling protein 2
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:polymorphism, insertion:promoter:-866G>A (rs659366)(human) DNA:SNPs, insertion/deletion, haplotypes:promoter, 3' utr:-2723T>A, -866G>A, *158_159ins45 (human)
|
CTD RGD |
PMID:11381268 PMID:17870627 |
RGD:2313512 RGD:737761 |
NCBI chrNW_004936498:3,059,700...3,066,112
Ensembl chrNW_004936498:3,059,297...3,066,197
|
|
G
|
Ucp3
|
uncoupling protein 3
|
no_association susceptibility
|
ISO
|
DNA:polymorphism:exon (human) DNA:polymorphism:promoter:-55C>T (human) ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity | ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: UCP3 POLYMORPHISM G/A | ClinVar Annotator: match by term: UCP3-related condition ClinVar Annotator: match by term: Monogenic Obesity | ClinVar Annotator: match by term: Obesity | ClinVar Annotator: match by term: Obesity disorder | ClinVar Annotator: match by term: UCP3 POLYMORPHISM G/A | ClinVar Annotator: match by term: UCP3-related condition
|
OMIM RGD ClinVar |
PMID:9700198 PMID:9769326 PMID:10431807 PMID:10480626 PMID:10618503 PMID:18249216 PMID:21544083 PMID:25741868 PMID:28492532 More...
|
RGD:2313506 RGD:2313526 |
NCBI chrNW_004936498:3,082,575...3,095,739
Ensembl chrNW_004936498:3,082,575...3,095,737
|
|
G
|
Ulk4
|
unc-51 like kinase 4
|
|
ISO
|
ClinVar Annotator: match by term: Obesity
|
ClinVar |
|
|
NCBI chrNW_004936473:30,034,159...30,536,450
Ensembl chrNW_004936473:30,038,164...30,536,567
|
|
G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent
|
RGD |
PMID:19260948 |
RGD:2312763 |
NCBI chrNW_004936748:785,491...802,791
Ensembl chrNW_004936748:785,455...803,048
|
|
G
|
Vgf
|
VGF nerve growth factor inducible
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12177191 |
|
NCBI chrNW_004936543:1,059,292...1,062,384
Ensembl chrNW_004936543:1,059,799...1,061,646
|
|
G
|
Vhl
|
von Hippel-Lindau tumor suppressor
|
|
ISO
|
associated with hepatocellular carcinoma;RNA:decreased expression:liver:
|
RGD |
PMID:31321740 |
RGD:155882550 |
NCBI chrNW_004936602:3,135,790...3,140,622
|
|
G
|
Vldlr
|
very low density lipoprotein receptor
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11557677 PMID:20975297 |
RGD:1625568 |
NCBI chrNW_004936503:2,407,040...2,440,366
Ensembl chrNW_004936503:2,405,689...2,440,502
|
|
G
|
Vwf
|
von Willebrand factor
|
|
ISO
|
protein:increased expression:plasma associated with Diabetes Mellitus, Type 2;protein:increased expression:plasma
|
RGD |
PMID:16631442 PMID:16739871 |
RGD:1625710 RGD:1625711 |
NCBI chrNW_004936709:1,578,137...1,741,877
Ensembl chrNW_004936709:1,579,096...1,741,754
|
|
G
|
Wnt10b
|
Wnt family member 10B
|
|
ISO
|
DNA:SNP:CDS:amino acid C256Y, mutant unable to activate WNT/beta-catenin signaling pathway
|
RGD |
PMID:16477437 PMID:17578883 |
RGD:2300029 RGD:2326237 |
NCBI chrNW_004936512:6,768,240...6,774,172
Ensembl chrNW_004936512:6,768,240...6,774,172
|
|
G
|
Wnt3a
|
Wnt family member 3A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28242765 |
|
NCBI chrNW_004936864:150,742...179,205
Ensembl chrNW_004936864:150,732...192,423
|
|
G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
ISO
|
|
RGD |
PMID:7616299 |
RGD:13210504 |
NCBI chrNW_004936493:1,762,814...1,824,501
Ensembl chrNW_004936493:1,762,869...1,823,238
|
|
G
|
Zbtb7b
|
zinc finger and BTB domain containing 7B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936580:4,546,139...4,560,157
Ensembl chrNW_004936580:4,551,304...4,560,163
|
|
G
|
Zc3h10
|
zinc finger CCCH-type containing 10
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:31775033 |
|
NCBI chrNW_004936646:528,455...534,267
Ensembl chrNW_004936646:528,455...532,694
|
|
G
|
Zfhx3
|
zinc finger homeobox 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936475:21,005,242...21,235,992
Ensembl chrNW_004936475:21,080,302...21,231,544
|
|
G
|
Zfr2
|
zinc finger RNA binding protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29273807 |
|
NCBI chrNW_004936588:2,154,277...2,175,308
Ensembl chrNW_004936588:2,154,247...2,192,363
|
|
G
|
Znf711
|
zinc finger protein 711
|
|
ISO
|
ClinVar Annotator: match by term: Monogenic Obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936547:5,999,792...6,026,719
Ensembl chrNW_004936547:5,999,739...6,026,769
|
|
|
G
|
Ahcy
|
adenosylhomocysteinase
|
|
ISO
|
ClinVar Annotator: match by term: Obesity and hypopigmentation
|
ClinVar |
PMID:36536132 |
|
NCBI chrNW_004936561:6,314,797...6,333,961
Ensembl chrNW_004936561:6,314,705...6,334,439
|
|
G
|
Asip
|
agouti signaling protein
|
|
ISO
|
ClinVar Annotator: match by term: Obesity and hypopigmentation
|
ClinVar |
PMID:36536132 |
|
NCBI chrNW_004936561:6,341,667...6,346,440
Ensembl chrNW_004936561:6,341,623...6,346,458
|
|
G
|
Itch
|
itchy E3 ubiquitin protein ligase
|
|
ISO
|
ClinVar Annotator: match by term: Obesity and hypopigmentation
|
ClinVar |
PMID:36536132 |
|
NCBI chrNW_004936561:6,140,236...6,265,734
Ensembl chrNW_004936561:6,140,234...6,265,767
|
|
|
G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
|
ISO
|
ClinVar Annotator: match by term: NTRK2-related condition | ClinVar Annotator: match by term: Obesity, hyperphagia, and developmental delay
|
OMIM ClinVar |
PMID:9536098 PMID:15494731 PMID:17576681 PMID:25741868 PMID:27884935 PMID:28492532 PMID:29100083 PMID:35061034 More...
|
|
NCBI chrNW_004936680:267,850...621,467
Ensembl chrNW_004936680:267,596...615,928
|
|
|
G
|
Acsm3
|
acyl-CoA synthetase medium chain family member 3
|
|
ISO
|
associated with Hypertension, Essential;DNA:polymorphism:intron:
|
RGD |
PMID:14567496 |
RGD:7241282 |
NCBI chrNW_004936501:6,077,366...6,095,432
Ensembl chrNW_004936501:6,078,219...6,095,538
|
|
G
|
Amd1
|
adenosylmethionine decarboxylase 1
|
|
ISO
|
DNA:SNP: :rs2796749(human)
|
RGD |
PMID:22496743 |
RGD:14390074 |
NCBI chrNW_004936564:6,656,789...6,675,564
Ensembl chrNW_004936564:6,656,746...6,673,462
|
|
G
|
Lepr
|
leptin receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23038009 |
|
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
|
G
|
Apoa1
|
apolipoprotein A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25137265 |
|
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G
|
Apoa5
|
apolipoprotein A5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25137265 |
|
NCBI chrNW_004936542:2,069,683...2,071,344
Ensembl chrNW_004936542:2,069,683...2,071,353
|
|
G
|
Cetp
|
cholesteryl ester transfer protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25137265 |
|
NCBI chrNW_004936475:9,115,126...9,133,071
Ensembl chrNW_004936475:9,115,120...9,133,073
|
|
G
|
Fto
|
FTO alpha-ketoglutarate dependent dioxygenase
|
treatment
|
ISO
|
DNA:SNP: :rs17817449 (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:25137265 PMID:26849546 |
RGD:11054066 |
NCBI chrNW_004936475:6,321,725...6,689,410
Ensembl chrNW_004936475:6,321,711...6,689,588
|
|
G
|
Gpr17
|
G protein-coupled receptor 17
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34144038 |
|
NCBI chrNW_004936469:43,652,244...43,656,661
Ensembl chrNW_004936469:43,653,481...43,654,497
|
|
G
|
Rbp4
|
retinol binding protein 4
|
|
ISO
|
protein:increased expression:blood plasma (human)
|
RGD |
PMID:25356519 |
RGD:329853302 |
NCBI chrNW_004936601:1,401,215...1,410,195
Ensembl chrNW_004936601:1,402,691...1,410,208
|
|
|
G
|
Armc9
|
armadillo repeat containing 9
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,518,691...5,648,109
Ensembl chrNW_004936525:5,514,521...5,648,074
|
|
G
|
Atg16l1
|
autophagy related 16 like 1
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,973,574...4,010,442
Ensembl chrNW_004936525:3,972,558...4,010,514
|
|
G
|
B3gnt7
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,495,815...5,508,400
Ensembl chrNW_004936525:5,496,465...5,505,278
|
|
G
|
Cab39
|
calcium binding protein 39
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,955,252...6,002,917
Ensembl chrNW_004936525:5,954,978...6,032,644
|
|
G
|
Chrnd
|
cholinergic receptor nicotinic delta subunit
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,560,293...4,568,431
Ensembl chrNW_004936525:4,561,507...4,568,409
|
|
G
|
Chrng
|
cholinergic receptor nicotinic gamma subunit
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,550,987...4,556,574
Ensembl chrNW_004936525:4,550,987...4,556,576
|
|
G
|
Cops7b
|
COP9 signalosome subunit 7B
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,159,157...5,186,142
Ensembl chrNW_004936525:5,156,785...5,182,012
|
|
G
|
Ctr9
|
CTR9 homolog, Paf1/RNA polymerase II complex component
|
|
ISO
|
ClinVar Annotator: match by term: Predisposition to Wilms tumor
|
ClinVar |
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936528:7,585,937...7,613,022
Ensembl chrNW_004936528:7,585,787...7,613,047
|
|
G
|
CUNH2orf72
|
chromosome unknown C2orf72 homolog
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,766,084...5,800,949
|
|
G
|
Dgkd
|
diacylglycerol kinase delta
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,826,929...3,897,618
Ensembl chrNW_004936525:3,828,939...3,897,529
|
|
G
|
Dis3
|
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936511:8,082,909...8,105,203
Ensembl chrNW_004936511:8,082,406...8,108,233
|
|
G
|
Dis3l2
|
DIS3 like 3'-5' exoribonuclease 2
|
|
ISO
|
ClinVar Annotator: match by term: DIS3L2-related condition | ClinVar Annotator: match by term: Perlman syndrome | ClinVar Annotator: match by term: Predisposition to Wilms tumor
|
OMIM ClinVar |
PMID:6093533 PMID:9536098 PMID:10508986 PMID:16199547 PMID:16957732 PMID:17576681 PMID:22306653 PMID:23486540 PMID:23576526 PMID:23594738 PMID:23613427 PMID:23756462 PMID:24141620 PMID:25640679 PMID:25670083 PMID:25741868 PMID:25741875 PMID:26689913 PMID:27153395 PMID:27431325 PMID:28328139 PMID:28492532 PMID:29625052 PMID:30344923 PMID:30359267 PMID:31350202 PMID:31942411 PMID:33332384 PMID:33719213 PMID:34130653 PMID:35495172 PMID:35957908 PMID:35980532 PMID:36451132 More...
|
|
NCBI chrNW_004936525:4,718,773...5,058,512
Ensembl chrNW_004936525:4,719,121...5,008,014
|
|
G
|
Dnajb3
|
DnaJ heat shock protein family (Hsp40) member B3
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,630,584...3,631,530
|
|
G
|
Ecel1
|
endothelin converting enzyme like 1
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,599,840...4,608,469
Ensembl chrNW_004936525:4,600,246...4,608,508
|
|
G
|
Efhd1
|
EF-hand domain family member D1
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,445,779...4,484,674
Ensembl chrNW_004936525:4,445,773...4,484,680
|
|
G
|
Eif4e2
|
eukaryotic translation initiation factor 4E family member 2
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,519,709...4,549,364
Ensembl chrNW_004936525:4,519,724...4,549,364
|
|
G
|
Gigyf2
|
GRB10 interacting GYF protein 2
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,301,003...4,432,125
Ensembl chrNW_004936525:4,304,629...4,403,089
|
|
G
|
Gpr55
|
G protein-coupled receptor 55
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,869,416...5,888,789
Ensembl chrNW_004936525:5,869,416...5,888,789
|
|
G
|
Hjurp
|
Holliday junction recognition protein
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,528,379...3,544,088
|
|
G
|
Htr2b
|
5-hydroxytryptamine receptor 2B
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,711,894...5,729,074
Ensembl chrNW_004936525:5,712,329...5,729,831
|
|
G
|
Itm2c
|
integral membrane protein 2C
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,913,913...5,927,385
Ensembl chrNW_004936525:5,914,954...5,927,299
|
|
G
|
Kcnj13
|
potassium inwardly rectifying channel subfamily J member 13
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,361,755...4,374,130
Ensembl chrNW_004936525:4,362,376...4,374,414
|
|
G
|
LOC101973915
|
intestinal-type alkaline phosphatase
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,616,212...4,619,932
|
|
G
|
LOC101976447
|
uncharacterized LOC101976447
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,801,036...5,807,450
Ensembl chrNW_004936525:5,801,036...5,807,450
|
|
G
|
Mroh2a
|
maestro heat like repeat family member 2A
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,546,438...3,606,430
Ensembl chrNW_004936525:3,546,497...3,605,521
|
|
G
|
Neu2
|
neuraminidase 2
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,177,085...4,179,692
Ensembl chrNW_004936525:4,177,085...4,179,692
|
|
G
|
Ngef
|
neuronal guanine nucleotide exchange factor
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,250,389...4,282,041
Ensembl chrNW_004936525:4,220,385...4,282,065
|
|
G
|
Nmur1
|
neuromedin U receptor 1
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,355,570...5,386,284
Ensembl chrNW_004936525:5,382,372...5,385,788
|
|
G
|
Nppc
|
natriuretic peptide C
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,092,675...5,099,344
Ensembl chrNW_004936525:5,092,635...5,099,331
|
|
G
|
Nynrin
|
NYN domain and retroviral integrase containing
|
|
ISO
|
ClinVar Annotator: match by term: Predisposition to Wilms tumor
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936722:134,221...155,020
Ensembl chrNW_004936722:134,190...155,115
|
|
G
|
Pde6d
|
phosphodiesterase 6D
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,186,501...5,240,859
Ensembl chrNW_004936525:5,185,898...5,243,081
|
|
G
|
Prss56
|
serine protease 56
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,568,854...4,574,332
Ensembl chrNW_004936525:4,568,802...4,574,396
|
|
G
|
Psmd1
|
proteasome 26S subunit, non-ATPase 1
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,672,013...5,762,035
Ensembl chrNW_004936525:5,668,186...5,762,364
|
|
G
|
Ptma
|
prothymosin alpha
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,253,723...5,258,300
|
|
G
|
Sag
|
S-antigen visual arrestin
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,932,118...3,965,651
Ensembl chrNW_004936525:3,931,933...3,964,834
|
|
G
|
Snorc
|
secondary ossification center associated regulator of chondrocyte maturation
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:4,284,176...4,290,384
Ensembl chrNW_004936525:4,284,203...4,290,428
|
|
G
|
Sp100
|
SP100 nuclear antigen
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:6,136,343...6,231,051
|
|
G
|
Sp110
|
SP110 nuclear body protein
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:6,317,004...6,336,413
|
|
G
|
Sp140
|
SP140 nuclear body protein
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:6,239,566...6,301,657
|
|
G
|
Spp2
|
secreted phosphoprotein 2
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,360,978...3,384,035
Ensembl chrNW_004936525:3,360,990...3,383,934
|
|
G
|
Tex44
|
testis expressed 44
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:5,354,202...5,355,338
|
|
G
|
Trpm8
|
transient receptor potential cation channel subfamily M member 8
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,413,730...3,491,815
Ensembl chrNW_004936525:3,413,747...3,491,815
|
|
G
|
Usp40
|
ubiquitin specific peptidase 40
|
|
ISO
|
ClinVar Annotator: match by term: Perlman syndrome
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936525:3,759,982...3,826,190
Ensembl chrNW_004936525:3,760,280...3,826,206
|
|
|
G
|
Atp10a
|
ATPase phospholipid transporting 10A (putative)
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936471:40,868,114...40,976,707
Ensembl chrNW_004936471:40,782,793...40,976,524
|
|
G
|
Gabra5
|
gamma-aminobutyric acid type A receptor subunit alpha5
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936471:39,781,451...39,856,766
Ensembl chrNW_004936471:39,781,451...39,975,518
|
|
G
|
Gabrb3
|
gamma-aminobutyric acid type A receptor subunit beta3
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936471:39,791,633...40,193,049
Ensembl chrNW_004936471:39,791,613...40,187,923
|
|
G
|
Gabrg3
|
gamma-aminobutyric acid type A receptor subunit gamma3
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936471:39,184,683...39,256,439
Ensembl chrNW_004936471:39,185,702...39,751,187
|
|
G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
|
ISO
|
|
RGD |
PMID:15057669 |
RGD:12905043 |
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G
|
Hcrt
|
hypocretin neuropeptide precursor
|
|
ISO
|
protein:decreased expression:cerebrospinal fluid
|
RGD |
PMID:15613151 |
RGD:1600935 |
NCBI chrNW_004936490:17,007,001...17,008,363
Ensembl chrNW_004936490:17,006,997...17,008,369
|
|
G
|
Herc2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:25741868 PMID:28492532 PMID:28631899 |
|
NCBI chrNW_004936471:38,419,147...38,606,312
Ensembl chrNW_004936471:38,419,129...38,606,323
|
|
G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
|
ISO
|
OMIM:176270
|
MouseDO |
|
|
NCBI chrNW_004936499:1,002,083...1,109,446
Ensembl chrNW_004936499:1,004,732...1,109,377
|
|
G
|
Magel2
|
MAGE family member L2
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:25741868 PMID:27195816 PMID:28281571 PMID:28492532 PMID:28631899 |
|
NCBI chrNW_004936805:882,296...886,442
Ensembl chrNW_004936805:882,273...886,475
|
|
G
|
Mkrn3
|
makorin ring finger protein 3
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936805:933,791...936,023
Ensembl chrNW_004936805:933,725...936,043
|
|
G
|
Ndn
|
necdin, MAGE family member
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:25741868 PMID:28631899 |
|
NCBI chrNW_004936805:849,218...850,894
Ensembl chrNW_004936805:849,345...850,322
|
|
G
|
Oca2
|
OCA2 melanosomal transmembrane protein
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936471:38,612,450...38,952,150
Ensembl chrNW_004936471:38,612,427...38,952,199
|
|
G
|
Snrpn
|
small nuclear ribonucleoprotein polypeptide N
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome DNA:deletion
|
ClinVar RGD |
PMID:8723064 PMID:28631899 |
RGD:1601354 |
NCBI chrNW_004936805:86,244...91,074
Ensembl chrNW_004936805:85,051...94,547
|
|
G
|
Snurf
|
SNRPN upstream open reading frame
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936805:88,553...105,497
|
|
G
|
Ube3a
|
ubiquitin protein ligase E3A
|
|
ISO
|
ClinVar Annotator: match by term: Prader-Willi syndrome
|
ClinVar |
PMID:28631899 |
|
NCBI chrNW_004936471:41,187,665...41,290,345
Ensembl chrNW_004936471:41,187,612...41,283,517
|
|
|
G
|
Pomc
|
proopiomelanocortin
|
|
ISO
|
ClinVar Annotator: match by term: Obesity, adrenal insufficiency, and red hair due to POMC deficiency | ClinVar Annotator: match by term: POMC-related condition | ClinVar Annotator: match by term: Proopiomelanocortin deficiency
|
OMIM ClinVar |
PMID:8302318 PMID:9620771 PMID:9768693 PMID:10193875 PMID:10652501 PMID:11941477 PMID:12165561 PMID:14557433 PMID:16459314 PMID:18091355 PMID:18697863 PMID:18765507 PMID:19221669 PMID:20349035 PMID:23293326 PMID:23649472 PMID:24890885 PMID:25741868 PMID:27906547 PMID:28492532 PMID:29970488 PMID:34097736 PMID:35574020 More...
|
|
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
|
G
|
Cast
|
calpastatin
|
|
ISO
|
ClinVar Annotator: match by term: OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES | ClinVar Annotator: match by term: Obesity due to prohormone convertase I deficiency | ClinVar Annotator: match by term: PCSK1-related condition | ClinVar Annotator: match by term: Proprotein convertase 1/3 deficiency
|
ClinVar |
PMID:9207799 PMID:14617756 PMID:16199547 PMID:17595246 PMID:22210313 PMID:23383060 PMID:23562752 PMID:23800642 PMID:24041679 PMID:24135795 PMID:24280991 PMID:24932808 PMID:25272002 PMID:25741868 PMID:26207343 PMID:26786350 PMID:27187081 PMID:27391121 PMID:28377240 PMID:28492532 PMID:30383237 PMID:35574020 More...
|
|
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G
|
Pcsk1
|
proprotein convertase subtilisin/kexin type 1
|
|
ISO
|
ClinVar Annotator: match by term: OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES | ClinVar Annotator: match by term: Obesity due to prohormone convertase I deficiency | ClinVar Annotator: match by term: PCSK1-related condition | ClinVar Annotator: match by term: Proprotein convertase 1/3 deficiency
|
OMIM ClinVar |
PMID:9207799 PMID:14617756 PMID:16199547 PMID:17595246 PMID:22210313 PMID:23383060 PMID:23562752 PMID:23800642 PMID:24041679 PMID:24135795 PMID:24280991 PMID:24932808 PMID:25272002 PMID:25741868 PMID:26207343 PMID:26786350 PMID:27187081 PMID:27391121 PMID:28377240 PMID:28492532 PMID:30383237 PMID:35574020 More...
|
|
NCBI chrNW_004936523:7,009,966...7,050,300
Ensembl chrNW_004936523:7,010,068...7,050,468
|
|
|
G
|
Ric3
|
RIC3 acetylcholine receptor chaperone
|
|
ISO
|
ClinVar Annotator: match by term: Retinal dystrophy and obesity | ClinVar Annotator: match by term: TUB-related condition
|
ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:24375934 PMID:25741868 PMID:28492532 PMID:31785789 PMID:32037395 PMID:33057194 PMID:34906470 PMID:36498982 More...
|
|
NCBI chrNW_004936528:9,790,594...9,829,120
Ensembl chrNW_004936528:9,790,463...9,825,777
|
|
G
|
Tub
|
TUB bipartite transcription factor
|
|
ISO
|
ClinVar Annotator: match by term: Retinal dystrophy and obesity | ClinVar Annotator: match by term: TUB-related condition
|
OMIM ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:24375934 PMID:25741868 PMID:28492532 PMID:31785789 PMID:32037395 PMID:33057194 PMID:34906470 PMID:36498982 More...
|
|
NCBI chrNW_004936528:9,829,889...9,912,645
Ensembl chrNW_004936528:9,834,954...9,855,080
|
|
|
G
|
Cyfip1
|
cytoplasmic FMR1 interacting protein 1
|
|
ISO
|
associated with Fragile X Syndrome;mRNA:decreased expression:leukocyte (human)
|
RGD |
PMID:17435464 |
RGD:11558012 |
NCBI chrNW_004936471:38,264,455...38,331,995
Ensembl chrNW_004936471:38,267,703...38,332,218
|
|
G
|
Magel2
|
MAGE family member L2
|
|
ISO
|
ClinVar Annotator: match by term: MAGEL2-related condition | ClinVar Annotator: match by term: Schaaf-Yang syndrome
|
OMIM ClinVar |
PMID:24076603 PMID:24088041 PMID:25326635 PMID:25473036 PMID:25590979 PMID:25741868 PMID:26365340 PMID:26633545 PMID:27195816 PMID:27632685 PMID:28281571 PMID:28492532 PMID:29359444 PMID:29581464 PMID:29599419 PMID:29660409 PMID:30302899 PMID:31152388 PMID:31397880 PMID:31680349 PMID:31791363 PMID:32021601 PMID:32860008 PMID:33371171 More...
|
|
NCBI chrNW_004936805:882,296...886,442
Ensembl chrNW_004936805:882,273...886,475
|
|
G
|
Sim1
|
SIM bHLH transcription factor 1
|
|
ISO
|
ClinVar Annotator: match by term: Schaaf-Yang syndrome
|
ClinVar |
|
|
NCBI chrNW_004936651:1,841,040...1,911,944
Ensembl chrNW_004936651:1,841,054...1,911,944
|
|
|
G
|
Gfap
|
glial fibrillary acidic protein
|
|
ISO
|
ClinVar Annotator: match by term: Spastic paraplegia, intellectual disability, nystagmus, and obesity
|
ClinVar |
PMID:11138011 PMID:11567214 PMID:15732097 PMID:17065456 PMID:17383133 PMID:17894839 PMID:21533827 PMID:23432455 PMID:24427505 PMID:25741868 PMID:26486469 More...
|
|
NCBI chrNW_004936541:1,265,915...1,275,232
Ensembl chrNW_004936541:1,265,436...1,275,296
|
|
G
|
Kidins220
|
kinase D interacting substrate 220
|
|
ISO
|
ClinVar Annotator: match by term: Spastic paraplegia, intellectual disability, nystagmus, and obesity
|
OMIM ClinVar |
PMID:9536098 PMID:17576681 PMID:25741868 PMID:27005418 PMID:28492532 PMID:28934391 PMID:29667355 PMID:32909676 More...
|
|
NCBI chrNW_004936532:5,270,338...5,368,160
Ensembl chrNW_004936532:5,272,149...5,362,814
|
|
G
|
Lrba
|
LPS responsive beige-like anchor protein
|
|
ISO
|
ClinVar Annotator: match by term: Spastic paraplegia, intellectual disability, nystagmus, and obesity
|
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936689:429,907...1,080,226
Ensembl chrNW_004936689:430,293...1,079,838
|
|
|
G
|
Agrp
|
agouti related neuropeptide
|
|
ISO
|
ClinVar Annotator: match by term: Leanness, inherited
|
ClinVar |
PMID:11602360 PMID:12213871 PMID:15054840 PMID:25741868 |
|
NCBI chrNW_004936475:17,927,991...17,929,377
Ensembl chrNW_004936475:17,927,985...17,937,147
|
|
G
|
Igf1
|
insulin like growth factor 1
|
|
ISO
|
protein:decreased expression:serum:
|
RGD |
PMID:10578024 |
RGD:10045866 |
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
|
G
|
Abcg1
|
ATP binding cassette subfamily G member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17194745 |
|
NCBI chrNW_004936500:1,620,763...1,678,561
Ensembl chrNW_004936500:1,620,641...1,678,607
|
|
G
|
Acadm
|
acyl-CoA dehydrogenase medium chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936571:2,761,254...2,797,045
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12860835 |
|
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27020609 PMID:30813227 PMID:31306034 PMID:36029422 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G
|
Anxa2
|
annexin A2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936471:21,274,112...21,329,286
Ensembl chrNW_004936471:21,274,027...21,329,503
|
|
G
|
Anxa5
|
annexin A5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936662:926,302...959,964
Ensembl chrNW_004936662:925,940...939,451
|
|
G
|
Apbb2
|
amyloid beta precursor protein binding family B member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936482:8,166,380...8,489,489
|
|
G
|
App
|
amyloid beta precursor protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936640:1,549,977...1,787,436
Ensembl chrNW_004936640:1,550,167...1,787,286
|
|
G
|
Arhgef12
|
Rho guanine nucleotide exchange factor 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936542:5,197,100...5,335,338
Ensembl chrNW_004936542:5,262,217...5,331,426
|
|
G
|
Asip
|
agouti signaling protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:37769864 |
|
NCBI chrNW_004936561:6,341,667...6,346,440
Ensembl chrNW_004936561:6,341,623...6,346,458
|
|
G
|
Bcat1
|
branched chain amino acid transaminase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936548:2,385,756...2,454,423
|
|
G
|
Calm1
|
calmodulin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936488:17,580,425...17,588,480
Ensembl chrNW_004936488:17,580,454...17,588,507
|
|
G
|
Cav1
|
caveolin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936589:2,504,235...2,536,778
Ensembl chrNW_004936589:2,504,224...2,537,170
|
|
G
|
Cavin1
|
caveolae associated protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936490:17,197,585...17,200,041
|
|
G
|
Cd36
|
CD36 molecule (CD36 blood group)
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936810:791,823...838,303
Ensembl chrNW_004936810:758,182...838,365
|
|
G
|
Clic4
|
chloride intracellular channel 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936474:9,664,872...9,711,036
|
|
G
|
Cnr1
|
cannabinoid receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20107430 |
|
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
|
|
G
|
Copg2
|
COPI coat complex subunit gamma 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936579:4,648,006...4,782,815
Ensembl chrNW_004936579:4,647,946...4,785,336
|
|
G
|
Cpe
|
carboxypeptidase E
|
|
ISO
|
associated with kidney transplant;DNA:SNP:CDS (rs1946816) (human)
|
RGD |
PMID:26406335 |
RGD:405650673 |
NCBI chrNW_004936555:531,842...641,905
Ensembl chrNW_004936555:530,307...641,905
|
|
G
|
Ctsd
|
cathepsin D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936816:680,798...690,959
Ensembl chrNW_004936816:680,798...691,039
|
|
G
|
Ddo
|
D-aspartate oxidase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16525061 |
|
NCBI chrNW_004936564:6,280,890...6,299,838
Ensembl chrNW_004936564:6,280,014...6,299,856
|
|
G
|
Dnah11
|
dynein axonemal heavy chain 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936546:7,370,180...7,681,835
Ensembl chrNW_004936546:7,370,381...7,681,020
|
|
G
|
Drd2
|
dopamine receptor D2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20375926 |
|
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G
|
Dync1li2
|
dynein cytoplasmic 1 light intermediate chain 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936475:17,012,911...17,036,290
Ensembl chrNW_004936475:17,012,832...17,036,392
|
|
G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30971429 |
|
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G
|
Fbln2
|
fibulin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936898:112,687...148,686
|
|
G
|
Fbxo21
|
F-box protein 21
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936558:5,316,306...5,355,442
Ensembl chrNW_004936558:5,316,330...5,356,689
|
|
G
|
Fez2
|
fasciculation and elongation protein zeta 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936663:1,576,311...1,637,363
Ensembl chrNW_004936663:1,576,269...1,623,296
|
|
G
|
Fgf1
|
fibroblast growth factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936504:11,590,687...11,684,410
Ensembl chrNW_004936504:11,590,637...11,685,194
|
|
G
|
Fggy
|
FGGY carbohydrate kinase domain containing
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29220483 |
|
NCBI chrNW_004936522:2,196,664...2,589,311
Ensembl chrNW_004936522:2,196,015...2,589,296
|
|
G
|
Fstl1
|
follistatin like 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936536:7,132,369...7,186,951
Ensembl chrNW_004936536:7,126,966...7,187,269
|
|
G
|
Fto
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25322899 |
|
NCBI chrNW_004936475:6,321,725...6,689,410
Ensembl chrNW_004936475:6,321,711...6,689,588
|
|
G
|
Gdf15
|
growth differentiation factor 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936596:2,854,620...2,857,018
Ensembl chrNW_004936596:2,854,841...2,857,111
|
|
G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16493877 PMID:33301842 |
|
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G
|
Gnb3
|
G protein subunit beta 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16141801 |
|
NCBI chrNW_004936709:970,169...977,059
Ensembl chrNW_004936709:970,172...976,863
|
|
G
|
Gpr55
|
G protein-coupled receptor 55
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30148676 |
|
NCBI chrNW_004936525:5,869,416...5,888,789
Ensembl chrNW_004936525:5,869,416...5,888,789
|
|
G
|
Grb14
|
growth factor receptor bound protein 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936469:14,628,478...14,742,327
Ensembl chrNW_004936469:14,628,546...14,743,916
|
|
G
|
Gsn
|
gelsolin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936487:9,749,755...9,802,787
Ensembl chrNW_004936487:9,764,944...9,802,841
|
|
G
|
Hcrt
|
hypocretin neuropeptide precursor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27071101 |
|
NCBI chrNW_004936490:17,007,001...17,008,363
Ensembl chrNW_004936490:17,006,997...17,008,369
|
|
G
|
Hdhd2
|
haloacid dehalogenase like hydrolase domain containing 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936983:77,844...119,137
Ensembl chrNW_004936983:77,858...119,108
|
|
G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19434072 PMID:19997080 |
|
NCBI chrNW_004936499:1,002,083...1,109,446
Ensembl chrNW_004936499:1,004,732...1,109,377
|
|
G
|
Hycc2
|
hyccin PI4KA lipid kinase complex subunit 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936726:261,530...338,105
Ensembl chrNW_004936726:268,873...338,048
|
|
G
|
Ido1
|
indoleamine 2,3-dioxygenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27020609 |
|
NCBI chrNW_004936843:658,058...672,662
Ensembl chrNW_004936843:657,979...672,700
|
|
G
|
Igfbp5
|
insulin like growth factor binding protein 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936586:647,553...666,595
Ensembl chrNW_004936586:647,493...666,621
|
|
G
|
Il7
|
interleukin 7
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:20376352 |
|
NCBI chrNW_004936702:110,625...162,957
Ensembl chrNW_004936702:111,211...162,322
|
|
G
|
Insig2
|
insulin induced gene 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18195716 PMID:20373477 |
|
NCBI chrNW_004936469:52,120,063...52,140,646
Ensembl chrNW_004936469:52,117,733...52,140,765
|
|
G
|
Iqgap1
|
IQ motif containing GTPase activating protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936483:16,489,127...16,594,712
Ensembl chrNW_004936483:16,489,133...16,594,783
|
|
G
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27605626 |
|
NCBI chrNW_004936521:2,000,113...2,706,010
Ensembl chrNW_004936521:2,000,109...2,705,365
|
|
G
|
Kcnmb1
|
potassium calcium-activated channel subfamily M regulatory beta subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27288421 |
|
NCBI chrNW_004936609:4,451,526...4,458,665
Ensembl chrNW_004936609:4,451,492...4,458,712
|
|
G
|
Large1
|
LARGE xylosyl- and glucuronyltransferase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936492:6,160,979...6,657,491
Ensembl chrNW_004936492:6,289,517...6,659,465
|
|
G
|
Lbp
|
lipopolysaccharide binding protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936561:3,017,471...3,035,481
Ensembl chrNW_004936561:3,016,926...3,035,552
|
|
G
|
Lep
|
leptin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:15070752 PMID:15809509 PMID:17502770 PMID:19716478 PMID:21561152 PMID:25086370 PMID:27472835 PMID:29967158 PMID:38906502 More...
|
|
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Lepr
|
leptin receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15809509 PMID:29143802 PMID:29988851 PMID:36066211 PMID:36880193 PMID:39059604 More...
|
|
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
|
|
G
|
LOC101961588
|
cytochrome P450 2D17
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19997080 |
|
NCBI chrNW_004936718:153,340...157,966
|
|
G
|
LOC101968921
|
angiotensin-converting enzyme
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25322899 |
|
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G
|
LOC101969021
|
somatotropin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17372281 |
|
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G
|
Lpgat1
|
lysophosphatidylglycerol acyltransferase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936557:1,520,692...1,627,479
Ensembl chrNW_004936557:1,556,526...1,621,456
|
|
G
|
Map4
|
microtubule associated protein 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936596:1,455,705...1,546,007
|
|
G
|
Mapre1
|
microtubule associated protein RP/EB family member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936485:19,577,859...19,608,036
|
|
G
|
Mapt
|
microtubule associated protein tau
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29203278 |
|
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G
|
Me1
|
malic enzyme 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936510:7,425,983...7,571,090
Ensembl chrNW_004936510:7,426,347...7,571,553
|
|
G
|
Mest
|
mesoderm specific transcript
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936579:4,782,761...4,800,971
|
|
G
|
Metrnl
|
meteorin like, glial cell differentiation regulator
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:30213948 |
|
NCBI chrNW_004936923:423,618...442,261
Ensembl chrNW_004936923:423,615...442,327
|
|
G
|
Mmp12
|
matrix metallopeptidase 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936551:5,107,567...5,117,843
Ensembl chrNW_004936551:5,106,285...5,117,843
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25322899 |
|
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
|
|
G
|
Mprip
|
myosin phosphatase Rho interacting protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936741:757,618...864,051
Ensembl chrNW_004936741:757,639...858,654
|
|
G
|
Mrtfa
|
myocardin related transcription factor A
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:33779332 |
|
NCBI chrNW_004936492:1,234,025...1,384,838
Ensembl chrNW_004936492:1,282,674...1,383,696
|
|
G
|
Myo10
|
myosin X
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936480:19,280,723...19,443,267
Ensembl chrNW_004936480:19,282,085...19,443,271
|
|
G
|
Myo1b
|
myosin IB
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936506:6,832,132...7,004,262
Ensembl chrNW_004936506:6,832,670...7,004,273
|
|
G
|
Ndc1
|
NDC1 transmembrane nucleoporin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936522:7,303,366...7,353,700
Ensembl chrNW_004936522:7,302,776...7,355,794
|
|
G
|
Ndufb9
|
NADH:ubiquinone oxidoreductase subunit B9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936470:23,118,162...23,123,648
Ensembl chrNW_004936470:23,118,164...23,123,749
|
|
G
|
Nek7
|
NIMA related kinase 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936567:5,685,619...5,815,094
Ensembl chrNW_004936567:5,685,125...5,808,499
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35204086 |
|
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G
|
Nid1
|
nidogen 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936484:16,621,666...16,691,304
Ensembl chrNW_004936484:16,621,601...16,691,313
|
|
G
|
Npr3
|
natriuretic peptide receptor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936518:8,093,111...8,158,862
Ensembl chrNW_004936518:8,093,561...8,158,868
|
|
G
|
Nus1
|
NUS1 dehydrodolichyl diphosphate synthase subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33812996 |
|
NCBI chrNW_004936658:695,431...718,891
Ensembl chrNW_004936658:695,609...718,746
|
|
G
|
Osbpl8
|
oxysterol binding protein like 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936568:4,646,409...4,806,283
Ensembl chrNW_004936568:4,646,426...4,806,308
|
|
G
|
Palld
|
palladin, cytoskeletal associated protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936516:786,358...1,151,910
Ensembl chrNW_004936516:802,484...1,151,801
|
|
G
|
Palm2akap2
|
PALM2 and AKAP2 fusion
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936559:2,860,595...3,194,846
Ensembl chrNW_004936559:2,860,147...2,997,627
|
|
G
|
Pcyox1
|
prenylcysteine oxidase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936491:14,422,683...14,439,599
Ensembl chrNW_004936491:14,422,638...14,439,569
|
|
G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936566:3,924,013...3,951,052
Ensembl chrNW_004936566:3,923,934...3,951,073
|
|
G
|
Pomc
|
proopiomelanocortin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:4367732 PMID:6143199 |
|
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
G
|
Ppard
|
peroxisome proliferator activated receptor delta
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:20176998 |
|
NCBI chrNW_004936476:23,799,285...23,886,606
Ensembl chrNW_004936476:23,811,641...23,828,176
|
|
G
|
Prkd3
|
protein kinase D3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936663:979,136...1,047,633
Ensembl chrNW_004936663:979,130...1,049,427
|
|
G
|
Prps1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936499:7,114,838...7,136,468
Ensembl chrNW_004936499:7,115,780...7,136,449
|
|
G
|
Pycard
|
PYD and CARD domain containing
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:24508291 |
|
NCBI chrNW_004936501:13,550,702...13,552,774
Ensembl chrNW_004936501:13,550,679...13,552,805
|
|
G
|
Ramp2
|
receptor activity modifying protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936490:17,479,899...17,481,788
Ensembl chrNW_004936490:17,479,650...17,482,716
|
|
G
|
Rfng
|
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936594:5,554,948...5,557,981
|
|
G
|
Rpl28
|
ribosomal protein L28
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936886:633,303...635,888
Ensembl chrNW_004936886:633,050...637,193
|
|
G
|
Rps28
|
ribosomal protein S28
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936588:5,154,614...5,155,522
Ensembl chrNW_004936588:5,154,615...5,155,522
|
|
G
|
Rps8
|
ribosomal protein S8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936474:26,006,226...26,008,824
Ensembl chrNW_004936474:26,006,217...26,009,505
|
|
G
|
Ryk
|
receptor like tyrosine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936529:7,273,070...7,344,372
Ensembl chrNW_004936529:7,273,097...7,332,468
|
|
G
|
Sepsecs
|
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936477:4,335,945...4,368,117
Ensembl chrNW_004936477:4,336,059...4,368,901
|
|
G
|
Sestd1
|
SEC14 and spectrin domain containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936509:8,225,252...8,303,257
Ensembl chrNW_004936509:8,225,245...8,303,279
|
|
G
|
Setbp1
|
SET binding protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936517:1,616,169...1,798,002
Ensembl chrNW_004936517:1,616,169...1,970,398
|
|
G
|
Sipa1l1
|
signal induced proliferation associated 1 like 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936488:819,503...1,175,043
Ensembl chrNW_004936488:860,129...1,175,051
|
|
G
|
Slc6a3
|
solute carrier family 6 member 3
|
|
ISO
|
associated with kidney transplant;DNA:SNP:CDS (rs6347) (human)
|
RGD |
PMID:26406335 |
RGD:405650673 |
NCBI chrNW_004936815:359,775...400,690
Ensembl chrNW_004936815:359,775...400,690
|
|
G
|
Slu7
|
SLU7 homolog, splicing factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936515:3,172,962...3,179,915
Ensembl chrNW_004936515:3,168,838...3,178,588
|
|
G
|
Sorbs2
|
sorbin and SH3 domain containing 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936554:3,593,607...3,797,324
Ensembl chrNW_004936554:3,593,512...3,797,555
|
|
G
|
Sparc
|
secreted protein acidic and cysteine rich
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936515:11,026,156...11,046,812
Ensembl chrNW_004936515:11,025,724...11,046,849
|
|
G
|
Sptbn1
|
spectrin beta, non-erythrocytic 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936491:920,830...1,108,374
Ensembl chrNW_004936491:956,986...1,108,640
|
|
G
|
Sri
|
sorcin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:33930463 |
|
NCBI chrNW_004936763:715,884...728,548
Ensembl chrNW_004936763:710,777...730,276
|
|
G
|
Stim2
|
stromal interaction molecule 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936477:2,824,720...2,950,069
Ensembl chrNW_004936477:2,825,676...2,928,269
|
|
G
|
Sts
|
steroid sulfatase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:24497646 |
|
NCBI chrNW_004936644:1,328,327...1,395,856
Ensembl chrNW_004936644:1,325,713...1,395,923
|
|
G
|
Tacr1
|
tachykinin receptor 1
|
|
ISO
|
|
RGD |
PMID:21467195 |
RGD:5147668 |
NCBI chrNW_004936556:1,266,621...1,421,271
Ensembl chrNW_004936556:1,266,613...1,421,275
|
|
G
|
Tert
|
telomerase reverse transcriptase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:39265716 |
|
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20521320 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G
|
Tpm4
|
tropomyosin 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936596:4,406,301...4,423,775
Ensembl chrNW_004936596:4,406,283...4,418,932
|
|
G
|
Tsen2
|
tRNA splicing endonuclease subunit 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936602:1,163,927...1,195,163
Ensembl chrNW_004936602:1,164,227...1,195,221
|
|
G
|
Vdr
|
vitamin D receptor
|
|
ISO
|
|
RGD |
PMID:30905785 |
RGD:14402029 |
NCBI chrNW_004936512:5,741,836...5,800,999
Ensembl chrNW_004936512:5,740,748...5,801,109
|
|
G
|
Vim
|
vimentin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936520:10,051,692...10,059,324
Ensembl chrNW_004936520:10,052,012...10,059,182
|
|
G
|
Vps13d
|
vacuolar protein sorting 13 homolog D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936474:955,081...1,194,200
Ensembl chrNW_004936474:955,040...1,195,859
|
|
G
|
Zdhhc2
|
zDHHC palmitoyltransferase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936573:6,216,084...6,280,142
Ensembl chrNW_004936573:6,216,078...6,282,052
|
|
G
|
Zwilch
|
zwilch kinetochore protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19030233 |
|
NCBI chrNW_004936471:26,642,321...26,674,475
Ensembl chrNW_004936471:26,642,352...26,677,684
|
|
|
G
|
Ace2
|
angiotensin converting enzyme 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33007385 |
|
NCBI chrNW_004936470:4,964,526...5,011,808
Ensembl chrNW_004936470:4,965,332...5,011,702
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18230824 |
|
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G
|
Adora2a
|
adenosine A2a receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26526685 |
|
NCBI chrNW_004936619:597,970...618,564
Ensembl chrNW_004936619:608,441...616,779
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:34848246 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G
|
Alpk1
|
alpha kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27542954 |
|
NCBI chrNW_004936563:3,233,913...3,296,671
Ensembl chrNW_004936563:3,235,181...3,296,257
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24431404 PMID:35362542 |
|
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G
|
Atg5
|
autophagy related 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26568842 |
|
NCBI chrNW_004936564:2,759,085...2,885,394
Ensembl chrNW_004936564:2,758,598...2,885,420
|
|
G
|
Atg7
|
autophagy related 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26568842 |
|
NCBI chrNW_004936602:1,938,720...2,179,239
Ensembl chrNW_004936602:1,935,507...2,179,256
|
|
G
|
Atp7b
|
ATPase copper transporting beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:38761876 |
|
NCBI chrNW_004936565:4,694,294...4,763,661
Ensembl chrNW_004936565:4,694,281...4,763,773
|
|
G
|
Cd14
|
CD14 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28411859 |
|
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
|
|
G
|
Cln6
|
CLN6 transmembrane ER protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23789114 |
|
NCBI chrNW_004936471:28,069,058...28,084,607
Ensembl chrNW_004936471:28,070,462...28,084,648
|
|
G
|
Cnr1
|
cannabinoid receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31570772 PMID:32365865 |
|
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
|
|
G
|
Cnr2
|
cannabinoid receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:27611972 PMID:30102254 |
|
NCBI chrNW_004936474:9,019,044...9,020,110
Ensembl chrNW_004936474:9,019,067...9,020,110
|
|
G
|
Col2a1
|
collagen type II alpha 1 chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26070417 PMID:29908986 |
|
NCBI chrNW_004936512:5,861,933...5,894,898
Ensembl chrNW_004936512:5,861,933...5,892,853
|
|
G
|
Crh
|
corticotropin releasing hormone
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8986836 |
|
NCBI chrNW_004936496:7,759,656...7,761,555
Ensembl chrNW_004936496:7,760,532...7,761,122
|
|
G
|
Csf2
|
colony stimulating factor 2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:38348709 |
|
NCBI chrNW_004936647:3,081,896...3,083,864
Ensembl chrNW_004936647:3,081,896...3,083,864
|
|
G
|
Epo
|
erythropoietin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:8260696 |
|
NCBI chrNW_004936543:742,722...745,332
Ensembl chrNW_004936543:743,537...745,343
|
|
G
|
Fst
|
follistatin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:33034787 |
|
NCBI chrNW_004936480:13,990,967...13,997,248
Ensembl chrNW_004936480:13,990,929...13,997,248
|
|
G
|
Gnrh1
|
gonadotropin releasing hormone 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:24431404 |
|
NCBI chrNW_004936757:1,282,185...1,285,804
Ensembl chrNW_004936757:1,282,185...1,285,832
|
|
G
|
Hdac3
|
histone deacetylase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34973135 |
|
NCBI chrNW_004936504:12,530,546...12,546,556
Ensembl chrNW_004936504:12,530,528...12,546,556
|
|
G
|
Igf2bp1
|
insulin like growth factor 2 mRNA binding protein 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:38866309 |
|
NCBI chrNW_004936490:12,430,343...12,468,794
Ensembl chrNW_004936490:12,430,008...12,469,083
|
|
G
|
Il10
|
interleukin 10
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:24314293 PMID:27580383 |
|
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G
|
Ins
|
insulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22940631 PMID:29211853 |
|
NCBI chrNW_004936816:1,002,137...1,003,357
Ensembl chrNW_004936816:1,002,137...1,003,357
|
|
G
|
Lep
|
leptin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27417254 |
|
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G
|
Lif
|
LIF interleukin 6 family cytokine
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23291613 |
|
NCBI chrNW_004936904:410,043...413,256
Ensembl chrNW_004936904:410,043...413,257
|
|
G
|
LOC101968921
|
angiotensin-converting enzyme
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:33007385 |
|
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G
|
LOC101969021
|
somatotropin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:7711889 |
|
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G
|
LOC120889510
|
insulin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:29682576 PMID:34352274 |
|
|
|
G
|
Lrrk2
|
leucine rich repeat kinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31174552 |
|
NCBI chrNW_004936607:628,469...761,117
Ensembl chrNW_004936607:626,991...761,123
|
|
G
|
Ltf
|
lactotransferrin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:24587916 |
|
NCBI chrNW_004936596:344,287...373,788
Ensembl chrNW_004936596:344,274...373,952
|
|
G
|
Mapt
|
microtubule associated protein tau
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24556215 |
|
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G
|
Nppc
|
natriuretic peptide C
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:37352108 |
|
NCBI chrNW_004936525:5,092,675...5,099,344
Ensembl chrNW_004936525:5,092,635...5,099,331
|
|
G
|
Npy
|
neuropeptide Y
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25825358 |
|
NCBI chrNW_004936478:1,289,437...1,296,819
Ensembl chrNW_004936478:1,290,505...1,296,874
|
|
G
|
Otud7b
|
OTU deubiquitinase 7B
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:36639017 |
|
NCBI chrNW_004936580:278,263...300,278
Ensembl chrNW_004936580:278,257...338,526
|
|
G
|
Pomc
|
proopiomelanocortin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:1459535 PMID:11193135 |
|
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
G
|
Sirt4
|
sirtuin 4
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:35134463 |
|
NCBI chrNW_004936668:628,875...633,425
Ensembl chrNW_004936668:626,938...633,466
|
|
G
|
Snca
|
synuclein alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:32278788 |
|
NCBI chrNW_004936685:2,077,017...2,175,298
Ensembl chrNW_004936685:2,076,651...2,175,338
|
|
G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24163136 PMID:29434186 |
|
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
|
|
G
|
Tes
|
testin LIM domain protein
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:39237074 |
|
NCBI chrNW_004936589:2,755,905...2,796,244
Ensembl chrNW_004936589:2,755,903...2,796,308
|
|
G
|
Tlr3
|
toll like receptor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28726298 |
|
NCBI chrNW_004936554:3,370,766...3,388,125
Ensembl chrNW_004936554:3,369,469...3,385,907
|
|
G
|
Tlr4
|
toll like receptor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31442584 |
|
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G
|
Tsc22d3
|
TSC22 domain family member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22556341 |
|
NCBI chrNW_004936499:6,977,924...7,044,173
Ensembl chrNW_004936499:6,977,686...7,045,294
|
|
|
G
|
Hdac8
|
histone deacetylase 8
|
|
ISO
|
DNA:snp:intron:c.164+5G>A (human)
|
RGD |
PMID:22889856 |
RGD:13208817 |
NCBI chrNW_004936762:1,425,337...1,652,058
Ensembl chrNW_004936762:1,425,335...1,652,063
|
|
G
|
Las1l
|
LAS1 like ribosome biogenesis factor
|
|
ISO
|
ClinVar Annotator: match by term: LAS1L-related condition | ClinVar Annotator: match by term: Wilson-Turner syndrome
|
OMIM ClinVar |
PMID:1746601 PMID:24647030 PMID:25644381 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936635:2,560,586...2,580,309
Ensembl chrNW_004936635:2,560,471...2,581,785
|
|
G
|
Zc3h12b
|
zinc finger CCCH-type containing 12B
|
|
ISO
|
ClinVar Annotator: match by term: Wilson-Turner syndrome
|
ClinVar |
|
|
NCBI chrNW_004936635:2,580,693...2,690,297
Ensembl chrNW_004936635:2,588,510...2,641,616
|
|